JPH024576B2 - - Google Patents
Info
- Publication number
- JPH024576B2 JPH024576B2 JP54132510A JP13251079A JPH024576B2 JP H024576 B2 JPH024576 B2 JP H024576B2 JP 54132510 A JP54132510 A JP 54132510A JP 13251079 A JP13251079 A JP 13251079A JP H024576 B2 JPH024576 B2 JP H024576B2
- Authority
- JP
- Japan
- Prior art keywords
- microparticles
- drug
- cervix
- progesterone
- uterus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims description 141
- 239000003814 drug Substances 0.000 claims description 74
- 229940079593 drug Drugs 0.000 claims description 67
- 239000000427 antigen Substances 0.000 claims description 61
- 108091007433 antigens Proteins 0.000 claims description 61
- 102000036639 antigens Human genes 0.000 claims description 61
- 239000003433 contraceptive agent Substances 0.000 claims description 56
- 239000011159 matrix material Substances 0.000 claims description 53
- 229940088597 hormone Drugs 0.000 claims description 51
- 239000005556 hormone Substances 0.000 claims description 51
- 230000002254 contraceptive effect Effects 0.000 claims description 40
- 230000027758 ovulation cycle Effects 0.000 claims description 37
- 229940011871 estrogen Drugs 0.000 claims description 24
- 239000000262 estrogen Substances 0.000 claims description 24
- 239000000583 progesterone congener Substances 0.000 claims description 22
- 230000001105 regulatory effect Effects 0.000 claims description 10
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 8
- 239000004626 polylactic acid Substances 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 229920000954 Polyglycolide Polymers 0.000 claims description 3
- 239000004633 polyglycolic acid Substances 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Natural products OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims 1
- 210000004013 groin Anatomy 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 239000011859 microparticle Substances 0.000 description 135
- 210000003679 cervix uteri Anatomy 0.000 description 66
- 239000000186 progesterone Substances 0.000 description 60
- 229960003387 progesterone Drugs 0.000 description 60
- 210000004291 uterus Anatomy 0.000 description 53
- 210000001215 vagina Anatomy 0.000 description 46
- 238000000034 method Methods 0.000 description 44
- 239000003094 microcapsule Substances 0.000 description 30
- 230000000694 effects Effects 0.000 description 26
- 229940124558 contraceptive agent Drugs 0.000 description 24
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 23
- 229960005309 estradiol Drugs 0.000 description 22
- 229930182833 estradiol Natural products 0.000 description 22
- 241000282520 Papio Species 0.000 description 19
- 210000000056 organ Anatomy 0.000 description 18
- 230000001850 reproductive effect Effects 0.000 description 18
- 239000002245 particle Substances 0.000 description 17
- 241001506137 Rapa Species 0.000 description 16
- 230000003053 immunization Effects 0.000 description 16
- 239000010419 fine particle Substances 0.000 description 14
- 238000002649 immunization Methods 0.000 description 14
- 230000007723 transport mechanism Effects 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 11
- 210000004696 endometrium Anatomy 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- 210000005000 reproductive tract Anatomy 0.000 description 9
- 230000009885 systemic effect Effects 0.000 description 9
- 238000012384 transportation and delivery Methods 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000000981 epithelium Anatomy 0.000 description 8
- 210000000110 microvilli Anatomy 0.000 description 8
- 210000000582 semen Anatomy 0.000 description 8
- 230000008602 contraction Effects 0.000 description 7
- 210000004907 gland Anatomy 0.000 description 7
- 230000003054 hormonal effect Effects 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 230000003442 weekly effect Effects 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- -1 antibodies Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 230000002357 endometrial effect Effects 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 210000003756 cervix mucus Anatomy 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000037020 contractile activity Effects 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 238000010255 intramuscular injection Methods 0.000 description 5
- 239000007927 intramuscular injection Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000003821 menstrual periods Effects 0.000 description 5
- 230000003248 secreting effect Effects 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241001504519 Papio ursinus Species 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000003111 delayed effect Effects 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 210000005002 female reproductive tract Anatomy 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000016087 ovulation Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000036765 blood level Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000001000 micrograph Methods 0.000 description 3
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 3
- 230000002611 ovarian Effects 0.000 description 3
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000008177 pharmaceutical agent Substances 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 241000589876 Campylobacter Species 0.000 description 2
- LVHOURKCKUYIGK-RGUJTQARSA-N Dimethisterone Chemical compound C1([C@@H](C)C2)=CC(=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](C#CC)(O)[C@@]2(C)CC1 LVHOURKCKUYIGK-RGUJTQARSA-N 0.000 description 2
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 241000606790 Haemophilus Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 241000224526 Trichomonas Species 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000002060 circadian Effects 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 229950006690 dimethisterone Drugs 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 229960002568 ethinylestradiol Drugs 0.000 description 2
- 229940012028 ethynodiol diacetate Drugs 0.000 description 2
- ONKUMRGIYFNPJW-KIEAKMPYSA-N ethynodiol diacetate Chemical compound C1C[C@]2(C)[C@@](C#C)(OC(C)=O)CC[C@H]2[C@@H]2CCC3=C[C@@H](OC(=O)C)CC[C@@H]3[C@H]21 ONKUMRGIYFNPJW-KIEAKMPYSA-N 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 2
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- IMSSROKUHAOUJS-MJCUULBUSA-N mestranol Chemical compound C1C[C@]2(C)[C@@](C#C)(O)CC[C@H]2[C@@H]2CCC3=CC(OC)=CC=C3[C@H]21 IMSSROKUHAOUJS-MJCUULBUSA-N 0.000 description 2
- 229960001390 mestranol Drugs 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229940053934 norethindrone Drugs 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000027272 reproductive process Effects 0.000 description 2
- 238000004626 scanning electron microscopy Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 210000003934 vacuole Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 108090000107 Acrosin Proteins 0.000 description 1
- 241000606750 Actinobacillus Species 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000223836 Babesia Species 0.000 description 1
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- 241000589567 Brucella abortus Species 0.000 description 1
- 241001509299 Brucella canis Species 0.000 description 1
- 241001148106 Brucella melitensis Species 0.000 description 1
- 241001148111 Brucella suis Species 0.000 description 1
- 241001647378 Chlamydia psittaci Species 0.000 description 1
- QMBJSIBWORFWQT-DFXBJWIESA-N Chlormadinone acetate Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 QMBJSIBWORFWQT-DFXBJWIESA-N 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- QBUKXFWXPPPZAX-UHFFFAOYSA-N ClC1=CC=C(C=2CCCC12)O.ClC1(CCC2=CC=CC=C12)O Chemical compound ClC1=CC=C(C=2CCCC12)O.ClC1(CCC2=CC=CC=C12)O QBUKXFWXPPPZAX-UHFFFAOYSA-N 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000701081 Equid alphaherpesvirus 1 Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010018693 Granuloma inguinale Diseases 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000009066 Hyaluronoglucosaminidase Human genes 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000012695 Interfacial polymerization Methods 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- YNVGQYHLRCDXFQ-XGXHKTLJSA-N Lynestrenol Chemical compound C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 YNVGQYHLRCDXFQ-XGXHKTLJSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- IMONTRJLAWHYGT-ZCPXKWAGSA-N Norethindrone Acetate Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@](C#C)(OC(=O)C)[C@@]1(C)CC2 IMONTRJLAWHYGT-ZCPXKWAGSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 101800000143 Peptide gamma Proteins 0.000 description 1
- 239000000381 Placental Lactogen Substances 0.000 description 1
- 102000004576 Placental Lactogen Human genes 0.000 description 1
- 108010003044 Placental Lactogen Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000158504 Rhodococcus hoagii Species 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000607729 Salmonella enterica subsp. enterica serovar Abortus Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- 239000000219 Sympatholytic Substances 0.000 description 1
- 241000223997 Toxoplasma gondii Species 0.000 description 1
- 241000589886 Treponema Species 0.000 description 1
- 241000186064 Trueperella pyogenes Species 0.000 description 1
- 241000223104 Trypanosoma Species 0.000 description 1
- PVDLDDBZCWVZBX-FTWOUWFXSA-N [(8r,9s,13s,14s,17s)-3-(3-cyclopentylpropanoyloxy)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@H]4OC(=O)CCC1CCCC1)C)CC2=CC=3OC(=O)CCC1CCCC1 PVDLDDBZCWVZBX-FTWOUWFXSA-N 0.000 description 1
- 239000004015 abortifacient agent Substances 0.000 description 1
- 231100000641 abortifacient agent Toxicity 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 201000008680 babesiosis Diseases 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- GLSDDNIVGUGTHY-UHFFFAOYSA-M benzyl-dimethyl-[2-[2-[2-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]azanium;chloride Chemical compound [Cl-].CC(C)(C)CC(C)(C)C1=CC=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 GLSDDNIVGUGTHY-UHFFFAOYSA-M 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 229940056450 brucella abortus Drugs 0.000 description 1
- 229940038698 brucella melitensis Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 229960001616 chlormadinone acetate Drugs 0.000 description 1
- 229960004407 chorionic gonadotrophin Drugs 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000027326 copulation Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000009503 electrostatic coating Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003133 ergot alkaloid Drugs 0.000 description 1
- 239000003687 estradiol congener Substances 0.000 description 1
- 229960001348 estriol Drugs 0.000 description 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- QFXZANXYUCUTQH-UHFFFAOYSA-N ethynol Chemical compound OC#C QFXZANXYUCUTQH-UHFFFAOYSA-N 0.000 description 1
- 210000004996 female reproductive system Anatomy 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 239000003688 hormone derivative Substances 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000010406 interfacial reaction Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960001910 lynestrenol Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960002985 medroxyprogesterone acetate Drugs 0.000 description 1
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 description 1
- 229960004296 megestrol acetate Drugs 0.000 description 1
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229940051921 muramidase Drugs 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960001652 norethindrone acetate Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000011599 ovarian follicle development Effects 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 238000005240 physical vapour deposition Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- RJKFOVLPORLFTN-UHFFFAOYSA-N progesterone acetate Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(=O)C)C1(C)CC2 RJKFOVLPORLFTN-UHFFFAOYSA-N 0.000 description 1
- 229940077150 progesterone and estrogen Drugs 0.000 description 1
- 230000001141 propulsive effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010040400 serum sickness Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001150 spermicidal effect Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000000948 sympatholitic effect Effects 0.000 description 1
- 238000012385 systemic delivery Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000002993 trophoblast Anatomy 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 239000006216 vaginal suppository Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ã女æ§çæ®èåšã®åå®®ããã³ã©ãã管
ãžæ²»çäžããŸãã¯å»åŠäžã®è¬å€ããã³è©²è¬å€ã®æ
äžããããã®æ¹æ³ã«é¢ãããã®ã§ããã åŸæ¥ã女æ§ã®çæ®èåšãåãæ±ãæ¹æ³ãšããŠ
ã¯ãç æ°ãåŠçããããããã³å¥³æ§ã®çæ®é±æã
調æŽããããã«ç 人ã«è¬ç©ã飲çšãããã泚å°ã
ãã®ãäž»ãªæ¹æ³ã§ãã€ãã女æ§çæ®èåšãåŠçœ®ã
ãéãè£ã«çŽæ¥ã«æ²»çå€ãæäžããããšã«ããã
ãã€ãã®æ¹æ³ãç¥ãããŠãããé¿åŠå¹æã®ããã¹
ããã€ããåå®®ã«çŽæ¥éãå±ããããšã«ããéæ
ãããäžã€ã®æè¡ã¯ãè¬çšå éšåå®®è£ å ·ã§ãããš
ããã®ããã²ã¹ãã«ãè£ å ·ã§ããããã®è£ å ·ã«ã€
ããŠã¯ãã¶ãã¢ããŒãã«ããç±³åœç¹èš±ç¬¬3699951
å·ããã³ç¬¬3777015å·ã«èšèŒãããŠãããæ¿å ¥è£
å ·ã®æ¬ ç¹ã¯ãè£ã«ãã®è£ å ·ãå ¥ããããã«ã¯ãç
ç·Žããå€ç§å»ã®æããããªããã°ãªããªãããšã§
ãããåŸã€ãŠãæåãŸãã¯æäœã®ãããªä»ã®è¬å€
ãšåæ§ã«èªåã§æäžã§ããé¿åŠå€ã®æ¹è¯æ¹æ³ã®å¿
èŠã«è¿«ãããŠããã é¿åŠå€ããã€ã¯ãã«ãã»ã«ã®ããã¡ã«ããŠãè£
ã«æ¿å ¥ããããã€ãã®æè¡ãç¥ãããŠããããã
ããã®æè¡ã«ãããŠã¯ããã€ã¯ãã«ãã»ã«ã®åå®®
é ãéããŠã®åå®®ãžã®èŒžéã¯ã§ããªããäŸãã°ã
ç±³åœç¹èš±ç¬¬3921636å·ããã³ç±³åœç¹èš±3918452å·ã§
ã¯ãè¬å€ã¯ãè£ã«æ¿å ¥ãããã¿ã³ãã³äžã§åŸ®ç²å
ãã解æŸãããã ã¶ãã¢ããŒãã«ããç±³åœç¹èš±ç¬¬3699951å·ãã
ã³ç±³åœç¹èš±ç¬¬3777015å·äžã«ç€ºãããæè¡ã«ãã
ãŠã¯ãé¿åŠã®ç®çã§ãåå®®äžã«ããã²ã¹ããã³ã
çŽæ¥è§£æŸããããã«ãã¶ã€ã³ãããå éšåå®®è£ å ·
ã«ã€ããŠè¿°ã¹ãŠãããããããªãããã®è£ å ·ã¯ã
çç©åŠçã«å£åããªããã®ã§ãããåå®®ã«è£ å ¥ã
ãããåå®®ããã¯ããããããå Žåã«çç·Žããå€
ç§å»ã«ããè¡ããªããã°ãªããªããåŸã€ãŠããã®
è£ å ·ã¯ãèªåã§äœ¿çšããããšãã§ããªããšããäº
å®ã«ããå¶éãåããŠããã åæã®ç 究ã§ã¯ãè£ã«æ¿å ¥åŸãåå®®é ãéããŠ
åå®®ãžç§»åãããããªå¯èœãªç²åç¶ç©è³ªã®åéã
調æ»ããããšãè¡ãããããã®å ŽåãççŽ ç²åã®
æµ®éç©ãå«ããã€ããããã®ççŽ ç²åããåå®®é
ã«æœããå ŽåãççŽ ç²åã亀æ¥ã®åŸãåå®®ããå
åããããšãã§ããããšãå€æããŠããã
ïŒAmerskachïŒâSterilitat UndãFrigidtatâ
Muchen MedïŒWchnschr.77ïŒ225ïŒ1930ïŒJ.
Traplã®âheuve Anschauunger uber den Ei
und Samentransport in den Geshlechtsteilen
de FrauâZentralbl Gynak67ïŒ547ïŒ1943ã§ã¯ã
åå®®é ãã€ããã䜿çšããªããŠããã«ãŒãã³ç²å
ã¯ç§»äœããããšã瀺ããççŽ ä»¥å€ã®éèªåæ§ããŸ
ã移äœããããšã蚌æ ç«ãŠããããã«ãŸããR.
Krehbielããã³H.P.Carstensã®âRoentgen
RabbitâAm.J.physiol.125ïŒ571ïŒ1959ã§ã¯ãã
ããã®è£ã«æŸå°ç·é®æãªã€ã«ïŒradioâ
opaqueoilïŒãå ¥ããå Žåãé°éãåºæ¿ãããåŸ
ãŸã§åŠšå®³ãããããšã瀺ãããŠããããŸãä»ã®ç
究è çãããŒã©ãã³äžã®ã°ã©ãã¢ã€ãããã³ææ
ã¯ãåå®®é ãéããŠèŒžéãããªãããšã瀺ããŠã
ãããã®ããŒã¿ã®æå³ãããšããã¯ãç²åã®ç¹æ§
ã茞ééçšã«åœ±é¿ãåãŒããšããããšãšã茞é
ã¯ãçèã®åçž®ã«ããä¿é²ããããšããããšã§ã
ããHartmanã¯ãâHow Do Sperms GetãInto
the uterusïŒâFertil.and Steril ïŒïŒ403ïŒ1957
ã®äžã§ãçæ®ç³»ã«ããã粟åã®èŒžéã«é¢ããŠã茞
éã¯ãäž»ã«ç²åãšå¥³æ§çæ®ç³»ã®çèçµç¹ãšã®åå
ã«ããçããããšã瀺ããŠãããE.S.E.Hafezã
ãã³T.N.Euansã®ç·šéã«ããHarper and RowïŒ
New York 1973 çºè¡ã®G.M.Duncanããã³D.
R.Kalkwarf ã«ããâHuman ReproductionïŒ
Conception and Contraceptionäžã®
âSubstained Release Systems for Fertity
Controlâã«ãããŠãã»ãŒç²Ÿåã®é ã®å€§ããã®é
èªåæ§ç²åã¯ãåå®®é ãéããŠçŽæ¥ã©ãã管ã«ç§»
äœãããšããããšãå®éšã«ããçµè«ä»ããããã
ããªããããã®è«æã§ã¯ãïŒã1400ÎŒã®å€§ããç¯
å²ã®ã»ã«ããŒã¹ã¢ã»ããŒãããã¬ãŒããããªãã
ãã²ã¹ããã³å«æãã€ã¯ãã«ãã»ã«ã¯ãåå®®é ã
éããŠåå®®ã«ç§»äœããã«ãéã®æ¹åã«èŒžéããã
ããšã瀺ããŠãããåŸã€ãŠãã®æç®ã§ã¯ã5ÎŒã
ã倧ããªãã€ã¯ãã«ãã»ã«ã¯ã女æ§çæ®åšã®å éš
ã«ç§»äœããªãããšãæ確ã«ç€ºåããŠããã åŸã€ãŠãæ¬çºæã®äžã€ã®ç®çã¯ãå»è¬ããã³æ²»
çå€ãè£ã«å±éšçã«æäžããããšãã§ãã女æ§ç
æ®èåšãæ²»çããããåå®®é ãéããŠåå®®ã®äžã«
éãããšã®ã§ããè¬å€ãšãã®æ¹æ³ãæäŸããããš
ã«ããã ããã«æ¬çºæã®ä»ã®ç®çã¯ãè£ã«å ¥ããå Žåã
çæ®èåšã®èªç¶ã®èŒžéæ©æ§ã«ãããåå®®é ãéã
ãŠåå®®ã«éãããšã®ã§ããè¬å€ãå«æãã埮ç²å
ç¶è¬å€ãæäŸããããšã«ããã ç°¡åã«è¿°ã¹ãã°æ¬çºæã®ãããã®ç®çããã³ä»
ã®ç®çã¯ãè¬å€ãå«æããŠãªãç¹å®ã®åŸ®ç²åç¶è¬
å€ãè£ã«å ¥ããå éšåšç®¡ã®èªç¶ã®èŒžéæ©æ§ã«ã
ãããã®åŸ®ç²åãåå®®é ãéããŠåå®®ã«éã¶ããš
ã«ããã女æ§çæ®èåšãžã®è¬å€ã®éæ¬ãå¯èœã«ã
ãããšã«ããéæã§ããã æ¬çºæã®æ倧ã®ç®çã¯ãå°ããšãïŒçš®ã®è¬å€ã
æããŠãªã埮ç²åãæäŸããããšã«ããã該埮ç²
åãè£å ã«å ¥ããå Žåãèªç¶ã®èŒžéæ©æ§ã«ããå
å®®é ãéããŠå°ãªããšãåå®®å ã«ãããŠå¯èœãªã
ã©ãã管å ã«éã³ããããšãã§ããããã§è¬å€ã®
解æŸãçããããã«ãããã®ã§ãããæ¬çºæã®äž
ã€ã®æ æ§ã§ã¯ã埮ç²åã®éæ¬ã¯ãçš®ã ã®æåãã
ã³æäœãçŽæ¥å¥³æ§çæ®èåšãŸã§åã³ãçæ®åšç®¡ã®
åŠçœ®ã®ããã«æåããã³æäœã®å šèº«çå°å ¥ãè¡ã
ãªãã§ããããã«ããããã«è¡ããããå šèº«çå°
å ¥ã¯ãçæ®åšç®¡ã®åŠçœ®ã®ããäœå ã«å€ãã®æåãŸ
ãã¯æäœãæäžããããã®æ段ãšããŠäºå®äžå©çš
ããããšãã§ããªããæ¬çºæã®ç¬¬ïŒã®äž»ãªæ æ§
ã¯ãé¿åŠå€ãè£ã«å°å ¥ããããã®é¿åŠå€ãå«æã
ãŠãªã埮ç²åç¶è¬å€ãæäŸããããšã«ããã該埮
ç²åã®å°å ¥ã«ããããããåå®®é ãéããŠåå®®ã«
éã¶ããšãã§ãããæ¬çºæã®é¿åŠå€ã®çŽæ¥ããã³
å±éšçå°å ¥ã¯ãå€ãã®çš®é¡ã®é¿åŠå€ãå®è³ªçã«ã
ãå°éã®æè¬ã«ãããå šèº«ã«å°å ¥ãããããå€ã
ã®è¬å€ã«ããéæããããšåæ§ã®é¿åŠå¹æãæå©
ã«éæã§ããå©ç¹ããããæ¬çºæã«ããã°ãæçµ
é±æã®å®å®ãã女æ§ã«ãããŠéåžžã®ç¶æ äžã«é¿åŠ
å€ãå«ã埮ç²åãéã¶ããšãå¯èœã§ãããããŸ
ããæ¬çºæã«ããã°ãæçµé±æã®å®å®ããªã女æ§
ãå®å®åããããšãã§ãããšåæã«ãå éšåšç®¡
ã¯ãé¿åŠå€ãå«ã埮ç²åã®åå®®é ããåå®®ããã³
ã©ãã管ãžã®éæ¬ããŸããŸãåããããããããš
ãã§ããããã奜ãŸããå¹æãé¿åŠå€ã«å ããŠã
ããã«æçµé±æ調æŽããã³åå®®é éšèŒžéä¿é²ãã«
ã¢ã³ïŒå³ã¡éåžžã¯ãšã¹ããã²ã³ãŸãã¯ããã²ã¹ã
ã³ã§ãããïŒã埮ç²åäžã«äœµçšããããšã«ããé
æã§ããã æäœã®åœ¹ç®ãäœå ã«ãããŠæåã®å¹æãé»æ¢ã
ãããã«åºæ¿ããããåºæ¬çæ¹æ³ã«ã¯äºã€ããã
æ£è ã掻åçã«å ç«ãããããæ£è ã«å ççæäœ
ã®çæãèªå°ããããã«æåãæäžãããéåžžã
ãã®æè¡ã«ãããŠã¯ãå åã«é«æ°Žæºã®æäœåå¿ã
éæãããåãïŒé±éãŸã§ãå¿ èŠãšããããã®é
ããå«ãŸããŠããã®ã§ã掻åå ç«æè¡ã¯ãçãã
æœäŒæéã®äŒææ§ã®ç æ°ã®åŠçã掻çºã«é²è¡äžã®
ç æ°ã®åŠçããã³è¬ç©ãæ¯çŽ ããã«ã¢ã³ããã³é µ
çŽ ã®å¹æã転æãŸãã¯ä¿®æ£ã®ããã«ã¯ãéçãã
ãã第ïŒã®åºæ¬çãªå ç«æè¡ã¯ãæäœãäžæçãª
å ç«ä¿è·ãéæããããã«æäžãããå身å ç«ã§
ãããå身å ç«ã¯ãçç©åŠçå¹æãæ¥æ¿ã§ããã
å ç«äžè¶³ã®ç æ°ã«ããã€ãæ£è ã«æå¹ã«å©çšãã
ããšãã§ãããããã«æŽ»åå ç«ã¯ãåç©ã®çš®å±ã
ä¿è·æäœã®åæãšããŠå©çšããããšãã§ããã®ã§
éæ¯æ§æåã®äœ¿çšã«å¶éããªãã埮ç²åã®èŒžé
ã¯ãå ççãªåµå·£ã®ã¹ããã€ããã«ã¢ã³å³ã¡ãšã¹
ãã©ãžãªãŒã«ããã³ããã²ã¹ããã³ã«ããé±æå€
åã«ããæ¯é ãããŠãããæçµé±æã®æåã®14æ¥
éãŸãã¯ãæçµé±æã®æ¿Ÿèæ§ãŸãã¯ãšã¹ãããŒã²
ã³æ®µéã®éã¯ãåµå·£ã¯ãåå®®é ã®çèã®åçž®ã«åº
æ¿å¹æã®ãããšã¹ãã©ãžãªãŒã«ãã€ãããæ¿Ÿè段
éã®éãåå®®é ã®åçž®ã®é »åºŠããã³æ¯å¹ ã¯ããã®
ææã«æåµãè¡ãããïŒã14æ¥ã®éã«ç¢ºå®ã«å¢å
ãããããŠãæçµé±æã¯ãå¡ãã®ïŒLutialïŒãŸã
ã¯åŠåš å段éã«å ¥ãããã®æåµå·£ã¯ããã²ã¹ãã
ã³ãåæ³ãããããã²ã¹ããã³ã¯ãåå®®é ã®åçž®
ã®æŽ»æ§ãé»æ¢ããå¹æãŸãã¯ãåå®®é ã®çèåŒç·©
å¹æãæã€ãŠãããåµå·£ãã«ã¢ã³ããŸãåå®®é ã®
现èã«ãããŠå¯Ÿæå¹æã瀺ãããšã¹ãã©ãžãªãŒã«
ã«ãããããã²ã¹ããã³ããåå®®é ã«ãŒã¡ã³ã«ã
ããŠããããã®çæç©ã®è§£æŸãä¿é²ããéãåå®®
é ã®çŽ°èã«ãããŠåæ³çæç©ã®ä¿é²ãçããã åå®®é ã®æµäœãŸãã¯ç²æ¶²ã¯ãåçã§ããããã
ãã²ã«ã®æ°Žæã¿ã€ãã§ããã粟液ã®å Žåãšåæ§
ã«ãæ¬çºæã®åŸ®ç²åç¶è¬å€ã®èŒžéã¯ãåå®®é ã®å
çž®ãä¿é²ãããšã¹ããã²ã³ã«ããæäŸãããæšé²
åãšåæ§ã«ãåå®®é ã®ç²æ¶²ã®ééæ§ã«äŸåããã
ã®ã§ãããåå®®é ãéããŠã®åŸ®ç²åç¶è¬å€ã®èŒžé
ã®ããã®æã奜ãŸããææã¯ãåå®®ãæ倧ã®åçž®
掻æ§ããã³åå®®é ç²æ¶²ééæ§ã瀺ãæã«ãããåŸ
ã€ãŠã粟åãŸãã¯åŸ®ç²åã®åå®®é ãéããŠã®èŒžé
ã®æ倧é床ã¯ãæçµé±æã®12ã16æ¥ã®éã«çãã
ã¯ãã§ãããããããªããæåµã®å®éã«èµ·ãæ¥
ã¯ãåå人ã«ããïŒãïŒæ¥ãããå€åãããã®ã§
ããã人ã«ãã€ãŠã¯é±æã®12æ¥ç®ããåã«ããã
ãã®èŒžéãçãããéåžžãåå®®é ã¯ãæçµé±æã®
æåã®12æ¥éãåæ§ã«ç¬¬16ã28æ¥ç®ã®éã«ãããŠ
ã¯èŒžéã¯ãããŸããããã§ã¯ãªãããã®ããã«ã
æåãæäœããŸãã¯é¿åŠå€ãå«ãæ¬çºæã®åŸ®ç²å
ç¶è¬å€ãåå®®é ã«éæ¬ããããã«ã埮ç²åã¯ãè£
å ã«æçµé±æã®ç¬¬16æ¥ç®ä»¥åã奜ãŸããã¯ã第12
æ¥ç®ä»¥åã«æäžããã°ããã æ¬çºæã®äž»ãªå ·äœäŸã«ãããŠã¯ããšã¹ããã²ã³
ããã³ããã²ã¹ãã³ãã«ã¢ã³ã¯ãå éšåšç®¡ã«ã茞
éåºæ¿å¹æãæã€ãšããäºå®ã«ãããå©ç¹ããã
ããããããã®ããã«ããšã¹ããã²ã³ãŸãã¯ãã
ã²ã¹ãã³ã®ãããããšè¬å€ãšãå«æãã埮ç²åãŸ
ãã¯ãè¬å€ãå«æãã埮ç²åãšæ··åãããšã¹ãã
ãŒã²ã³ãŸãã¯ããã²ã¹ãã³å«æ埮ç²åã¯ãè£ã«å ¥
ããããšã«ãããæçµé±æã®æ£ç¢ºã§ãªã婊人ã®æ
çµé±æã調æŽããããšãŸãåå®®é ãéããŠåå®®ã
ãã³ã©ãã管ãžæ¬çºæã®åŸ®ç²åç¶è¬å€ãéã¶ããš
ãå¯èœã§ãããçç©åŠçã«æå¹ãªéã®ãå±éšçã«
åžåãããããã²ã¹ãã³ãŸãã¯ãšã¹ããã²ã³ã¯ã
åå®®é ã®åå®®å èã«ãããŠå¿ èŠãªåæ³å€åããã
ããã埮ç²åã®èŒžéã«å¿ èŠãªåå®®é ã®å瞮掻åã
ä¿é²ããã茞é掻åãäžåºŠå§ãŸããšã埮ç²åã¯å
å®®é ãéããŠåå®®ã«éã°ããããšã¹ããã²ã³ãã
ã³ããã²ã¹ãã³ã®äž¡æ¹ãé©éã§äœ¿çšãããšã茞é
ãåºæ¿ãããããããªãããããã²ã¹ãã³ããã
ãŸãé«ãæ¿åºŠæ°Žæºã§äœ¿çšãããšãããã²ã¹ãã³ã¯
åå®®é ã®çµç¹ã«ãããŠçèãåŒç·©ãããå¹æãã
ãããã«ã埮ç²åã®èŒžéã«éå¹æããããããã
ãããæäžãããããã²ã¹ãã³ã®éå¹æã¯ãäžè¿°
ããããã«åå®®é ã®çµç¹ã®é¿åŠæŽ»åãæã€ãšã¹ã
ã©ãžãªãŒã«ã®ãããªãšã¹ããã²ã³å«æ埮ç²åãå
åãªæ¿åºŠã§æäžããããšã«ãããå埩ãããããš
ãã§ãããäžè¬ã«ããšã¹ãã©ãžãªãŒã«ãã埮ç²å
ã®ããã¡ã§å±éšçã«éã³ããå Žåãæäžãã¹ã埮
ç²åã®éã¯ãïŒã14æ¥éã«ããã€ãŠãïŒæ¥åœã
0.1ãïŒmgã§å åã§ãããäžæ¹ã埮ç²åå ã«ãã
ã²ã¹ããã³ãå«ãŸããŠããå Žåãæäžãã¹ã埮ç²
åã®éã¯ãïŒã14æ¥éã«ããã€ãŠãïŒæ¥åœã0.5
ãïŒmgã§å åã§ããã äžèšããããã«æ¬çºæã®åŸ®ç²åç¶è¬å€ã¯ãé¿åŠ
å€ãæåãŸãã¯æäœãåå®®é ã«å±éšçã«æäžãã
ããšãå¯èœã§ãããåæã«é©åœãªåµå·£ãã«ã¢ã³ã
æäžããããšã«ãããæçµé±æã®æ£ç¢ºã§ãªã婊人
ã®æçµé±æãå€ççã«æŽ»çºåããããšãã§ããã
ããŠåå®®é ãã埮ç²å茞éã®ããã«åºæ¿ããããš
ãã§ããããã€ãŠããšã¹ããã²ã³å«æ埮ç²åã¯ã
ãšã¹ãã©ãžãªãŒã«ãŸãã¯åæãšã¹ããã²ã³ãåå®®
é ã§14æ¥éã«ããã€ãŠè§£æŸãããããã«ããæçµ
é±æã®æåã®ååãéãåããããã«æäžããã
ãšãã§ãããåå®®é ãéããŠåŸ®ç²åã®èŒžéãçã
ãå Žåã埮ç²åäžã®è¬å€ãŸãã¯å¥ã ã®åŸ®ç²åäžã®
è¬å€ã¯ãåå®®ã«éã°ããããšã¹ããã²ã³å«æ埮ç²
åã®æäžåŸã®14æ¥ç®ã«ãä»»æã«æäœãŸãã¯æåã
å«æããŠããŠããŸããªãããããã²ã¹ããã³ãå«
æãã埮ç²åãã次ãã§æäžããããã®ããã«ã
ãŠãå®å šã«èªç¶ã®æçµé±æãéãåããããšãã§
ãããã®éæåãŸãã¯æäœä¿è·ãã§ããã®ã§ã
ããæ¬çºæã®ç¯å²ã«ã¯ããã¡ããããšã¹ããã²ã³
ãŸãã¯ããã²ã¹ãã³ãå«æãã埮ç²åãåå®®é ã®
äžã«å ¥ããæçµé±æã調æŽããŠãããåå®®é ã茞
éããããšãåãå ¥ããããæçµã®ææã«ãæå
ãŸãã¯æäœãå«æãã埮ç²åãæäžããå Žåãå«
ãŸããŠããã人工çã«å°ã³ãããé±æã«ãããŠ
ã¯ãåå®®é ãéããŠã®æ倧茞éã¯ã第12æ¥ã第16
æ¥ã®éã«éæããããæ¬çºæã®æè¡ã«ãããŠãé±
æ調æŽãã«ã¢ã³ãå±éšçã«æäžããå Žåæå¹ãªãš
ã¹ãã©ãžãªãŒã«æŽ»æ§ã¯ãïŒæ¥åœã0.01ã0.07mgã®
æè¬çã§ãéæããããŸãæå¹ãªããã²ã¹ããã³
掻åã¯ãïŒæ¥åœã0.04ã0.14mgã®æè¬çã§éæã
ããããšã¹ãã©ãžãªãŒã«ããã³ããã²ã¹ããã³
ã¯ãéžæ調æŽãã«ã¢ã³ã§ãããããããªãããä»
ã®åšç¥ã®åæãšã¹ããã²ã³é¡ããã³ããã²ã¹ãã³
ããåã ãšã¹ãã©ãžãªãŒã«ããã³ããã²ã¹ããã³
ã®ä»£çšç©ãšããŠå©çšã§ããããšã¯æçœã§ããã奜
ãŸãããšã¹ããã²ã³é¡ã«ã¯ããšã¹ããã³ãã¡ã¹ã
ã©ããŒã«ããšãããŒã«ãšã¹ãã©ãžãªãŒã«ãïŒâã¡
ããã·ãšã¹ããã³ãïŒâããããã·ãšã¹ããã³ã
ãã³ãšã¹ããªãªãŒã«ãå«ãŸããã奜ãŸããããã²
ã¹ãã³ãé¡ã«ã¯ããã¬ãã³ããã³ããžã¡ãã¹ãã
ã³ ãšãããžãªãŒã«ãžã¢ã»ããŒãããã¬ãããžãª
ãŒã«ããã¬ãã³ããã³ã¢ã»ããŒãããã³ãã«ã²ã¹
ãããŒã«ãå«ãŸãããåæååç©ã䜿çšãããå Ž
åã䜿çšãããæè¬éã¯ãåæãšã¹ããã²ã³ãŸã
ã¯ããã²ã¹ãã³ååç©ã®çç©åŠçæå¹æ§ã«å®å šã«
äŸåãããã®ã§ããã æäœãæåãŸãã¯é¿åŠå€ããã³ïŒãŸãã¯æçµé±
æ調æŽãã«ã¢ã³ã®ãããªè¬å€ãå«æããæ¬çºæã®
埮ç²åç¶è¬å€ã¯ãçš®ã ã®é åã§ã圢æããããšã
ã§ãããäŸãã°ãæãåçŽãªç¶æ ã®ãã®ãšããŠã®
第ïŒå³ããã³ç¬¬ïŒå³ã«ç€ºãããåäžæ§é ã®åŸ®ç²å
ã¯ãçç©åŠçã«å£åå¯èœã§ãããçç©åŠçã«é©å
ããããšã®ã§ãããããªãã¯ã¹ç©è³ªïŒïŒãŸãã¯23ïŒ
ã«ãäžæ¹ã§ã¯æãŸããæåãŸãã¯æäœïŒããŸãã¯
ä»æ¹ã§ã¯é¿åŠå€ïŒïŒããã³é±æ調æŽãã«ã¢ã³ïŒïŒ
ãå®å šã«åæ£ãããããšã«ãã補é ãããã埮ç²
åã¯ãè£ã«å ¥ãããããšããã€ãããšããšãã¯ã
ããããã§é£ç¶çã«ãè£ã«å ¥ããæããã埮ç²å
ãåå®®é ãéãéã°ãåå®®å ã«å ¥ããŸã§ã®é·ãæ
éã«ããã€ãŠã奜ãŸããæ¯æ¥ã®è¬å€ã®æè¬ãéæ
ããããã«ç®çã®è¬å€ã解æŸãããã埮ç²åãé±
æ調æŽãã«ã¢ã³ãå«ãå Žåã¯ããã«ã¢ã³ã®é£ç¶ç
解æŸãåå®®é ã®ç²æ¶²ã®ç¹æ§ããã³åå®®é ã®å瞮掻
åã調æŽããããã®ç¹æ§ã®å ·äœäŸã«ããã埮ç²å
ã¯ãè£ã«å ¥ããæããããããã®æŽ»æ§æåãé£ç¶
çã«è§£æŸããã®ã§ããã®åŸ®ç²åã¯ãæçµé±æã®é
ã«äžåã ãæäžããã°ããããã«ãæçµé±æã®åš
æã«è¿ãæå¹å¯¿åœãæã€ããã«ã€ããã°æãéœå
ã®ããçµæãéæã§ãããããããªãããããã¯
åã«å¥œãŸããå ·äœäŸã§ããã埮ç²åã¯é¿åŠå¹æã
ãã³é±æ調æŽå¹æãéæããã«å¿ èŠãšãããã
ããäœåãæè¬ããããšãã§ããã 第ïŒå³ã¯ãæåãŸãã¯æäœïŒããããªãã¯ã¹ç©
質äžã«æ··åãããŠãããããã次ã«è¬å€ãå«ãŸãª
ããããªãã¯ã¹ç©è³ªã®å€ç®ïŒã«ããåããŸãããŠ
ããåäžæ§é ã®åŸ®ç²åã®ããäžã€ã®å ·äœäŸã§ã
ãã埮ç²åãã粟å代çšæŽ»æ§ãæã€ãããªå€§ãã
ã§ããããã®çš®ã®åŸ®ç²åã®åœ¢æ ã¯ã埮ç²åãè£ã«
å ¥ããåŸããã°ããã®éè¬å€ã®è§£æŸãé ãããã
ãããªå Žåã奜ãŸãããäŸãã°ãäžèšã®ãããªåŸ®
ç²åã䜿çšããããšã«ããçããè¬å€ã®é ããŠã
ãã®è§£æŸã¯ã埮ç²åãè£ã«å ¥ããããå€å£ãã»ãš
ãã©åãå»ãããè¬å€ã®æŸåºãå§ãŸãæç¹ãŸã§åŸ®
ç²åãå£åãã以åã«åå®®é ãéããŠåå®®ã®äžã«
茞éãããã®ã«å åãªæéã確ä¿ããããšãã§ã
ãã 第ïŒå³ã¯ãé¿åŠå€ïŒïŒãšãé±æ調æŽãã«ã¢ã³ïŒ
ïŒã®è¯ïŒïŒãããããªãã¯ã¹ç©è³ªïŒïŒã®æ®»ïŒïŒäž
ã«ã«ãã»ã«åããã埮ç²åã瀺ãããã®åŸ®ç²åã®
ç²åã®åœ¢æ ã¯ãäžèšã®ç¬¬ïŒå³ã®åŸ®ç²åã«ã€ããŠèš
èŒããããã«ãå°å ¥ããã埮ç²åã®æŽ»æ§æåã®è§£
æŸãé ããæ¹ãããå Žåã«éœåãã䜿çšãããã ããã«ç¬¬ïŒå³ã«ç€ºããããããªç°ãªã埮ç²å圢
æ ã«ãããŠã¯ã埮ç²åã¯ãå€éã®æäœãŸãã¯æå
ãå³åº§ã«è§£æŸããããã«ã€ããããŠããããã®ç®
çãéæããããã«ã埮ç²åã¯ãæåãŸãã¯æäœ
ã®è¯ïŒãæ®»ã®ãããªãã¯ã¹ç©è³ªïŒã®äžã«ã«ãã»ã«
åãããŠãããè¬å€ã®è¯ãå«ã埮ç²åã¯ã埮ç²å
ã®å€æ®»ã厩å£ããããã®å å æ§ã®èŠçŽ ãå©çšã§ã
ããããªå Žåã«ç¹ã«é©ããŠãããäŸãã°ãäžæ¹ã®
è£å ã«ãããPHãšä»æ¹ã®åå®®é ãšåå®®å ã«ããã
PHãšã®å·®ãå©çšããŠãå€æ®»ã®åŽ©å£ãã埮ç²åãå
å®®é ãŸãã¯åå®®ã®å°åž¯ã«éãããšãçããããã«
ããããã®å Žåè£å ã®é žæ§PHã¯ã埮ç²åã®æ®»ã«ã»
ãšãã©ãŸãã¯å šã圱é¿ãäžããªããããããªã
ãã埮ç²åã¯ãåå®®é ã«éã°ãããšãããã§äžæ§
ã®PHã«ãããããå€æ®»ã厩å£ããå³åº§ã«è¬å€ã®è§£
æŸãéå§ããããã¯ãæ¥æ¿ãªææã«ããã€ããé«
æ¿åºŠã®æ¯çŽ ã«ç¯ãããæ£è ã«æäœãããããã®é
éã¶ã®ã«é©ããŠãŠããããã®åŠæ¹ã¯ãåèªããã¹
ã«ç¬¬äžæ¬¡å ç«ãåããåŸã®äºåºŠç®ã®å¿çãæäžã
ãããšãå¿ èŠãšããããããªå Žåã«é©ããŠããã å°ã ãäžèª¿ãªæ£è ã®åŠçœ®ã«ãããŠã¯ãæåãŸã
ã¯æäœãéæ¬ çã«æäžããããšãã§ãããšããã
ããã¯ã第ïŒå³ã«ç€ºããããããªãåç¬ãŸãã¯ã
ããªãã¯ã¹ç©è³ªã«åæ£ãããè¬å€ïŒãšãè¬å€ãå«
ãŸãªããããªãã¯ã¹ç©è³ªïŒã®äº€äºã®å±€ãåäžå¿å±€
ã«ãããŠåœ¢æãããŠãããããªæ§é ãæã€åŸ®ç²å
ã䜿çšããããšã«ããéæã§ããããã®ãããªåŸ®
ç²åããè£ã«å ¥ããå Žåãè¬å€ã®è§£æŸã¯ã埮ç²å
ã®å€åŽã®å±€ã厩å£ãããŸã§èµ·ããªããäžå±€ãåºãŠ
ãããšè¬å€ã®è§£æŸãéå§ãããã®å±€ã厩å£ãããŸ
ã§ç¶ããè¬å€ã解æŸãããè¬å€ã®è§£æŸã¯ã次ã®äž
å±€ã§ããè¬å€ãå«ãŸãªãå±€ã«éãããšããåæ¢ã
ãããã®æè¡ã®é©å¿äŸã¯ãæãå€åŽã®è¬å€å±€ãæ
åããäžå®ã®ç¶æé±æã®éãæåã解æŸãã次ã
ã§äŸãã°ïŒãïŒé±éã®è¬å€ã解æŸããªãé±æãç¶
ããããªæŽ»æ§å ç«ã«ãããŠèŠãåºããããè¬å€ã
å«ãŸãªãå±€ã厩å£ããåŸãæå解æŸã®ç¬¬ïŒã®é±æ
ãå§ãŸãããã®ããã«ã埮ç²åãäžåºŠæäžããã
ãšã«ããã第äžåã®æè¬ãããã«ç¶ã次åã®æè¬
ãå¯èœã«ãªãã åå®®é ãéããŠåå®®ãžã®æåãŸãã¯æäœã®éæ¬
ã®ã¿ãªãããèªç¶ã®èŒžéæ©æ§ã掻çºã«ãã調æŽã
ãããã«é±æ調æŽãã«ã¢ã³ãæäžããå¿ èŠããã
å Žåã第ïŒå³ã«ç€ºããããªæåãŸãã¯æäœãšãé±
æ調æŽãã«ã¢ã³ã®äž¡æ¹ããããªãã¯ã¹ç©è³ªã«åæ£
ãããåäžæ§é ã®åŸ®ç²åãæäžããããšãã§ã
ãããã®ããã«ã埮ç²åãè£å ã«å ¥ãããšããã«
ã¢ã³ãšæåãŸãã¯æäœã®è§£æŸãå§ãŸããçµå±ã埮
ç²åã¯åå®®é ãéããŠåå®®å ã«éã°ãããé±æ調
æŽãã«ã¢ã³ãå«æããæå€æ®»ãããªãã¯ã¹ç©è³ªå±€
ãšãæåãŸãã¯æäœãå«æãããããªãã¯ã¹ç©è³ª
ã®å åŽè¯ãšãæã€åŸ®ç²åã䜿çšããã°ãæäžã®ã
ãéžæçæçãã§ããããã®ãããªåŸ®ç²åãæäž
ããå Žåãé±æ調æŽãã«ã¢ã³ã®ç¶æããã解æŸã
çãåå®®é ã茞éãåããããæã«ã埮ç²åã¯ã
åå®®é ããåå®®ã«èŒžéããããæåãŸãã¯æäœã®
解æŸã¯ã埮ç²åã®äžå±€ã«ããã埮ç²åã®æåãŸã
ã¯æäœã®è¯ãåºãŠããæã«ãåå®®é ãŸãã¯åå®®å
ã«ãããŠèµ·ãã第ïŒå³ã¯äžèšãããããªæ§é ã®åŸ®
ç²åå³ã¡ãå€åŽã®é±æ調æŽãã«ã¢ã³ãå«æããå±€
ïŒãå åŽã®æåãŸãã¯æäœãå«æããè¯ïŒïŒãå
ã¿èŸŒãã§ãããæåãŸãã¯æäœã¯ãåç¬ã§åŸ®ç²å
ã®è¯ãæ§æããããšãã§ãããæ®»ïŒïŒãã€ããã
ãã«ãããªãã¯ã¹ç©è³ªäžã«åæ£ãããŠãããããŸ
ããå€åŽã®å±€ãŸãã¯æ®»ïŒã¯ããããªãã¯ã¹ç©è³ªäž
ã«æçµé±æ調æŽãã«ã¢ã³ãåæ£ãããããšã«ãã
ã€ããã åè¿°ããããã«ãæäœãŸãã¯æåã¯ãåç¬ã§ã
ãŸãã¯é±æ調æŽãã«ã¢ã³ãšã®çµåãã«ãããŠãè¬
å€ãŸãã¯è€æ°ã®è¬å€ãã©ã®ããã«è§£æŸããããã«
äŸåããŠãçš®ã ã®ããã¡ã§åŸ®ç²åäžã«æ··åããã
ãšãã§ãããããã«ç¬¬ïŒã第ïŒå³åã³ç¬¬ïŒå³ã«ç€º
ããã¿ã€ãã®è€å±€åŸ®ç²åã¯ãéåžžåäžã®ãããªã
ã¯ã¹ç©è³ªããã€ããããããæ æ³ã«ãã€ãŠã¯æãŸ
ãããªãå Žåããããã埮ç²åã®é£ãåãã®å±€ã
ç°ãªããããªãã¯ã¹ç©è³ªã䜿çšããŠã€ããããšã
ã§ãããããã«ãå Žåã«ãã€ãŠã¯ãïŒçš®ä»¥äžã®ç
ç¶ãåŠçœ®ããããã«ãå éšçæ®åšç®¡ã«ïŒçš®ä»¥äžã®
æäœãŸãã¯æåãéã³ããããšãã§ããã ãã®ããã«ãäŸãã°ïŒçš®ã®ç°ãªãç æ°ãååç
ã«åŠçœ®ããããã«ãïŒçš®ã®ç°ãªãæäœãå«ãåäž
埮ç²åãã€ããããããæäžããã°ãããå®éã«
ããæ æ³äžã«ãããŠã¯ãåã埮ç²åäžã«ããæå
ãŸãã¯æäœã§ç¬¬ïŒã®äžèª¿ã«å¯ŸããŠã¯æ£è ã掻åç
ã«å ç«ããåæã«ç¬¬ïŒã®äžèª¿ã«å¯ŸããŠã¯æ£è ãå
åçã«å ç«ããã®ãæãŸããå Žåãããããã¡ã
ããïŒçš®ä»¥äžã®æäœãŸãã¯æåãïŒã€ã®åŸ®ç²åäž
ã«æ··åããå Žåã§ïŒãã®å Žåãããããæ¥è§Šãã
å¯èœæ§ããããïŒããã«åŸ®ç²åã®ç°ãªãå±€ã«ãªã
å Žåã«ã¯ããããã¯ãçžäºã«åå¿ããªããã®ã§ãª
ããŠã¯ãªããªãã ããã«ç¬¬ïŒå³ã«ã¯ãå Œçšã§ããå³ã¡çžäºã«åå¿
æ§ã®ãªãé¿åŠå€ïŒïŒãšé±æ調æŽãã«ã¢ã³ïŒïŒãã
ãããªãã¯ã¹ç©è³ªäžã«åæ£ããããããè¯ïŒïŒã
圢æããŠããä»çš®ã®åŸ®ç²åã®ããã¡ã瀺ãããŠã
ãããã®åŸ®ç²åã¯ããããªãã¯ã¹ç©è³ªïŒïŒã®æ®»ïŒ
ïŒäžã«ãè¬å€å«æãããªãã¯ã¹ç©è³ªã®ç²åãã«ã
ã»ã«åããããšã«ããã€ããããããããªãã¯ã¹
å åŽè¯ïŒïŒãšæ®»ïŒïŒã®ãããªãã¯ã¹ç©è³ªïŒïŒãã
ã³ïŒïŒã¯åçš®ã®ç©è³ªã§ãã€ãŠããç°çš®ã®ç©è³ªã§ã
ã€ãŠããããç°çš®ã®ãããªãã¯ã¹ç©è³ªã䜿çšãã
å Žåããããªãã¯ã¹ç©è³ªã®åŽ©å£é床ãç°ãªãã
ãšããŸãã¯ããããªãã¯ã¹ç©è³ªããã®è¬å€ã®æ¡æ£
é床ãç°ãªãããšã«ããå©ç¹ãå©çšã§ããããšã
å¿ èŠãªå Žåã«ç¹ã«æçšã§ãããé¿åŠå€ããã³é±æ
調æŽãã«ã¢ã³ã®è§£æŸã¯ãããªãã¯ã¹ç©è³ªã®æ®»ïŒïŒ
ã厩å£ãããŸã§çããªãã 第ïŒå³ã¯ããããªãã¯ã¹ç©è³ªïŒïŒäžã«ããé¿åŠ
å€ïŒïŒã®è¯ïŒïŒãã€ãããã次ãã§é ã«ãè¯ïŒïŒ
ã¯é±æ調æŽãã«ã¢ã³ïŒïŒãå«æãããããªãã¯ã¹
ç©è³ªïŒïŒã®æ®»ïŒïŒã«ããå å²ããã埮ç²åæ§é ã®
ãã®ã瀺ãããã®ç²åã®ããã¡ãæã€åŸ®ç²åã¯ã
æçµé±æã調æŽããåå®®é ããã®åŸ®ç²åã®èŒžéã
åºæ¿ããé±æ調æŽãã«ã¢ã³ïŒïŒã ãã®æåã®åºã
ã®è§£æŸãéæããããã«ãè£å ã«åŸ®ç²åãæ¿å ¥ã
ãããšãæãŸããå Žåã«ãããŠç¹ã«æå¹ã§ããã
ãã®ããã«ããŠãæçµé±æã®èª¿æŽããã³å°ãªããš
ã埮ç²åã®åæã®äœå 茞éã¯ãå åŽã®è¯ïŒïŒãã
ã«ãã»ã«åãããé¿åŠå€ïŒïŒã®è§£æŸãã§ãããã
å åã«é²åºãããæãŸã§ã«èµ·ãåŸãããã¡ããã
é¿åŠå€ã¯åç¬ã§ããŸãã¯ãæ®»ã®ãããªãã¯ã¹ç©è³ª
ïŒïŒãšåçš®ã§ãç°ãªããã®ã§ãã€ãŠãããŸããªã
ãè¯ã®ãããªãã¯ã¹ç©è³ªå šäœã«åæ£ããããã®ã
ã«ãã»ã«åããã å€å±€åŸ®ç²åã®ããã¡ã¯ã第ïŒïŒå³ã«ç€ºãããã
ãã®åŸ®ç²åã¯ãé¿åŠå€ïŒïŒãåç¬ã®ãŸãã¯ããã
ããããªãã¯ã¹ç©è³ªäžã«åæ£ãããå åŽè¯ïŒïŒã
ããªãããã®è¯ïŒïŒã¯ããããªãã¯ã¹ç©è³ªïŒïŒã®
æ®»ïŒïŒã«ããã«ãã»ã«åããããã®æ®»ïŒïŒã¯ãé
ã«é±æ調æŽãã«ã¢ã³ïŒïŒãå«æãããããªãã¯ã¹
ç©è³ªïŒïŒãããªãå€æ®»ïŒïŒäžã«ã«ãã»ã«åãã
ãããã®ç¹æ®ãªããã¡ã®åŸ®ç²åã¯ããã®åŸ®ç²åã
è£å ã«æäžããåŸãé±æ調æŽãã«ã¢ã³ãæäžãã
ããšãå¿ èŠãªãããªå Žåã«æçšã§ãããé±æ調æŽ
ãã«ã¢ã³ã®ãã¹ãŠã解æŸãããåŸã®é¿åŠå€ã®è§£æŸ
ã¯ãå åŽã®æ®»ïŒïŒããé¿åŠå€ã®è¯ïŒïŒããã®è§£æŸ
ãã§ããããã«ãªãã«å åãªçšåºŠãŸã§åŽ©å£ãããŸ
ã§é ãããäžæ¹ã埮ç²åã®èŒžéã¯ã埮ç²åã®å€§å
ãåå®®ã®äžã«éã³ããŸããŠãããé¿åŠå€ã®é ãã
解æŸãéæãããããã«è¡ãããã æ¬çºæã®åŸ®ç²åç¶è¬å€ã®ç©çç圢ç¶ã«ã€ããŠã¯
çç¶ãåµåœ¢ã®ãããªæŽã€ãããã¡ã®ãã®ãããäž
èŠåãªããã¡ãŸã§å¯èœãªããã¡ã®å€åãèš±ãã
ããããããªãã埮ç²åã®ããã¡ã¯ã埮ç²åã®äœ
å 茞éã«é¢ããŠã®èŠä»¶ãšãªããªããéåžžãå»è¬å€
ã¯åŸ®ç²åããããããªãã¯ã¹ç©è³ªã®æ®µã ã®åŽ©å£ã«
ãããããã³ïŒãŸãã¯ãããªãã¯ã¹ç©è³ªããã®å»
è¬å€ã®æµžéã«ããã溶åºããã æ¬çºæã®åŸ®ç²åã®å€§ããã¯ãéèŠã§ãããäœæ
ãªã該埮ç²åã¯ãçæ®åšç®¡ã®èªç¶ã®èŒžéæ©æ§ã«ã
ããåå®®é ããäžåãã«åå®®å ããã³ã€ãã«ã¯ã©
ãã管ã®äžã«ãŸã§éã¶ããšãã§ããããã«ç²Ÿæ¶²ä»£
çšæŽ»æ§ãæã€å¿ èŠãããããã§ããã埮ç²åãã
倧ãããããšã埮ç²åãè¿œãåºãããã«ãåå®®é
ã®èçž®ãçããŠããŸãããŸã埮ç²åãããŸãå°ã
ããããšãçæ®èåšã®äžã«äžåãã«éã¶ããšã§ã
ãªããªããéåžžã埮ç²åã¯ã20ã70ÎŒã奜ãŸãã
ã¯20ã60ÎŒã®å€§ããã®ãã®ãããã 埮ç²åã圢æãããŸãé¿åŠå€ããã³é±æ調æŽã
ã«ã¢ã³ããã®äžã«åæ£ããããããªãã¯ã¹ç©è³ªã¯
粟液代çšæŽ»æ§ã®ç¹ã®ã¿ã§ãªããçç©åŠçã«é©åã
ãããšããç¹ã§éèŠã§ããããããªãã¯ã¹ç©è³ªãš
ããŠäœ¿çšã§ããç©è³ªã§ããããã«ã¯ãããããç
æ®èåšã«ãããŠäžå©ãªå¹æããããããªããã®ã§
ãªããŠã¯ãªããªãããŸããçç©åŠçã«é©åãåŸã
ãã®ã§ããã¹ãã§ãåå®®é ãŸãã¯åå®®ã®çµç¹ãåº
æ¿ãããé ã¬ã³æ§ã§ãã€ããããŠã¯ãªããããŸ
ããäœå çµç¹äžã§ççãèµ·ãããªããã®ã§ããã¹
ãã§ããããŸãäœå çµç¹ãšé©åæ§ããããããã«
åå®®é ã®ç²æ¶²ãšæ··åã§ãããã®ã§ãªããŠã¯ãªããª
ããä»ã®éèŠãªèŠçŽ ãšããŠã¯ã該ãããªãã¯ã¹ç©
質ã¯äœå ã«ãããŠçç©åŠçã«å£åãåŸããã®ã§ã
ããååŠå·¥çšã«ãããäœå ã«ãããéç©ããªãã
ãã«ãçŽã¡ã«å解ããããšãã§ããªããã°ãªããª
ãããŸãã埮ç²åã®ããã¡ã«ããå Žåãå°ããšã
女æ§ã®æ¯æã®æçµé±æã«å¯Ÿå¿ããæéã«ããã€ãŠ
ãã€ãããšåŽ©å£ããèœåãæã€å¿ èŠãããã該ã
ããªãã¯ã¹ç©è³ªãšããŠäœ¿çšããããªãç©è³ªã®å¥œãŸ
ããäŸã«ã¯ãããªã°ãªã³ãŒã«é žãïœïŒïœâããªä¹³
é žããããã®å ±éåäœçãå«ãŸãããä»ã®æçšãª
ãããªãã¯ã¹ç©è³ªã«ã¯ã°ãªã»ããŒã«ã¢ããŒããã³
ãžã¹ãã¢ã¬ãŒãããããä»ã®ãããªãã¯ã¹ç©è³ªã«
ã¯ãåå®®é ã®äžæ§ç°å¢äžã«å解ãããããªãã®ã
å«ãŸããã æäœãŸãã¯æåãå«æãã埮ç²åã®æ§é ã«ã€ã
ãŠãå®è³ªçã«ããããªãå ¬ç¥ã®æäœãŸãã¯æåã
ã埮ç²åäžã«æ··å ¥ããããšãã§ããããç¹ã«çæ®
èåšã®ç¶æ ããã³ç æ°ã®åŠçã«ãããŠç¹ã«äœ¿çšã
ãããããªãã®ã奜ãŸããã æ¬çºæã®åŸ®ç²åäžã«æ··å ¥ããããšã®ã§ãã奜ãŸ
ããæåãšããŠã¯ã人éãŸãã¯åç©ã®ãã¯ããªã¢
èããã³ããŒã«ã¹èããããçæ®å·¥çšã«å«ãŸãã
é µçŽ ããã³ä»ã®çç©åŠçå åããŸã䜿çšããããš
ãã§ããã奜ãŸããç åèæåã«ã¯ããã€ã»ãªã¢
ãªã³ç èããã€ã¯ããã¯ããªãŠãŒã çµæ žèããã«
ãã¹ããŒã«ã¹ïŒããŠãŒã¢ãã¹ ïŒåããã³ïŒåïŒ
ãã€ã³ãã ã¢ã«ãã«ã³ãº ãã€ã³ãã ããã
ã«ã«ãº ããªã³ã¢ãã¹ ããŒãžããªã¹ãããšã¢ã
ã€ã©ã¹ ããŒãžããªã¹ã第矀é£éç¶çèãšã³
ãªããã€ã¯ããã©ãºã ãããã¹ããã¢ãã€ã©ã¹
ããŠã¯ã¬ã€ã€ãã°ã©ããŠããŒã ã€ã³ã°ã€ããŒ
ã¬ããªã³ããã㢠ããã¬ãŠã ããã¬ããã ã
ãªããŠãŒã ããã«ã»ã© ã¢ããŒãã¹ããã«ã»ã©
ã¡ãªãã³ã·ã¹ããã«ã»ã© ã¹ã€ã¹ããã«ãã© ã
ã€ãã¹ãã«ã³ãããã¯ãã« ããšãŒã¿ã¹ãã«ã³ã
ããã¯ãã« ããšãŒã¿ã¹ ã€ã³ãã¹ãã€ããªã¹ã
ã¬ããã¹ãã© ãã¢ãŒãããªã¹ããªã¢ ã¢ãã·ã
ã²ãã¹ããã«ã»ã© ãªãŒãã¹ãã€ã¯ã€ãŒã ãã«
ãã¹ ããŒã«ã¹ ïŒãã€ã¯ã€ãŒã ã¢ã«ããªã¿ã¹
ããŒã«ã¹ãIBRâIBPããŒã«ã¹ãBVDâMBã
ãŒã«ã¹ãã¯ã©ãã㢠ãã·ã¿ã·ãŒãããªã³ã¢ãã¹
ããŒã¿ã¹ããããœãã©ãºã ãŽã³ãã€ã€ããšã¹
ããšãªã㢠ã³ãªãã¢ã¯ãããã·ãªã¹ ãšã¯ãŠ
ã€ããµã«ã¢ãã© ã¢ããŒã¿ã¹ããªãŒãã¹ ãµã«ã¢
ãã© ã¢ããŒã¿ã¹ ãšã¯ãŠã€ããã»ãŠãã¢ãã¹
ã¢ãšã«ã®ããŒãµãã³ãªããã¯ããªãŠã ãšã¯ãŠ
ã€ãã³ãªããã¯ããªãŠã ããªã²ãã¹ãã¢ã¯ãã
ãã¯ããªãŠã¹ ã»ããã¹ããã€ã³ãã©ãºã ãã
ã²ãã¿ãªãŠã ãã¢ã¹ãã«ã®ã«ã¹ ããŠãŒãã¬ã
ã¹ãã¢ãã·ã㢠ã©ã¢ãŒãµãããªãããœãŒãããš
ã¯ã€ããŒãã ãããã·ã¢ ã«ããªã€ãã¯ãã¹ããª
ããŠã ãã¿ãŒããªã©ãããã çæ®å·¥çšå«ãŸããé µçŽ ã®å¥œãŸããäŸãšããŠã¯ã
ãªããã¯ã¬ã¢ãŒãŒãããŠãŒã©ããžããŒãŒãããªã
ã·ã³ãã°ãªã³ãŒã²ã³ ãã¹ãã€ã©ãŒãŒãã¹ããŒã
ã©ã¯ãã€ã㯠ããããã²ããŒãŒãã¹ããŒã ã
ã¢ã«ããããŒãŒãã¢ããã·ã³ããªãã¹ãã¢ã¿ãŒãŒ
ã¢ã«ã«ãªã³ ãã¹ãã¿ãŒãŒãã¢ã«ã«ãªã³ ãã¹
ãã¿ãŒãŒ ãšã¹ãã©ãŒãŒãã¢ãããããããŒãŒã
ããªãã·ã³ ãã¢ããªãã·ã³ãã¢ãã©ãŒãŒãã ã©
ãããŒãŒãã¢ã¯ããœããŒã« ãããã€ããŒãŒããž
ãšã¹ãã©ãŒãŒãã°ã«ã¿ãã³é žããããã²ããŒãŒã
ã³ãã¯é žããããã²ããŒãŒãããŒã¿ãŒâã°ãªã³ã
ã¹ãã¿ãŒãŒããªããŒãŒãATPâã¢ãŒãŒ ã¢ã«ã
ã¢ãŒããããŒã ã¬ã³ããŒã°ã«ã¿ãããã©ã³ã¹
ãããããŒãŒãã¹ãããŒã«âïŒâããŒã¿ãŒãªãŒã«
âããããã²ããŒãŒãDPNâãžâã¢ããã©ãŒãŒ
ãããã æåãšããŠåããã«ã¢ã³ã§ã¯ãããŠãŒãã³ã³ãª
ãªãã㯠ãŽãããããã€ã³ ãã«ã¢ã³ãããŠãŒ
ãã³ ãã©ã»ã³ã¿ã« ã©ã¯ããŒã²ã³ãããã²ã¹ã
ãã³ããšã¹ãã©ãžãªãŒã«çã奜ãŸãããä»ã®æå
ã«ã¯ãæ é€èœå±€ã®çŽ°è質衚é¢ã«çããèã«é¢ãã
现è質æåãããã äžè¿°ããç åèã«è¿œå ããŠã女æ§çæ®åšç®¡ã«æ
æãããããšã®ã§ããç åèã®æ··åç©ãããŸã埮
ç²åäžã«æ··å ¥ããããšãã§ããã 埮ç²åäžã«æ··å ¥ããããšã®ã§ããå身å ç«ã®ã
ãã®æäœã®äŸã«ã¯ã掻åå ç«ã®ããã«æå¹ã§ãã
äžèšã®æåã®ãã¹ãŠã«å¯Ÿå¿ãããã®ãå«ãŸããã
粟液ãåµãåŠåš ã«ããçæç©çã«å¯ŸããŠæå¹ãªæ
äœãããŸã䜿çšããããšãã§ããã æåãŸãã¯æäœãå«æããæ¬çºæã®åŸ®ç²åã察
象ã«æäžããå ŽåãæåãŸãã¯æäœã®å¿ èŠãšãã
ãæè¬éããå¿ èŠãšããæéã«ããã€ãŠå¿ èŠãšã
ãåããåŒãåºãã®ã«å åãªéã§æäžããããæ
åã«ã€ããŠã¯ãïŒã14æ¥ã®éã«ããã€ãŠãïŒæ¥åœ
ãçŽ0.5ãïŒmgãšãªãããã«ããã次åã®å ç«ã®
ããã«å¿ èŠãšãããæè¬ç¯å²ã¯ã24æéã«ããã€
ãŠïŒæ¥åœã0.5ãïŒmgãŸã§å€åãããæäœã®æäž
ã«ããå身å ç«ã«ã€ããŠã¯ãæäžãããæäœã®é
éã¯ãå¿ ããããèªããããæ²»çå¹æãšé¢é£ãã
ãã®ã§ã¯ãªããå身å ç«ã®ããã®æè¬ã«ã€ããŠã®
éèŠãªå åã¯ãæäœã®æ»Žå®éãŸãã¯çç©åŠçå¹èœ
ã§ãããæäœã®æ»Žå®éã¯ãè©Šéšç¶æ³äžã«ãããå¹
æãåŒãåºãæäœã®æ倧åžé床ã«çžåœãããæäœ
ã®ïŒçš®ã®ç°ãªã調æŽè£œåã¯ãããããç°ãªãçç©
åŠäžã®å¹èœãæã€ã®ã§ééåºæºã«ãããŠåæ§ã«å¹
é©ãããã®ã§ã¯ãªããæ¬çºæã®å®æœã«ãããŠæäž
ãããæäœã«ã€ããŠã¯ããããïŒïŒ500ã®å ç«åŠ
äžã®æ»Žå®éãæ倧ã®çç©åŠäžã®å¹èœã§ããããã
ã«å ç«ã°ãããªã³ãŸãã¯æäœãåå®®é ãåå®®ãã
ã³ã©ãã管ã«éã°ãããã®å²åã¯ãïŒæ¥åœãã®æ
äœã0.1mgãè¶ããŠã¯ãªããªããæ²»çäžã®å¹æã
äžããããã«æå¹ãªãã®æ°Žæºä»¥äžã®ãããã®æè¬
å²åããåãå ¥ããããšãã§ããã æåãæäœãŸãã¯é¿åŠå€ãå«æããæ¬çºæã®åŸ®
ç²åã¯ãè¬å€ç©è³ªãå«æãã埮ç²åã®è£œé ã®ãã
ã«ãä»æ¥ãŸã§ã«å©çšãããŠããåšç¥ã®è£œæ³ã®ãã
ãã«ãã€ãŠãã補é ããããšãã§ãããæåãŸã
ã¯æäœãããã«ååšãããããšãå¿ èŠãªå Žåã®é±
æ調æŽãã«ã¢ã³ã®éã¯ãèšççã§ã¯ãªãããéåžž
埮ç²åã¯ãçŽ10ééïŒ ãã60ééïŒ ã奜ãŸããã¯
10ééïŒ ãã50ééïŒ æã奜ãŸããã¯10ééïŒ ã
ã25ééïŒ ã®æäœãŸãã¯æåãå«æãããã®ã§ã
ãã èšåºè¬äžã«æäœãæäžããããšã«ããæ£è ã«å
身å ç«ãã€ããã ãããã®ç¬¬äžã®å¶éã¯ãåç©äž
ã§ç£åºãããæäœã¯ã人éã®åçŽè ã«æ³šå ¥ããå Ž
åãããªããã°ãã°è¡æž ç ãŸãã¯éé žçãèµ·ãã
ãšã§ãããããããªãããæ¬çºæã®å±éšçã«æäž
ããæè¡ã«ããã°ãå¿ èŠãšãããæäœãããå°é
ã®æè¬éã§ãã¿ãŸãæäœãå šèº«ã«æäžããããšã
ãªãã®ã§äžã«è¿°ã¹ããããªåé¡ãèµ·ããªãã掻å
å ç«ã¯ãææç ã«å¯Ÿããæ°žä¹ çãªä¿è·ã®ããã®ã
ããªå Žåã«ã¯ãå身å ç«ãããããå©ç¹ãããã
ãã®ããã«ãæåãæ¬çºæã®æ¹æ³ã«ããåå®®ãŸã
ã¯ã©ãã管ã«éãã å Žåãç®çãšããå ç«åŠäžã®
å¹æãçºæ®ããã°ããã§ãªããå šèº«ã®å ç«ã«å¯Ÿå¿
ããŠã€ããããæäœã®ã¿ã€ãããæ§é äžããã³åº
æ¬çã«ç¬ç¹ã§ããæäœãåæ³ãããå šèº«çãªæäœ
ã¯çæ®åšç®¡ããã¯åæ³ãããªãããã®ããå šèº«ç
å ç«ã¯ãåå®®é ãåå®®ããã³ã©ãã管ã®æ¶²äžã«æ
äœãã€ããã®ã«æå¹ãªæ¹æ³ã§ã¯ãªãã 掻åå ç«ã®ä»ã®ç¹ã¯ãå粟èœåã«é¢ä¿ããŠã
ãããã®å Žåã粟液æåã¯ãæåå«æã®åŸ®ç²åã
åå®®é ãåå®®ããã³ã©ãã管ã®äžãžã®èŒžéããã
ãšã«ããéã³èŸŒãŸãããç¶æãããæéã«ããã€
ãŠãã€ãããšè§£æŸãããæåã¯ãæ¬è³ªçã«åå®®
é ãåå®®ããã³ã©ãã管ãããªãå éšåšç®¡ãèŠã€
ãŠãã液ç¶å±€äžã«ä¿è·ã®ããã®æäœãåæ³ããã
ãã«ãåšç®¡ã®åæ³çµç¹ãåºæ¿ããã亀æ¥ããã³è£
å ãžã®ç²Ÿæ¶²ã®æŸäžã®åŸãåå®®é ã®ç²æ¶²äžã®æäœã
åå®®é äžã®ç²Ÿæ¶²ã®è çãèµ·ãããããŠåå®®å ã«ç²Ÿ
液ãããã«é²å ¥ããŠããã®ãé²æ¢ããã粟液ã«å¯Ÿ
ããæäœã¯ãŸãè çã ãã§ãªãææ³ã§ãã粟液ã
äžæŽ»æ§åããã æ¬çºæã®é¿åŠå€å«æ埮ç²åã«ã€ããŠã¯ãç®çãš
ããé¿åŠå¹æãæã€ãã®ã§ãç¹ã«åºä¹³åç©ã«ãã
ãŠå¹æã®ãããã®ã§ãããããªãé¿åŠå€ã®çš®é¡ã
æ¬çºæã®åŸ®ç²åäžã«å ¥ããããšãã§ãããé¿åŠå€
ã®å¥œãŸããäŸãšããŠã¯ãããã«ããšããã·ããªãª
ãã·ãšãã¬ã³ ãšãããŒã«ããã³ãŒãããŠã ã¯
ãã©ã€ã ïŒãã³ãžã«ãžã¡ãã«ãïŒïŒâïŒïŒïŒïŒïŒ
ïŒïŒïŒâããã©ã¡ãã«ããã«âããšããã·ïŒãšã
ãã·ïŒãšãã«ãã¢ã³ã¢ããŠã ã¯ãã©ã€ãïŒãã¯ã
ãªã³ãããŒã«ïŒïŒâã¯ããâïŒâã€ã³ãããŒã«ïŒ
çã®ãããªç²Ÿæ¶²æ®ºçååç©ãããã³ããã²ã¹ãã
ã³ïŒâ³ïŒâãã¬ã°ããâïŒïŒ20âãžãªã³ïŒããšã¹
ãã©ãžãªãŒã«ïŒãšã¹ãã©ãžãªãŒã«ïŒïŒ17βâãžã·
ããªããŒãïŒãã¬ãã³ããã³ïŒ17âããããã·â
19âãã«â17αâãã¬ã°ã³âïŒâãšã³â20âã€ã³
âïŒâãªã³ïŒããã¬ã°ã¹ãã¬ã«ïŒïœïŒïŒâ13βâ
ãšãã«â17αâãšããã«â17βâããããã·âïŒ
âãšã³âïŒâãªã³ïŒããšãããžãªãŒã«ãžã¢ã»ããŒ
ãïŒ3βïŒ17βâãžã¢ã»ããã·â17αâãšããã«â
ïŒâãšã¹ãã¬ã³ïŒããªãã¹ãã¬ããŒã«ïŒ17αâãš
ããã«ãšã¹ãã«âïŒâãšã³â17βâãªãŒã«ïŒãã¡
ãããã·âããã²ã¹ããã³ã¢ã»ããŒãïŒ17βâã
ãããã·â6αâã¡ãã«ãã¬ã°ã³âïŒâãšã³âïŒïŒ
20âãžãªã³ïŒãžã¡ãã¹ããã³ïŒ17βâããããã·
â6αâã¡ãã«â17âïŒâããããã«âã¢ã³ãã
ã¹ãâïŒâãšã³âïŒâãªã³ïŒãã¡ã²ã¹ãããŒã«ã¢
ã»ããŒãïŒ17αâããããã·âïŒâã¡ãã«ãã¬ã°
ã³âïŒïŒïŒâãžãšã³âïŒïŒ20âãžãªã³ ã¢ã»ããŒ
ãïŒãã¯ãã«ããžãã³ ã¢ã»ããŒãïŒïŒâã¯ãã
â17âããããã·âãã¬ã°ãâïŒïŒïŒâãžãšã³â
ïŒïŒ20âãžãªã³ ã¢ã»ããŒãïŒããšããã«ãšã¹ã
ã©ãžãªãŒã«ïŒ17αâãšããã«âïŒïŒïŒïŒïŒïŒ10ïŒ
âãšã¹ãã©ããªãšã³3βâãžãªãŒã«ïŒãã¡ã¹ãã©ã
ãŒã«ïŒïŒâã¡ããã·â19âãã«ãŒ17αâãã¬ã°ã
ãŒïŒïŒïŒïŒïŒïŒ10ïŒâããªãšã³â20âã€ã³â17â
ãªãŒã«ïŒçã®ãããªå€©ç¶ãŸãã¯åæãã«ã¢ã³ãå«
ãŸãããæ¬çºæã®ç¯å²å ã«ããä»çš®ã®ååç©ã®äŸ
ã«ã¯ãåºä¹³é¡ã«ãããŠåæã«å èãèªçºãããã
ãªãã®ããããå èè¬æŽ»æ§ããã€ååç©ã®å¥œãŸã
ãäŸã«ã¯ãæãã¹ã¿ãã³é¡ã现èæ¯æ§è¬ããšã«ãŽ
ããã¢ã«ã«ãã€ãé¡ããã«ã¢ã³ãããã¹ã¿ã°ã©ã³
ãžã³é¡E2ããã³F2αïŒ11αïŒ15ïŒïœïŒâãžãããã
ã·âïŒâã±ãããã¹ã¿âïŒâã·ã¹â13âãã©ã³ã¹
âãžãšãã€ãã¯é žããã³ã9αïŒ11αâ15ïŒïœïŒâ
ããªããããã·âããã¹ã¿âïŒâã·ã¹â13âãã©
ã³ã¹âãžãšãã€ãã¯é žã®åã ïŒã®ãããªããã¹ã¿
ã°ã©ã³ãžã³é¡ã亀æç¥çµç Žå£æ§ååç©çãå«ãŸã
ãããã¡ãããåã ã®ååç©ãçç©åŠçã«é©åã
åŸããã®ã§ããå Žåã¯ãçš®ã ã®é¿åŠå€ã®æ··åç©
ãããŸã䜿çšã§ããã è£å ã«å ¥ããæ¬çºæã®åŸ®ç²åã®éã¯ãç®çãšã
ãé¿åŠå¹æãéæããããã«åå®®ããã³ã©ãã管
ã«éã°ããªããã°ãªããªãé¿åŠå€ã®éã«äŸåã
ããé¿åŠå¹æããããããã«ã¢ã³ã®å Žåã«ãããŠ
ã¯æäžãã¹ããã«ã¢ã³ã®æè¬ã¯ãïŒæ¥åœã20ÎŒg
ã1000ÎŒgã®ç¯å²ã«ããã粟液殺çé¿åŠå€ã®å Žå
ã§ã¯ãæçµé±æã®ã»ãšãã©ã®æ¥ã«ããã€ãŠæ¯æ¥ã®
æè¬éãæè¬ããå¿ èŠã¯ãªããåŠåš ãå¯èœãªäžé
é±æã®ãããã®æ°æ¥éã«ç²Ÿæ¶²æ®ºçå€ãåŠåš ãé²æ¢
ããã®ã«å åãªçšåºŠã®æè¬éã§æè¬ããã®ã¿ã§ã
ããéåžžãïŒæ¥éãïŒæ¥åœã25ÎŒgã1000ÎŒgã®æ
è¬éã«ããã°ãç®çãšããå¹æãéãããããã
ããã®å èè¬ã¯ãæçµã®åæ¢æã®ããåŸã®ïŒãïŒ
æ¥éãïŒæ¥åœããïŒã500mgã®æè¬éã§æäžãã
ã°ãããæåãŸãã¯æäœãå«æãããããŠæçµé±
æ調æŽãã«ã¢ã³ã®ããã®åŸ®ç²åã®è£œé ã«éããŠ
ã¯ã埮ç²åã®è£œé æ³ãšããŠã®åŸæ¥æ³ã®ãããã§ã
å©çšããããšãã§ãããç¹å®ã®æ¹æ³ã®éžæã¯äž»ã«
ãããªãã¯ã¹ç©è³ªã«ããæè¡äžã®å¿ èŠæ§ããã³ã
埮ç²åã®äœ¿çšç®çã«äŸåãããäžè¬ã«ããã€ã¯ã
ã«ãã»ã«åæ¹æ³ã¯ãïŒã€ã®ã¿ã€ãã«åé¡ãããã
å³ã¡(1)æ°Žçžãšææ©çžã®åé¢å·¥çšã溶èåæ£ããã³
ã¹ãã¬ãŒä¹Ÿç¥ãå«ãçžåé¢æ¹æ³ã(2)çé¢éåãå³
æéåããã³ååŠçèžçºæåºãå«ãçé¢åå¿ã(3)
æµååºã¹ãã¬ãŒã³ãŒãã€ã³ã°ããã³è€æ°ãŸãã¯å
äžå£ã«ããé å¿åã«ããã³ãŒãã€ã³ã°ãéé»ã³ãŒ
ãã€ã³ã°ããã³ç©ççèžæ°æåºãå«ãç©ççæ¹
æ³ãã§ããã å»çå€ããã³æ²»çå€ãå«æãã埮ç²åã¯ãçš®ã
ã®æ¹æ³ã§è£å ã«å ¥ããããšãã§ããã奜ãŸããæ¹
æ³ã¯ãç¹å®æ°ã®åŸ®ç²åããè£å ã«ç°¡åã«æã§æ¿å ¥
ããããšãã§ããããã«ãã¶ã€ã³ãããã³ã³ãã
ãŒäžã«åäœãããããšã«ãããã®ã§ãããæ¿å ¥ã³
ã³ãããŒã¯ãè£å ã«å ¥ããåŸãæ°å以å ã«æº¶è§£
ãã埮ç²åã解æŸããããšã®ã§ããçç©åŠçã«å
解å¯èœãªç©è³ªããã€ããããå¿ èŠããããè¬çšã¿
ã€ãã®ãŒã©ãã³ã«ãã»ã«ãã埮ç²åã®ããã®èŒžé
æ©æ§ãšããŠäŸ¿å©ã«äœ¿çšããããšãã§ãããæè¬é
ã«ã€ããŠã¯ãæ¿å ¥è£ å ·äžã®åŸ®ç²åã®æ°ãå¢ããã
ããæžããããããããšã«ããå€ããããšãã§ã
ãããã¡ãããçš®ã ã®ä»ã®æ¹æ³ã®ãããããããŸ
ããã®å¥œãŸããæ¹æ³ãšåæ§ã«å©çšããããšã§ã
ããäŸãã°ã埮ç²åã¯ããŒã©ãã³ã®ãããªé©åœãª
åæ£åªäœã䜿çšããããšã«ãã埮ç²åãåŠçãã
æãåçŽã§æãçŽæ¥çãªæ¹æ³ã§ããåºäœè£çšåº§è¬
ã«æ圢ããããšãã§ãããã¯ãªãŒã ããŒãªãŒãçº
泡äœãŸãã¯æ¶²ç¶ã®ãã®ãã埮ç²åã®åæ£åªäœãšã
ãŠäœ¿çšã§ããããã®ã¿ã€ãã®è£œå€ã¯è£ å¡«å¯èœãªæ³š
å°åšãŸãã¯ãšã¢ããŸã«è£ å ·ãŸãã¯ããŒãããŠãŒã
ãŸãã¯ãã«ãã®ãããªå å§è£æ¿å ¥å ·ã䜿çšããŠè£
å ã«å ¥ããããšãã§ãããè£ãŸãã¯çŽè žã«å»è¬å€
ãæäžããããã®ä»ã®çš®é¡ã®è£ å ·ã䟿å©ã«äœ¿çšã
ãããšãã§ããããŒã©ãã³ã«ãã»ã«ãããŸã埮ç²
åã®éæ¬ã®ããã«éœåã®ããéæ¬å ·ã§ããã 以äžãæ¬çºæã«ã€ããŠã®ãããå®å šãªç解ã®ã
ãç¹å®ã®å®æœäŸãæãããããããã®å®æœäŸã¯ã
åã«æ¬çºæã説æããããã®ãã®ã«ããããç¹ã«
ç¹å®ããªãããããæ¬çºæãäœãå¶éãããã®ã§
ã¯ãªãã å®æœäŸ ïŒ ããã²ã¹ããã³å«æããªä¹³é žãã€ã¯ãã«ãã»ã«
ã®è£œé 2.5gã®ããã²ã¹ããã³ãš10.0gã®dlâããªä¹³é ž
ãã38gã®å¡©åã¡ãã¬ã³ã«æº¶è§£ãããåŸãããç²
çæ§æº¶æ¶²ã¯ã120mlã®ïŒééïŒ ã®ããªããã«ã¢ã«
ã³ãŒã«æº¶æ¶²ãå«ã250mlçšããŸã«æ³šã蟌ãã ãåŸ
ãããåæ£æ¶²ãå®å®ãªãšãã«ãžãšã³ãçŽåŸ50ã
100ÎŒã®ç¯å²ã§ããå°æ»Žãã€ããããã«ãªããŸã§
çŽ2000rpmã§æ¹æããããšãã«ãžãšã³ãçºæ³¡ãã¯
ããããŸã§ç空ã«åŒãã次ãã§æ¹æã600rpmãŸ
ã§æžããããïŒæéåŸãã»ãšãã©ã®å¡©åã¡ãã¬ã³
ã¯èžçºãããé£ç¶çæ¹æã¯ãåæã®ãã€ã¯ãã«ã
ã»ã«ãåéããªãããã«å¿ èŠã§ãªãã 次ãã§ãã®ãšãã«ãžãšã³ãé å¿åé¢ã«ãããæ°Ž
æ§ããªããã«ã¢ã«ã³ãŒã«æº¶æ¶²ãéãã«æ³šãããã
ãŠãã€ã¯ãã«ãã»ã«ããè±ã€ãªã³åæ°Žã®150mläž
ã«åæ£ãããããã®åŸãçŽ18æéã«ããã€ãŠæ¹æ
ãããæ°Žåæ£æ¶²ãç空ã«ããã 次ãã§åæ£æ¶²ãé å¿åé¢ã«ãããåŸããããã€
ã¯ãã«ãã»ã«ããæ°Žã§æŽããããã«ç空濟éã«ã
ãéãããã€ã¯ãã«ãã»ã«ãã宀枩äžã§é«åºŠã®ç
空äžã«äžå€ä¹Ÿç¥ããããããããµããã«ããã43
ã61ÎŒã®ç¯å²ã®éšåãåŸãããã®è£œé å·¥çšã«ã
ãã22±1.5ééïŒ ã®ããã²ã¹ããã³ãå«æãã
ãã€ã¯ãã«ãã»ã«ãåŸãã å®æœäŸ ïŒ ããã²ã¹ããã³å«æã°ãªã»ããŒã«ã¢ãã¹ãã¢ã¬
ãŒããã€ã¯ãã«ãã»ã«ã®è£œé 4gã®æº¶èã°ãªã»ããŒã«ã¢ãã¹ãã¢ã¬ãŒãã«1.0g
ã®ããã²ã¹ããã³ãæ·»å ãã溶èæ··åç©ã®äžéš
ãã溶解ã¹ãã¬ã€ãŒã®è²¯èµåšã«æ³šã蟌ãã§ã167
âãŸã§å ç±ãããå·åŽãè¡ãããã«è£ 眮å ã«çªçŽ
ã®æµããæ¯å60lå ¥ããã溶解混åç©ãåŽé§åã
ãããã®ã¹ãã¬ã€ãŒäžãžã®çªçŽ ã®æµãã¯ãæ¯å
5.75lã®æ倧é床ã«èª¿æŽããããšã¢ããŸã«ã¯ãçŽ
ã¡ã«ã¹ãã¬ãŒããããã€ã¯ãã«ãã»ã«ã¯éãã
ãããµããã«ããããã43ã61ÎŒã®éã®ç¯å²ã®å€§
ããåºåãéããããããã®æ¹æ³ã«ãã補é ãã
ããã€ã¯ãã«ãã»ã«ã¯ãçç¶ã§ããã20ééïŒ ã®
ããã²ã¹ããã³ã®çè«éãå«ãã§ããã å®æœäŸ ïŒ ïŒé ã®ã²ã²ã«ã7.87mgã®ããã²ã¹ããã³ãå«æ
ããdlâããªä¹³é žãã€ã¯ãã«ãã»ã«ãã泚å°ãäž
æ¹ïŒé ã®ã²ã²ã«ã¯7.87mgã®ããã²ã¹ããã³ãå«æ
ããdlâããªä¹³é žãã€ã¯ãã«ãã»ã«ãè£ãéããŠ
æäžããããã¹ãŠã®ã²ã²ã¯ç¬¬ïŒæ¥ã«åŠçœ®ãããã
ã«åå®®ã®çæ€ã第12æ¥ã«åã€ããæ¯æ¥ã®ãšã¹ãã©
ãžãªãŒã«ããã³ããã²ã¹ããã³ã®è¡æ¶²ã¬ãã«ãã
ãŸãåŸããããæ¯æ¥ã®åå®ã®çµæã¯ç¬¬ïŒïŒå³ã«ç€º
ããã第ïŒïŒïŒ¡å³ã¯ããã€ã¯ãã«ãã»ã«ã®çèå
泚å°ã«ã€ããŠã®ããã²ã¹ããã³ããã³ãšã¹ãã©ãž
ãªãŒã«ã®ã¬ãã«ããäžæ¹ç¬¬ïŒïŒïŒ¢å³ã«ã¯ããã€ã¯
ãã«ãã»ã«ãè£ã«æäžããå Žåã«ã€ããŠã®ããã²
ã¹ããã³ããã³ãšã¹ãã©ãžãªãŒã«ã®ã¬ãã«ã瀺ã
ãã®ã§ãããå³äž35.75mgã¯æäžãããã€ã¯ãã«
ãã»ã«ã®ééã§ãããããã²ã¹ããã³å«æéã¯å
è¿°ããããã«7.87mgïŒ7.87mg÷35.75mgÃ100ïŒçŽ
22ééïŒ ïŒã§ãããçèå 泚å°ããããã²ã²ã®æ¹
ãè£å ã«åŠçœ®ããã²ã²ãããé«ãããã²ã¹ããã³
ã®æ¿åºŠãæããã«èŠãåºããããããã«ã€ããŠã¯
äºã€ã®å¯èœæ§ãäºæž¬ããããå³ã¡ (1) è£å ã«å ¥ãããããã€ã¯ãã«ãã»ã«ã®äžéšã
ããåŠçœ®åŸã®ïŒæ¥ç®ãŸã§ã®ãã€ãŠããªãããšã (2) è£å ã«å ¥ããããšã«ããããã€ã¯ãã«ãã»ã«
ãã解æŸãããããã²ã¹ããã³ã®äžéšããè¡æ¶²
ã®æµãã«ãšã©ããªãããããã®å¯èœæ§ã®äž¡æ¹ã
å€åãäºã€ã®åŠçœ®æ¹æ³ã®éã®ããã²ã¹ããã³ã®
å šèº«çã¬ãã«ã«ãããå·®ç°ã«é¢äžããŠãããã
ãã²ã¹ããã³ã®å šèº«ãžã®éæ¬ãåç¬ã§ãããè£
å ã«åŠçœ®ããåç©ã«ãããŠãåå®®ãžã®çŽæ¥ã®å±
éšç茞éã®å¯èœæ§ãæé€ããããšãããšãçè«
çã«ã¯æ³šå°ã«ããåŠçœ®ãããã²ã²ã«ãããŠã¯ã
è£å ã«åŠçœ®ãããã²ã²ã«ãããŠãããã匷ãé¿
åŠå¹æãæåŸ ã§ããããããŠæçšéã«å¯Ÿå¿ãã
å®éšããã®çµæã¯ããã®æåŸ ãæ¯æããŠããã
ããããªãããã²ã²ã®åå®®å èçæ€ã®æ¯èŒã®ã
ãã®çµç¹åŠäžã®å®éšã¯ãã®ä»®å®ãæ¯æããŠããª
ããè£æè¬ã«ããæ²»çããã²ã²ã«ãããããã²
ã¹ããã³äžèªå ã«ããåæ³æŽ»æ§ã®ã¬ãã«ã«ã€ã
ãŠãçèå 泚å°ã«ããæ²»çãããã²ã²ãšæ¯èŒã
ãå Žåãçµç¹åŠäžã®å®éšã§ã¯ãé¡èãªæžå°ã¯çŸ
ãããªããããã¯ãããã²ã¹ããã³ã®å šèº«çã¬
ãã«ã«ãããå·®ç°ã«åºããã°ãããã»ã©äºæã
ããªãã€ãããšã§ããããã®è¡šé¢äžã®ççŸãã
çºèŠã¯ãå®éã«ãè£å åŠçããã²ã²ã«ã€ããŠ
ã®ãããã²ã¹ããã³ã®å±éšç茞éã®å¯èœæ§ãæ¯
æããŠããã第ïŒïŒïœå³ããã³ç¬¬ïŒïŒïœå³ã¯ã
7.87mgã®ããã²ã¹ããã³ãå«æããŠãããã€ã¯
ãã«ãã»ã«ã®è£å æäžã«ããåŠçœ®ãããã²ã²ã®
åå®®å èã®çµç¹ã®å€èŠ³ã瀺ããã®ã§ããã
ïŒåã ã20åããã³100åã§æ¡å€§ããïŒïŒ¥æ±æ
çµç¹ã§ãããïŒç¬¬ïŒïŒïœããã³ïŒïŒïœå³ã¯ã
åã 20åããã³100åã§æ¡å€§ããåãçµç¹
ïŒPASæ±æïŒã§ããã è£ã«åŠçœ®ããåç©ã«ãããããã²ã¹ããã³ã®å±
éšçéæ¬ãæ¯æããçµç¹åŠäžã®èšŒæ ã®ç¬¬ïŒã¯ãå
å®®å èçµç¹ã«ãããããã²ã¹ããã³ã«èªåŒããã
å€åãã埮ç²åã泚å°ã«ããåŠçœ®ãããã²ã²ã®å
å®®å èã§ã¯åäžã«å šäœã«èµ·ãããäžæ¹åŸ®ç²åãè£
å ã«æ¿å ¥ãããã«ããåŠçãããã²ã²ã§ã¯ããã®
å¹æãå±éšåãããŠãããè¡šé¢äžç®ã®äžã«ããè¡š
é¢è ºã«ãããŠç¥èŠã§ãã匷床ã®åºæ¿ã§ãè ºããè º
ãŸã§å€åããïŒç¬¬ïŒïŒå³åç §ïŒãšãã芳å¯ã«åºã
ããŠããããããã泚å°ã«ããåŠçœ®ãåããã²ã²
ã«ãããŠã¯ãè¡šé¢è ºã«ãµãããŠã¯ãªã€ãŒ
ïŒSubnuclearïŒç©ºèããªããè£ã«åŠçããã²ã²ã«
ãããŠã¯è¡šé¢è ºã«ããããã®ãµãããŠãŒã¯ãªã€ãŒ
空èãååšãããšããããšã¯ãè£ã«åŠçœ®ããã²ã²
ã«ãããŠãå±éšçãªåå®®å éšãžã®éæ¬ãè¡ããã
ããšã蚌æ ç«ãŠãŠããã é»åé¡åŸ®é¡ãèµ°æ»ããããšã«ããè¡šé¢äžç®çµç¹
ã®æ¯èŒå®éšã¯ããã€ã¯ãã«ãã»ã«ã«ããè£å åŠçœ®
ã«ããå±éšåãããé¿åŠå¹æã«ã€ããŠã®ããã«é²
ãã 蚌æ ãæäŸããŠãããå³ã¡ç¬¬ïŒïŒå³ã¯ãåå®®
ã®äžç®è¡šé¢ã®çµç¹ãæ¯èŒããŠãããã®ã§ããã第
ïŒïŒïœå³ã¯åžžæ ã®æªåŠçœ®ã®ç¬¬12æ¥ç®ã®ã²ã²ã®åå®®
å èã第ïŒïŒïœå³ã¯åžžæ ã®æªåŠçœ®ã®ç¬¬20æ¥ç®ã®å
å®®å èã第ïŒïŒïœå³ã¯ãåŠçœ®ãæœãã12æ¥ç®ã®å
å®®å èïŒ7.87mgã®ããã²ã¹ããã³ãå«æãããã€
ã¯ãã«ãã»ã«ã®çèå 泚å°ã«ããïŒã第ïŒïŒïœå³
ã¯ãåŠçœ®ãã»ã©ããã12æ¥ç®ã®åå®®å èïŒ7.87mg
ã®ããã²ã¹ããã³ãå«æãããã€ã¯ãã«ãã»ã«ã®
åå®®å æäžã«ããïŒã§ããã ããã²ã¹ããã³ã¯ãè ºã®äžç®çŽ°èã®å è¡šé¢
ïŒluminal surfaceïŒã«é¡èãªåŸ®å°çµšæ¯æ¬æ¥ã®çªèµ·
ã®çæãå°ã³ãã埮å°çµšæ¯ã¯ãæåµã®åã«ã¯ãæ®
éã¯ååšããªããïŒç¬¬12æ¥ç®ã®èª¿æŽãåç §ïŒãã
ãæåµã®åŸã«ã¯ãéåžžã«ç®ç«ã€ãŠãããïŒç¬¬20æ¥
ç®ã®èª¿æŽãåç §ïŒç¬¬ïŒæ¥ã第12æ¥ã®éã«é£ç¶çã«
ããã²ã¹ããã³åŠçãè¡ããšå€æ°ã®åŸ®å°çµšæ¯ã®çª
èµ·ã®çæãèµ·ããã 埮å°çµšæ¯ã¯ã泚å°ã§åŠçœ®ããã²ã²ã®åå®®å èè¡š
é¢äžã«ãåäžãªååžã§çãããããããªããè£å
ã«åŠçœ®ããã²ã²ã«ãããŠã¯ã埮å°çµšæ¯ã¯ç¬ç¹ã®æ
ç¹ã§çããã埮å°çµšæ¯ã®ãããç¶ã®äžåäžãªååž
ã¯ã埮å°çµšæ¯ã®ãããªãäžç®çŽ°èã«ããã垯åãš
埮å°çµšæ¯ã倧ãããå€ãã垯åãšã®éã«çããã
è¡šé¢äžç®ã®åœ¢æ ã«ãããããã²ã¹ããã³ã«ããç
ããå€åã®äžåäžãªååžã¯ãããã²ã¹ããã³ã®åº
æ¿ã®å±éšåããã垯åã瀺ããã®ã§ãããå šèº«ç
ã«æäžããå Žåãåå®®å èã®ãã¹ãŠã®åž¯åãåäž
ãªè¬å€ã®æäžãåããããå±éšçæäžã®å Žåã¯ã
埮ç²åãåå®®å ã«ååšãããšããã«ãããããé«
ããŸãã¯ããäœãæäžãåããã 第ïŒïŒïŒ¡å³ããã³ç¬¬ïŒïŒïŒ¢å³ã¯ãçèå 泚å°ã«
ããå ŽåïŒç¬¬ïŒïŒïŒ¡å³ïŒãšè£å æäžã«ããå Žå
ïŒç¬¬ïŒïŒïŒ¢å³ïŒã®ã²ã²ã«ã€ããŠã®äžèšã®æ¡ä»¶äžã«
ãããŠã®1.57mgã®ããã²ã¹ããã³å«æãã€ã¯ãã«
ãã»ã«ã®æäžã«ããããã²ã¹ããã³ãšãšã¹ãã©ãž
ãªãŒã«ã¬ãã«ãæ¯èŒãããã®ã§ãããå³äž7.15mg
ã¯æäžãããã€ã¯ãã«ãã»ã«ã®ééã§ããããã€
ã¯ãã«ãã»ã«ããã®ãããªå°éã§æäžããå Žåã
ããã泚å°ã«ããæäžããå Žåãšã¹ãã©ãžãªãŒã«
ã«ã€ããŠã¯ããããªé»æ¢å¹æã瀺ãããè£å æäž
ã®å Žåã«ã¯ãå¹æããªãã泚å°ã§åŠçœ®ããã²ã²ã®
å Žåãå€ççããã²ã¹ããã³ã¯ã第ïŒæ¥ç®ãš12æ¥
ç®ã®éã«è¡æ¶²äžã«äœã¬ãã«ã§ååšãããããããª
ããè£çµç±ã®å Žåãå€ççããã²ã¹ããã³ã¯ã第
ïŒæ¥ç®ãã第12æ¥ç®ã®éã«ãããŠãåææè¡ã®æ
ç¥ç¯å²ã§ã¯è¡æ¶²äžã«æ€åºãããªãã€ãã 第ïŒïŒå³ã«ç€ºãããæ¯èŒãã«ã¢ã³ããŒã¿ããã³
å±éšçéæ¬ã®å¯èœæ§ãé€å€ããå Žåãè£ã«åŠçœ®ã
ãã²ã²ã®åå®®å èã®çµç¹ã¯ãåžžæ ã®æªåŠçœ®ã®èª¿æŽ
ã«ãããŠèŠ³å¯ããããã¿ãŒã³ãšäŒŒãŠãããäºæž¬ã
ãã®ãçè«çã§ããããã«ã¿ããã埮ç²åã®äœæ
è¬éã§ãè£çµç±ã§åŠçœ®ããã²ã²ã«ãããããã²ã¹
ããã³ããã³ãšã¹ãã©ãžãªãŒã«ã®äž¡æ¹ã®è¡æ¶²ã¬ã
ã«ãåžžæ ã«ãããŠçãããããšåäžã§ããããš
ãããã®äºæž¬ã«å¯Ÿããçè«çæ ¹æ ã§ãããããã
ãªããã泚å°ã«ããåŠçœ®ããåç©ã«ã€ããŠã¯ãã
ã®åŠçã«ãããæ€åºã§ããã ãã®ããã²ã¹ããã³
ã¬ãã«ãã第ïŒã12æ¥ç®ã®éã«è¡æ¶²äžã«çºèŠãã
ãã®ã§åäžã®çè«çæ ¹æ ã¯ä¿ãŠãªããããã«ãšã¹
ãã©ãžãªãŒã«ã¬ãã«ã¯ãåžžæ ã®èª¿æŽãšæ¯èŒããå Ž
åãããåäœäžããããã«ã¿ãããããããŸãã
çµç¹åŠäžã®èª¿æ»çµæã¯ããã®äºæž¬ãããçµæã«å
ãããã®ã§ãããè£å çµç±ã«ããåŠçœ®ãããã²ã²
ã«ããã枬å®å¯èœãªå šèº«çãªããã²ã¹ããã³ããª
ãã®ã«ãããããããåå®®å èã¯æãããªåŠåš å
ã®å¹æã瀺ãã é»åé¡åŸ®é¡ãèµ°æ»ãããããšã«ããè¡šé¢äžç®çµ
ç¹ã®æ€æ»ã§ã¯ã第ïŒïŒå³ã«ç€ºãããã«ããã²ã¹ã
ãã³ã®åºæ¿ã®æãããªèšŒæ ã瀺ã埮å°çµšæ¯ã®é »ç¹
ãªçºçãçŸããããç¹ã«ã第ïŒïŒïœå³ããã³ç¬¬ïŒ
ïŒïœå³ã¯ãæçµé±æã®ç¬¬12æ¥ç®ã«åŠçœ®ããã²ã²ã®
è¡šé¢äžç®ã®äœãæ¡å€§ïŒ9600ïŒããã³é«ãæ¡å€§
ïŒ18240ïŒã«ããé¡åŸ®é¡åŸåçã§ããã第ïŒïŒïœå³
ã¯ãäžç®è¡šé¢ã«ããããã€ã¯ãã«ãã»ã«å«æãã
ã²ã¹ããã³ã瀺ãäžç®ã®é¡åŸ®é¡åçã§ãããäžæ¹
第ïŒïŒïœå³ã¯ããã€ã¯ãã«ãã»ã«ãã®ãã®ã®é¡åŸ®
é¡åçã§ãããäžç®çµç¹ã«ãããããã²ã¹ããã³
ã«ããèªåŒãããå€åã¯ãæ¡çšããæ€åºè©Šéšæ³ã«
ãã€ãŠæž¬å®ããã«ã¯äœãããå šèº«çãªããã²ã¹ã
ãã³ã«å¯Ÿå¿ããŠçããããããããããã説æ
ã¯ãããã²ã¹ããã³ã®çŽæ¥ã®å±éšçåå®®å éæ¬ã«
ããçµæã§ãããšããããšã«ãªãã æã匷調ãããã¹ãç¹ã¯ããã€ã¯ãã«ãã»ã«ã®
å°ãªãæè¬éïŒå³ã¡ããã²ã¹ããã³ã®7.87mgïŒ
ã§ãåæ³å€åããåå®®å èã«ãããŠçãããšãã
ããšã§ãããããã«ãå€åã䌎ãæè¬éã®å¯Ÿå¿
ã¯ãæè¬éã®å¢å ã«ãšããªããçæ®æ©èœãé»æ¢ã
ãã®ã«å åãªå¹æã¬ãã«ãéæããããšãå¯èœã§
ããããšã®ç€ºåã衚瀺ããŠããã 第ïŒïŒïŒ¡å³ããã³ç¬¬ïŒïŒïŒ¢å³ã¯ãæçµé±æã®å
æ¥ã«ããäºé ã®ã²ã²ã®éã®åå®®é çèã®å瞮掻å
ãæ¯èŒãããã®ã§ãããW.D.Blairããã³L.R.
Beckã«ããScriptor PublicationïŒã³ãã³ããŒã²
ã³ïŒçºè¡ã®Ovun Transport and Fertility
Regulation 1976幎ã®41ã74é ã®èšèŒã«ããã€ã
ãããç¹æ®å€æåšããåã ã®ã²ã²ã®åå®®é ã«å ¥ã
ããã®ãçšããŠããã®å³ã«ç€ºãããåå®®é ã®åçž®
ã®ãã¿ãŒã³ã枬å®ããããã®å€æåšããã¹ããªã
ããã€ãŒãèšé²åšã«ã€ãªãã ã第ïŒïŒïŒ¡å³ã¯ããš
ã¹ãã©ãžãªãŒã«ãå«æãã埮ç²åãè£å ã«å ¥ãåŠ
眮ããã²ã²ããåŸãããçµæã瀺ããã®ã§ããã
äžæ¹ç¬¬ïŒïŒïŒ¢å³ã¯ã埮ç²åã§åŠçããªã調æŽã²ã²
ããåŸãããçµæã瀺ããçµæã¯åŠçœ®ããããšã«
ãããåå®®é ã®åçž®ã®é »åºŠããã³æ¯å¹ ã®äž¡æ¹ãåº
æ¿ããããããã®åçž®ã¯ããã®åšç®¡ãéããŠåŸ®ç²
åãåããã æ¬é¡çºæã®å¥œãŸããæ æ§ã®è¥å¹²ã以äžã«èŠçŽã
ãŠåæããã (1) æåãŸãã¯æäœãå«æããŠãã埮ç²åãã女
æ§çæ®èåšã«å ¥ãããã®åŸ®ç²åãçæ®åšç®¡ã®èª
ç¶ã®éæ¬æ©æ§ã«ãããåå®®é éšãéããŠåå®®ã
ãã³ã©ãã管ã®äžã«éã°ããããã§æåã埮ç²
åã«ãã€ãŠã解æŸãããããšãããªã女æ§çæ®
èåšã®å ç«åå¿ã掻åçãŸãã¯ååçã«èªåŒã
ãæ¹æ³ã (2) 埮ç²åã20ã70ÎŒã®å€§ããç¯å²ã§ããããã
ãªãã¯ã¹ç©è³ªãããªä¹³é žãããªã°ãªã³ãŒã«é žãŸ
ãã¯ãããã®æ··åç©ã§ããåèšç¬¬ïŒé èšèŒã®æ¹
æ³ã (3) æåãããã¯ããªã¢èãŸãã¯ããŒã«ã¹èã§ã
ãåèšç¬¬ïŒé èšèŒã®æ¹æ³ã (4) æäœãŸãã¯æåãšãæçµé±æ調ç¯ãã«ã¢ã³ã
å«æãã埮ç²åãè£ã«å ¥ãã埮ç²åããã®ãã«
ã¢ã³ã®åžåã«ããå éšçæ®åšç®¡ã®èªç¶ã®éæ¬æ©
æ§ãåºæ¿ãã埮ç²åã粟液代çšæŽ»æ§ã«ãããå
å®®é ããåå®®ããã³ã©ãã管ã®äžã«ãã®éæ¬æ©
æ§ã§éã°ããããã§ã埮ç²åããæäœã解æŸã
ããããšãããªã女æ§çæ®èåšãååçãŸãã¯
掻åçã«å ç«ããæ¹æ³ã (5) æçµé±æ調æŽãã«ã¢ã³ãããã²ã¹ãã³ãŸãã¯
ãšã¹ããã²ã³ã§ããåèšç¬¬ïŒé èšèŒã®æ¹æ³ã (6) æåããããŒã«ã¹èãŸãã¯ãã¯ããªã¢èã§ã
ãåèšç¬¬ïŒé èšèŒã®æ¹æ³ã (7) è£å ã§ããšã¹ããã²ã³ããæçµé±æã®ãšã¹ã
ãã²ã³æ®µéã®ïŒã14æ¥ãéãåããããã«ãå®
å®ããŠè§£æŸããããã«è£å ã«ãšã¹ããã²ã³ãå«
æãã埮ç²åãå ¥ããåå®®é ã®åŸ®ç²åã®éæ¬ã
ä¿é²ããè£å ã§ããã²ã¹ãã³ããæçµé±æã®ïŒ
ã28æ¥åŸã«è§£æŸããæçµé±æã®ããã²ã¹ãã³æ®µ
éãéãåããããã«ãè£å ã«ããã²ã¹ãã³ã
å«æãã埮ç²åãå ¥ããããã«æçµé±æã®12ã
16æ¥ã®éã«ãæäœãŸãã¯æåãå«ã埮ç²åãã
åå®®é ãéããŠåå®®ããã³ã©ãã管ãŸã§æ倧é
æ¬ããããšãã§ãããããããææã«ãæåãŸ
ãã¯æäœãå«ã埮ç²åãè£å ã«å ¥ããåå®®ãã
ã³ã©ãã管ã§æäœãŸãã¯æåã解æŸããããã
ã«ããããšãããªã女æ§çæ®èåšã«å¯ŸããŠæäœ
ãŸãã¯æåãæè¬ããŠã女æ§ã®æçµé±æãéã
åããæ¹æ³ã (8) é¿åŠå€ãšçç©åŠçã«å£åãåŸãçç©åŠçã«å Œ
çšã§ãããããªãã¯ã¹ç©è³ªãããªã粟液代çšæŽ»
æ§ãæããé¿åŠã®ããã«æå¹ãªéã®åŸ®ç²åãè£
ã®äžã«å ¥ãããããŠããã®åŸ®ç²åããçæ®èåš
ã®èªç¶ãªèŒžéæ©æ§ã«ãããåå®®é ãéããŠåå®®
ã«éæ¬ããããããã§åŸ®ç²åããé¿åŠå€ã解æŸ
ããããšã«ãããé¿åŠå€ãåå®®ããã³ã©ãã管
ã«çŽæ¥éæ¬ãããããšã«ãããªããé¿åŠå€ã®å
å®®ããã³ã©ãã管ãžã®èŒžéæ¹æ³ã (9) 埮ç²åããæçµé±æã®äžéé±æãã以åã«è£
ã«å ¥ããããšããããŠé¿åŠå€ãããã²ã¹ããã³
ãŸãã¯ãšã¹ãã©ãžãªãŒã«ã§ãããåèšç¬¬ïŒé èš
èŒã®æ¹æ³ã (10) é¿åŠå€ããçæ®èåšã«ïŒæ¥åœã0.10ã1.0mg
ãã€è§£æŸãããåæ第ïŒé èšèŒã®æ¹æ³ã (11) é¿åŠå€ãåå®®ããã³ã©ãã管ã«éæ¬ãããã
ã®æ¹æ³ã§ãã€ãŠã埮ç²åããé¿åŠå€ãšããŠãã«
ã¢ã³ã䜿çšããå Žåãé±æ調æŽãã«ã¢ã³ãšããŠ
é¿åŠå€ãšç°ãªããã®ã䜿çšãããšããæ¡ä»¶äž
ã«ãçç©åŠçã«å£åããããšãã§ãããããç
ç©åŠçã«å Œçšããããšã®ã§ãããããªãã¯ã¹ç©
äžã«ååšããé¿åŠå€ãšé±æ調æŽãã«ã¢ã³ãšãã
ãªããã®ã§ããããã®ç²Ÿæ¶²ä»£çšæŽ»æ§ãæãã埮
ç²åãè£å ã«é¿åŠã®ããã®å¹æéã§å ¥ããåå®®
é ãéããŠåå®®ããã³ã©ãã管ã®äžãžãšåãã
çæ®èåšã®èªç¶èŒžéæ©æ§ãåºæ¿ããã®ã«å åãª
éã«ãããŠã埮ç²åããé±æ調æŽãã«ã¢ã³ãé£
ç¶çã«è§£æŸããã埮ç²åãåå®®é ããåå®®ãã
ã³ã©ãã管ã®äžã«ééãããšããããã§é¿åŠå€
ã®è§£æŸãçããããã«ããããšãããªãæ¹æ³ã (12) 埮ç²åããæçµé±æã®äžéé±æ以åã«è£ã«å ¥
ããåèšç¬¬11é èšèŒã®æ¹æ³ã (13) æçµé±æ調æŽãã«ã¢ã³ããããã²ã¹ãã³ãŸ
ãã¯ãšã¹ããã²ã³ã§ããåèšç¬¬11é èšèŒã®æ¹
æ³ã (14) ãšã¹ããã²ã³å«æ埮ç²åãè£ã«å ¥ãããã
ã§ãšã¹ããã²ã³ãå®å®ããŠè§£æŸãããæçµé±æ
ã®ãšã¹ããã²ã³åå¿ææã®ïŒã14æ¥ãéãå
ãããããŠãåå®®é ã§ã®åŸ®ç²åã®èŒžéãä¿é²
ããããã²ã¹ãã³å«æ埮ç²åãè£å ã«å ¥ããè£
ã«ãããŠãããã²ã¹ãã³ãæçµé±æã®ïŒã28æ¥
ã®åŸã«è§£æŸãããããã«ãããæçµé±æã®ãã
ã²ã¹ãã³æ®µéãéãåããããã«é¿åŠå€ãå«æ
ãã埮ç²åããæçµé±æã®12ã16æ¥ã®éã«ãã
ãåå®®é ãéããŠåå®®ããã³ã©ãã管ãžã®æ倧
茞éã®ããã«å åãªããææã«è£ã«å ¥ããåå®®
ããã³ã©ãã管ã§é¿åŠå€ã解æŸãããããã«ã
ãããšãããªãã女æ§çæ®èåšãžã®é¿åŠå€ãæ
è¬ããŠã女æ§ã«ãããæçµé±æãéè€ããæ¹
æ³ã (15) ãšã¹ããã²ã³ãã埮ç²åããïŒæ¥åœã0.1ã
ïŒmgã®é床ã§è§£æŸãããããã«ããã²ã¹ãã³ã
ïŒæ¥åœã0.5ãïŒmgã§è§£æŸãããåèšç¬¬14é èš
èŒã®æ¹æ³ã (16) 埮ç²åå šäœããããã²ã¹ããã³ãåæ£ãã
ãããšã®ã§ããããªä¹³é žãããªã埮ç²åãè£ã«
å ¥ãã埮ç²åããã®ããã²ã¹ããã³ã®è§£æŸã«ã
ãã埮ç²åã®åå®®é ããåå®®ãžã®èŒžéãè¡ãã
ãã®èªç¶ã®èŒžéæ©æ§ãåºæ¿ãããããã«ç®çãš
ããé¿åŠå¹æãéæããã®ã«å åãªéã«ãããŠ
åå®®é ã«ããã埮ç²åããã®ããã²ã¹ããã³ã®
åå®®ããã³ã©ãã管ãžã®ããã«é²ãã 解æŸãè¡
ãããšãããªããå éšçæ®åšç®¡ãžã®é¿åŠå€ã®æ
è¬ã«ããå éšçæ®åšç®¡ã®èªç¶ã®èŒžéæ©æ§ãåºæ¿
ããæ¹æ³ã
ãžæ²»çäžããŸãã¯å»åŠäžã®è¬å€ããã³è©²è¬å€ã®æ
äžããããã®æ¹æ³ã«é¢ãããã®ã§ããã åŸæ¥ã女æ§ã®çæ®èåšãåãæ±ãæ¹æ³ãšããŠ
ã¯ãç æ°ãåŠçããããããã³å¥³æ§ã®çæ®é±æã
調æŽããããã«ç 人ã«è¬ç©ã飲çšãããã泚å°ã
ãã®ãäž»ãªæ¹æ³ã§ãã€ãã女æ§çæ®èåšãåŠçœ®ã
ãéãè£ã«çŽæ¥ã«æ²»çå€ãæäžããããšã«ããã
ãã€ãã®æ¹æ³ãç¥ãããŠãããé¿åŠå¹æã®ããã¹
ããã€ããåå®®ã«çŽæ¥éãå±ããããšã«ããéæ
ãããäžã€ã®æè¡ã¯ãè¬çšå éšåå®®è£ å ·ã§ãããš
ããã®ããã²ã¹ãã«ãè£ å ·ã§ããããã®è£ å ·ã«ã€
ããŠã¯ãã¶ãã¢ããŒãã«ããç±³åœç¹èš±ç¬¬3699951
å·ããã³ç¬¬3777015å·ã«èšèŒãããŠãããæ¿å ¥è£
å ·ã®æ¬ ç¹ã¯ãè£ã«ãã®è£ å ·ãå ¥ããããã«ã¯ãç
ç·Žããå€ç§å»ã®æããããªããã°ãªããªãããšã§
ãããåŸã€ãŠãæåãŸãã¯æäœã®ãããªä»ã®è¬å€
ãšåæ§ã«èªåã§æäžã§ããé¿åŠå€ã®æ¹è¯æ¹æ³ã®å¿
èŠã«è¿«ãããŠããã é¿åŠå€ããã€ã¯ãã«ãã»ã«ã®ããã¡ã«ããŠãè£
ã«æ¿å ¥ããããã€ãã®æè¡ãç¥ãããŠããããã
ããã®æè¡ã«ãããŠã¯ããã€ã¯ãã«ãã»ã«ã®åå®®
é ãéããŠã®åå®®ãžã®èŒžéã¯ã§ããªããäŸãã°ã
ç±³åœç¹èš±ç¬¬3921636å·ããã³ç±³åœç¹èš±3918452å·ã§
ã¯ãè¬å€ã¯ãè£ã«æ¿å ¥ãããã¿ã³ãã³äžã§åŸ®ç²å
ãã解æŸãããã ã¶ãã¢ããŒãã«ããç±³åœç¹èš±ç¬¬3699951å·ãã
ã³ç±³åœç¹èš±ç¬¬3777015å·äžã«ç€ºãããæè¡ã«ãã
ãŠã¯ãé¿åŠã®ç®çã§ãåå®®äžã«ããã²ã¹ããã³ã
çŽæ¥è§£æŸããããã«ãã¶ã€ã³ãããå éšåå®®è£ å ·
ã«ã€ããŠè¿°ã¹ãŠãããããããªãããã®è£ å ·ã¯ã
çç©åŠçã«å£åããªããã®ã§ãããåå®®ã«è£ å ¥ã
ãããåå®®ããã¯ããããããå Žåã«çç·Žããå€
ç§å»ã«ããè¡ããªããã°ãªããªããåŸã€ãŠããã®
è£ å ·ã¯ãèªåã§äœ¿çšããããšãã§ããªããšããäº
å®ã«ããå¶éãåããŠããã åæã®ç 究ã§ã¯ãè£ã«æ¿å ¥åŸãåå®®é ãéããŠ
åå®®ãžç§»åãããããªå¯èœãªç²åç¶ç©è³ªã®åéã
調æ»ããããšãè¡ãããããã®å ŽåãççŽ ç²åã®
æµ®éç©ãå«ããã€ããããã®ççŽ ç²åããåå®®é
ã«æœããå ŽåãççŽ ç²åã亀æ¥ã®åŸãåå®®ããå
åããããšãã§ããããšãå€æããŠããã
ïŒAmerskachïŒâSterilitat UndãFrigidtatâ
Muchen MedïŒWchnschr.77ïŒ225ïŒ1930ïŒJ.
Traplã®âheuve Anschauunger uber den Ei
und Samentransport in den Geshlechtsteilen
de FrauâZentralbl Gynak67ïŒ547ïŒ1943ã§ã¯ã
åå®®é ãã€ããã䜿çšããªããŠããã«ãŒãã³ç²å
ã¯ç§»äœããããšã瀺ããççŽ ä»¥å€ã®éèªåæ§ããŸ
ã移äœããããšã蚌æ ç«ãŠããããã«ãŸããR.
Krehbielããã³H.P.Carstensã®âRoentgen
RabbitâAm.J.physiol.125ïŒ571ïŒ1959ã§ã¯ãã
ããã®è£ã«æŸå°ç·é®æãªã€ã«ïŒradioâ
opaqueoilïŒãå ¥ããå Žåãé°éãåºæ¿ãããåŸ
ãŸã§åŠšå®³ãããããšã瀺ãããŠããããŸãä»ã®ç
究è çãããŒã©ãã³äžã®ã°ã©ãã¢ã€ãããã³ææ
ã¯ãåå®®é ãéããŠèŒžéãããªãããšã瀺ããŠã
ãããã®ããŒã¿ã®æå³ãããšããã¯ãç²åã®ç¹æ§
ã茞ééçšã«åœ±é¿ãåãŒããšããããšãšã茞é
ã¯ãçèã®åçž®ã«ããä¿é²ããããšããããšã§ã
ããHartmanã¯ãâHow Do Sperms GetãInto
the uterusïŒâFertil.and Steril ïŒïŒ403ïŒ1957
ã®äžã§ãçæ®ç³»ã«ããã粟åã®èŒžéã«é¢ããŠã茞
éã¯ãäž»ã«ç²åãšå¥³æ§çæ®ç³»ã®çèçµç¹ãšã®åå
ã«ããçããããšã瀺ããŠãããE.S.E.Hafezã
ãã³T.N.Euansã®ç·šéã«ããHarper and RowïŒ
New York 1973 çºè¡ã®G.M.Duncanããã³D.
R.Kalkwarf ã«ããâHuman ReproductionïŒ
Conception and Contraceptionäžã®
âSubstained Release Systems for Fertity
Controlâã«ãããŠãã»ãŒç²Ÿåã®é ã®å€§ããã®é
èªåæ§ç²åã¯ãåå®®é ãéããŠçŽæ¥ã©ãã管ã«ç§»
äœãããšããããšãå®éšã«ããçµè«ä»ããããã
ããªããããã®è«æã§ã¯ãïŒã1400ÎŒã®å€§ããç¯
å²ã®ã»ã«ããŒã¹ã¢ã»ããŒãããã¬ãŒããããªãã
ãã²ã¹ããã³å«æãã€ã¯ãã«ãã»ã«ã¯ãåå®®é ã
éããŠåå®®ã«ç§»äœããã«ãéã®æ¹åã«èŒžéããã
ããšã瀺ããŠãããåŸã€ãŠãã®æç®ã§ã¯ã5ÎŒã
ã倧ããªãã€ã¯ãã«ãã»ã«ã¯ã女æ§çæ®åšã®å éš
ã«ç§»äœããªãããšãæ確ã«ç€ºåããŠããã åŸã€ãŠãæ¬çºæã®äžã€ã®ç®çã¯ãå»è¬ããã³æ²»
çå€ãè£ã«å±éšçã«æäžããããšãã§ãã女æ§ç
æ®èåšãæ²»çããããåå®®é ãéããŠåå®®ã®äžã«
éãããšã®ã§ããè¬å€ãšãã®æ¹æ³ãæäŸããããš
ã«ããã ããã«æ¬çºæã®ä»ã®ç®çã¯ãè£ã«å ¥ããå Žåã
çæ®èåšã®èªç¶ã®èŒžéæ©æ§ã«ãããåå®®é ãéã
ãŠåå®®ã«éãããšã®ã§ããè¬å€ãå«æãã埮ç²å
ç¶è¬å€ãæäŸããããšã«ããã ç°¡åã«è¿°ã¹ãã°æ¬çºæã®ãããã®ç®çããã³ä»
ã®ç®çã¯ãè¬å€ãå«æããŠãªãç¹å®ã®åŸ®ç²åç¶è¬
å€ãè£ã«å ¥ããå éšåšç®¡ã®èªç¶ã®èŒžéæ©æ§ã«ã
ãããã®åŸ®ç²åãåå®®é ãéããŠåå®®ã«éã¶ããš
ã«ããã女æ§çæ®èåšãžã®è¬å€ã®éæ¬ãå¯èœã«ã
ãããšã«ããéæã§ããã æ¬çºæã®æ倧ã®ç®çã¯ãå°ããšãïŒçš®ã®è¬å€ã
æããŠãªã埮ç²åãæäŸããããšã«ããã該埮ç²
åãè£å ã«å ¥ããå Žåãèªç¶ã®èŒžéæ©æ§ã«ããå
å®®é ãéããŠå°ãªããšãåå®®å ã«ãããŠå¯èœãªã
ã©ãã管å ã«éã³ããããšãã§ããããã§è¬å€ã®
解æŸãçããããã«ãããã®ã§ãããæ¬çºæã®äž
ã€ã®æ æ§ã§ã¯ã埮ç²åã®éæ¬ã¯ãçš®ã ã®æåãã
ã³æäœãçŽæ¥å¥³æ§çæ®èåšãŸã§åã³ãçæ®åšç®¡ã®
åŠçœ®ã®ããã«æåããã³æäœã®å šèº«çå°å ¥ãè¡ã
ãªãã§ããããã«ããããã«è¡ããããå šèº«çå°
å ¥ã¯ãçæ®åšç®¡ã®åŠçœ®ã®ããäœå ã«å€ãã®æåãŸ
ãã¯æäœãæäžããããã®æ段ãšããŠäºå®äžå©çš
ããããšãã§ããªããæ¬çºæã®ç¬¬ïŒã®äž»ãªæ æ§
ã¯ãé¿åŠå€ãè£ã«å°å ¥ããããã®é¿åŠå€ãå«æã
ãŠãªã埮ç²åç¶è¬å€ãæäŸããããšã«ããã該埮
ç²åã®å°å ¥ã«ããããããåå®®é ãéããŠåå®®ã«
éã¶ããšãã§ãããæ¬çºæã®é¿åŠå€ã®çŽæ¥ããã³
å±éšçå°å ¥ã¯ãå€ãã®çš®é¡ã®é¿åŠå€ãå®è³ªçã«ã
ãå°éã®æè¬ã«ãããå šèº«ã«å°å ¥ãããããå€ã
ã®è¬å€ã«ããéæããããšåæ§ã®é¿åŠå¹æãæå©
ã«éæã§ããå©ç¹ããããæ¬çºæã«ããã°ãæçµ
é±æã®å®å®ãã女æ§ã«ãããŠéåžžã®ç¶æ äžã«é¿åŠ
å€ãå«ã埮ç²åãéã¶ããšãå¯èœã§ãããããŸ
ããæ¬çºæã«ããã°ãæçµé±æã®å®å®ããªã女æ§
ãå®å®åããããšãã§ãããšåæã«ãå éšåšç®¡
ã¯ãé¿åŠå€ãå«ã埮ç²åã®åå®®é ããåå®®ããã³
ã©ãã管ãžã®éæ¬ããŸããŸãåããããããããš
ãã§ããããã奜ãŸããå¹æãé¿åŠå€ã«å ããŠã
ããã«æçµé±æ調æŽããã³åå®®é éšèŒžéä¿é²ãã«
ã¢ã³ïŒå³ã¡éåžžã¯ãšã¹ããã²ã³ãŸãã¯ããã²ã¹ã
ã³ã§ãããïŒã埮ç²åäžã«äœµçšããããšã«ããé
æã§ããã æäœã®åœ¹ç®ãäœå ã«ãããŠæåã®å¹æãé»æ¢ã
ãããã«åºæ¿ããããåºæ¬çæ¹æ³ã«ã¯äºã€ããã
æ£è ã掻åçã«å ç«ãããããæ£è ã«å ççæäœ
ã®çæãèªå°ããããã«æåãæäžãããéåžžã
ãã®æè¡ã«ãããŠã¯ãå åã«é«æ°Žæºã®æäœåå¿ã
éæãããåãïŒé±éãŸã§ãå¿ èŠãšããããã®é
ããå«ãŸããŠããã®ã§ã掻åå ç«æè¡ã¯ãçãã
æœäŒæéã®äŒææ§ã®ç æ°ã®åŠçã掻çºã«é²è¡äžã®
ç æ°ã®åŠçããã³è¬ç©ãæ¯çŽ ããã«ã¢ã³ããã³é µ
çŽ ã®å¹æã転æãŸãã¯ä¿®æ£ã®ããã«ã¯ãéçãã
ãã第ïŒã®åºæ¬çãªå ç«æè¡ã¯ãæäœãäžæçãª
å ç«ä¿è·ãéæããããã«æäžãããå身å ç«ã§
ãããå身å ç«ã¯ãçç©åŠçå¹æãæ¥æ¿ã§ããã
å ç«äžè¶³ã®ç æ°ã«ããã€ãæ£è ã«æå¹ã«å©çšãã
ããšãã§ãããããã«æŽ»åå ç«ã¯ãåç©ã®çš®å±ã
ä¿è·æäœã®åæãšããŠå©çšããããšãã§ããã®ã§
éæ¯æ§æåã®äœ¿çšã«å¶éããªãã埮ç²åã®èŒžé
ã¯ãå ççãªåµå·£ã®ã¹ããã€ããã«ã¢ã³å³ã¡ãšã¹
ãã©ãžãªãŒã«ããã³ããã²ã¹ããã³ã«ããé±æå€
åã«ããæ¯é ãããŠãããæçµé±æã®æåã®14æ¥
éãŸãã¯ãæçµé±æã®æ¿Ÿèæ§ãŸãã¯ãšã¹ãããŒã²
ã³æ®µéã®éã¯ãåµå·£ã¯ãåå®®é ã®çèã®åçž®ã«åº
æ¿å¹æã®ãããšã¹ãã©ãžãªãŒã«ãã€ãããæ¿Ÿè段
éã®éãåå®®é ã®åçž®ã®é »åºŠããã³æ¯å¹ ã¯ããã®
ææã«æåµãè¡ãããïŒã14æ¥ã®éã«ç¢ºå®ã«å¢å
ãããããŠãæçµé±æã¯ãå¡ãã®ïŒLutialïŒãŸã
ã¯åŠåš å段éã«å ¥ãããã®æåµå·£ã¯ããã²ã¹ãã
ã³ãåæ³ãããããã²ã¹ããã³ã¯ãåå®®é ã®åçž®
ã®æŽ»æ§ãé»æ¢ããå¹æãŸãã¯ãåå®®é ã®çèåŒç·©
å¹æãæã€ãŠãããåµå·£ãã«ã¢ã³ããŸãåå®®é ã®
现èã«ãããŠå¯Ÿæå¹æã瀺ãããšã¹ãã©ãžãªãŒã«
ã«ãããããã²ã¹ããã³ããåå®®é ã«ãŒã¡ã³ã«ã
ããŠããããã®çæç©ã®è§£æŸãä¿é²ããéãåå®®
é ã®çŽ°èã«ãããŠåæ³çæç©ã®ä¿é²ãçããã åå®®é ã®æµäœãŸãã¯ç²æ¶²ã¯ãåçã§ããããã
ãã²ã«ã®æ°Žæã¿ã€ãã§ããã粟液ã®å Žåãšåæ§
ã«ãæ¬çºæã®åŸ®ç²åç¶è¬å€ã®èŒžéã¯ãåå®®é ã®å
çž®ãä¿é²ãããšã¹ããã²ã³ã«ããæäŸãããæšé²
åãšåæ§ã«ãåå®®é ã®ç²æ¶²ã®ééæ§ã«äŸåããã
ã®ã§ãããåå®®é ãéããŠã®åŸ®ç²åç¶è¬å€ã®èŒžé
ã®ããã®æã奜ãŸããææã¯ãåå®®ãæ倧ã®åçž®
掻æ§ããã³åå®®é ç²æ¶²ééæ§ã瀺ãæã«ãããåŸ
ã€ãŠã粟åãŸãã¯åŸ®ç²åã®åå®®é ãéããŠã®èŒžé
ã®æ倧é床ã¯ãæçµé±æã®12ã16æ¥ã®éã«çãã
ã¯ãã§ãããããããªããæåµã®å®éã«èµ·ãæ¥
ã¯ãåå人ã«ããïŒãïŒæ¥ãããå€åãããã®ã§
ããã人ã«ãã€ãŠã¯é±æã®12æ¥ç®ããåã«ããã
ãã®èŒžéãçãããéåžžãåå®®é ã¯ãæçµé±æã®
æåã®12æ¥éãåæ§ã«ç¬¬16ã28æ¥ç®ã®éã«ãããŠ
ã¯èŒžéã¯ãããŸããããã§ã¯ãªãããã®ããã«ã
æåãæäœããŸãã¯é¿åŠå€ãå«ãæ¬çºæã®åŸ®ç²å
ç¶è¬å€ãåå®®é ã«éæ¬ããããã«ã埮ç²åã¯ãè£
å ã«æçµé±æã®ç¬¬16æ¥ç®ä»¥åã奜ãŸããã¯ã第12
æ¥ç®ä»¥åã«æäžããã°ããã æ¬çºæã®äž»ãªå ·äœäŸã«ãããŠã¯ããšã¹ããã²ã³
ããã³ããã²ã¹ãã³ãã«ã¢ã³ã¯ãå éšåšç®¡ã«ã茞
éåºæ¿å¹æãæã€ãšããäºå®ã«ãããå©ç¹ããã
ããããããã®ããã«ããšã¹ããã²ã³ãŸãã¯ãã
ã²ã¹ãã³ã®ãããããšè¬å€ãšãå«æãã埮ç²åãŸ
ãã¯ãè¬å€ãå«æãã埮ç²åãšæ··åãããšã¹ãã
ãŒã²ã³ãŸãã¯ããã²ã¹ãã³å«æ埮ç²åã¯ãè£ã«å ¥
ããããšã«ãããæçµé±æã®æ£ç¢ºã§ãªã婊人ã®æ
çµé±æã調æŽããããšãŸãåå®®é ãéããŠåå®®ã
ãã³ã©ãã管ãžæ¬çºæã®åŸ®ç²åç¶è¬å€ãéã¶ããš
ãå¯èœã§ãããçç©åŠçã«æå¹ãªéã®ãå±éšçã«
åžåãããããã²ã¹ãã³ãŸãã¯ãšã¹ããã²ã³ã¯ã
åå®®é ã®åå®®å èã«ãããŠå¿ èŠãªåæ³å€åããã
ããã埮ç²åã®èŒžéã«å¿ èŠãªåå®®é ã®å瞮掻åã
ä¿é²ããã茞é掻åãäžåºŠå§ãŸããšã埮ç²åã¯å
å®®é ãéããŠåå®®ã«éã°ããããšã¹ããã²ã³ãã
ã³ããã²ã¹ãã³ã®äž¡æ¹ãé©éã§äœ¿çšãããšã茞é
ãåºæ¿ãããããããªãããããã²ã¹ãã³ããã
ãŸãé«ãæ¿åºŠæ°Žæºã§äœ¿çšãããšãããã²ã¹ãã³ã¯
åå®®é ã®çµç¹ã«ãããŠçèãåŒç·©ãããå¹æãã
ãããã«ã埮ç²åã®èŒžéã«éå¹æããããããã
ãããæäžãããããã²ã¹ãã³ã®éå¹æã¯ãäžè¿°
ããããã«åå®®é ã®çµç¹ã®é¿åŠæŽ»åãæã€ãšã¹ã
ã©ãžãªãŒã«ã®ãããªãšã¹ããã²ã³å«æ埮ç²åãå
åãªæ¿åºŠã§æäžããããšã«ãããå埩ãããããš
ãã§ãããäžè¬ã«ããšã¹ãã©ãžãªãŒã«ãã埮ç²å
ã®ããã¡ã§å±éšçã«éã³ããå Žåãæäžãã¹ã埮
ç²åã®éã¯ãïŒã14æ¥éã«ããã€ãŠãïŒæ¥åœã
0.1ãïŒmgã§å åã§ãããäžæ¹ã埮ç²åå ã«ãã
ã²ã¹ããã³ãå«ãŸããŠããå Žåãæäžãã¹ã埮ç²
åã®éã¯ãïŒã14æ¥éã«ããã€ãŠãïŒæ¥åœã0.5
ãïŒmgã§å åã§ããã äžèšããããã«æ¬çºæã®åŸ®ç²åç¶è¬å€ã¯ãé¿åŠ
å€ãæåãŸãã¯æäœãåå®®é ã«å±éšçã«æäžãã
ããšãå¯èœã§ãããåæã«é©åœãªåµå·£ãã«ã¢ã³ã
æäžããããšã«ãããæçµé±æã®æ£ç¢ºã§ãªã婊人
ã®æçµé±æãå€ççã«æŽ»çºåããããšãã§ããã
ããŠåå®®é ãã埮ç²å茞éã®ããã«åºæ¿ããããš
ãã§ããããã€ãŠããšã¹ããã²ã³å«æ埮ç²åã¯ã
ãšã¹ãã©ãžãªãŒã«ãŸãã¯åæãšã¹ããã²ã³ãåå®®
é ã§14æ¥éã«ããã€ãŠè§£æŸãããããã«ããæçµ
é±æã®æåã®ååãéãåããããã«æäžããã
ãšãã§ãããåå®®é ãéããŠåŸ®ç²åã®èŒžéãçã
ãå Žåã埮ç²åäžã®è¬å€ãŸãã¯å¥ã ã®åŸ®ç²åäžã®
è¬å€ã¯ãåå®®ã«éã°ããããšã¹ããã²ã³å«æ埮ç²
åã®æäžåŸã®14æ¥ç®ã«ãä»»æã«æäœãŸãã¯æåã
å«æããŠããŠããŸããªãããããã²ã¹ããã³ãå«
æãã埮ç²åãã次ãã§æäžããããã®ããã«ã
ãŠãå®å šã«èªç¶ã®æçµé±æãéãåããããšãã§
ãããã®éæåãŸãã¯æäœä¿è·ãã§ããã®ã§ã
ããæ¬çºæã®ç¯å²ã«ã¯ããã¡ããããšã¹ããã²ã³
ãŸãã¯ããã²ã¹ãã³ãå«æãã埮ç²åãåå®®é ã®
äžã«å ¥ããæçµé±æã調æŽããŠãããåå®®é ã茞
éããããšãåãå ¥ããããæçµã®ææã«ãæå
ãŸãã¯æäœãå«æãã埮ç²åãæäžããå Žåãå«
ãŸããŠããã人工çã«å°ã³ãããé±æã«ãããŠ
ã¯ãåå®®é ãéããŠã®æ倧茞éã¯ã第12æ¥ã第16
æ¥ã®éã«éæããããæ¬çºæã®æè¡ã«ãããŠãé±
æ調æŽãã«ã¢ã³ãå±éšçã«æäžããå Žåæå¹ãªãš
ã¹ãã©ãžãªãŒã«æŽ»æ§ã¯ãïŒæ¥åœã0.01ã0.07mgã®
æè¬çã§ãéæããããŸãæå¹ãªããã²ã¹ããã³
掻åã¯ãïŒæ¥åœã0.04ã0.14mgã®æè¬çã§éæã
ããããšã¹ãã©ãžãªãŒã«ããã³ããã²ã¹ããã³
ã¯ãéžæ調æŽãã«ã¢ã³ã§ãããããããªãããä»
ã®åšç¥ã®åæãšã¹ããã²ã³é¡ããã³ããã²ã¹ãã³
ããåã ãšã¹ãã©ãžãªãŒã«ããã³ããã²ã¹ããã³
ã®ä»£çšç©ãšããŠå©çšã§ããããšã¯æçœã§ããã奜
ãŸãããšã¹ããã²ã³é¡ã«ã¯ããšã¹ããã³ãã¡ã¹ã
ã©ããŒã«ããšãããŒã«ãšã¹ãã©ãžãªãŒã«ãïŒâã¡
ããã·ãšã¹ããã³ãïŒâããããã·ãšã¹ããã³ã
ãã³ãšã¹ããªãªãŒã«ãå«ãŸããã奜ãŸããããã²
ã¹ãã³ãé¡ã«ã¯ããã¬ãã³ããã³ããžã¡ãã¹ãã
ã³ ãšãããžãªãŒã«ãžã¢ã»ããŒãããã¬ãããžãª
ãŒã«ããã¬ãã³ããã³ã¢ã»ããŒãããã³ãã«ã²ã¹
ãããŒã«ãå«ãŸãããåæååç©ã䜿çšãããå Ž
åã䜿çšãããæè¬éã¯ãåæãšã¹ããã²ã³ãŸã
ã¯ããã²ã¹ãã³ååç©ã®çç©åŠçæå¹æ§ã«å®å šã«
äŸåãããã®ã§ããã æäœãæåãŸãã¯é¿åŠå€ããã³ïŒãŸãã¯æçµé±
æ調æŽãã«ã¢ã³ã®ãããªè¬å€ãå«æããæ¬çºæã®
埮ç²åç¶è¬å€ã¯ãçš®ã ã®é åã§ã圢æããããšã
ã§ãããäŸãã°ãæãåçŽãªç¶æ ã®ãã®ãšããŠã®
第ïŒå³ããã³ç¬¬ïŒå³ã«ç€ºãããåäžæ§é ã®åŸ®ç²å
ã¯ãçç©åŠçã«å£åå¯èœã§ãããçç©åŠçã«é©å
ããããšã®ã§ãããããªãã¯ã¹ç©è³ªïŒïŒãŸãã¯23ïŒ
ã«ãäžæ¹ã§ã¯æãŸããæåãŸãã¯æäœïŒããŸãã¯
ä»æ¹ã§ã¯é¿åŠå€ïŒïŒããã³é±æ調æŽãã«ã¢ã³ïŒïŒ
ãå®å šã«åæ£ãããããšã«ãã補é ãããã埮ç²
åã¯ãè£ã«å ¥ãããããšããã€ãããšããšãã¯ã
ããããã§é£ç¶çã«ãè£ã«å ¥ããæããã埮ç²å
ãåå®®é ãéãéã°ãåå®®å ã«å ¥ããŸã§ã®é·ãæ
éã«ããã€ãŠã奜ãŸããæ¯æ¥ã®è¬å€ã®æè¬ãéæ
ããããã«ç®çã®è¬å€ã解æŸãããã埮ç²åãé±
æ調æŽãã«ã¢ã³ãå«ãå Žåã¯ããã«ã¢ã³ã®é£ç¶ç
解æŸãåå®®é ã®ç²æ¶²ã®ç¹æ§ããã³åå®®é ã®å瞮掻
åã調æŽããããã®ç¹æ§ã®å ·äœäŸã«ããã埮ç²å
ã¯ãè£ã«å ¥ããæããããããã®æŽ»æ§æåãé£ç¶
çã«è§£æŸããã®ã§ããã®åŸ®ç²åã¯ãæçµé±æã®é
ã«äžåã ãæäžããã°ããããã«ãæçµé±æã®åš
æã«è¿ãæå¹å¯¿åœãæã€ããã«ã€ããã°æãéœå
ã®ããçµæãéæã§ãããããããªãããããã¯
åã«å¥œãŸããå ·äœäŸã§ããã埮ç²åã¯é¿åŠå¹æã
ãã³é±æ調æŽå¹æãéæããã«å¿ èŠãšãããã
ããäœåãæè¬ããããšãã§ããã 第ïŒå³ã¯ãæåãŸãã¯æäœïŒããããªãã¯ã¹ç©
質äžã«æ··åãããŠãããããã次ã«è¬å€ãå«ãŸãª
ããããªãã¯ã¹ç©è³ªã®å€ç®ïŒã«ããåããŸãããŠ
ããåäžæ§é ã®åŸ®ç²åã®ããäžã€ã®å ·äœäŸã§ã
ãã埮ç²åãã粟å代çšæŽ»æ§ãæã€ãããªå€§ãã
ã§ããããã®çš®ã®åŸ®ç²åã®åœ¢æ ã¯ã埮ç²åãè£ã«
å ¥ããåŸããã°ããã®éè¬å€ã®è§£æŸãé ãããã
ãããªå Žåã奜ãŸãããäŸãã°ãäžèšã®ãããªåŸ®
ç²åã䜿çšããããšã«ããçããè¬å€ã®é ããŠã
ãã®è§£æŸã¯ã埮ç²åãè£ã«å ¥ããããå€å£ãã»ãš
ãã©åãå»ãããè¬å€ã®æŸåºãå§ãŸãæç¹ãŸã§åŸ®
ç²åãå£åãã以åã«åå®®é ãéããŠåå®®ã®äžã«
茞éãããã®ã«å åãªæéã確ä¿ããããšãã§ã
ãã 第ïŒå³ã¯ãé¿åŠå€ïŒïŒãšãé±æ調æŽãã«ã¢ã³ïŒ
ïŒã®è¯ïŒïŒãããããªãã¯ã¹ç©è³ªïŒïŒã®æ®»ïŒïŒäž
ã«ã«ãã»ã«åããã埮ç²åã瀺ãããã®åŸ®ç²åã®
ç²åã®åœ¢æ ã¯ãäžèšã®ç¬¬ïŒå³ã®åŸ®ç²åã«ã€ããŠèš
èŒããããã«ãå°å ¥ããã埮ç²åã®æŽ»æ§æåã®è§£
æŸãé ããæ¹ãããå Žåã«éœåãã䜿çšãããã ããã«ç¬¬ïŒå³ã«ç€ºããããããªç°ãªã埮ç²å圢
æ ã«ãããŠã¯ã埮ç²åã¯ãå€éã®æäœãŸãã¯æå
ãå³åº§ã«è§£æŸããããã«ã€ããããŠããããã®ç®
çãéæããããã«ã埮ç²åã¯ãæåãŸãã¯æäœ
ã®è¯ïŒãæ®»ã®ãããªãã¯ã¹ç©è³ªïŒã®äžã«ã«ãã»ã«
åãããŠãããè¬å€ã®è¯ãå«ã埮ç²åã¯ã埮ç²å
ã®å€æ®»ã厩å£ããããã®å å æ§ã®èŠçŽ ãå©çšã§ã
ããããªå Žåã«ç¹ã«é©ããŠãããäŸãã°ãäžæ¹ã®
è£å ã«ãããPHãšä»æ¹ã®åå®®é ãšåå®®å ã«ããã
PHãšã®å·®ãå©çšããŠãå€æ®»ã®åŽ©å£ãã埮ç²åãå
å®®é ãŸãã¯åå®®ã®å°åž¯ã«éãããšãçããããã«
ããããã®å Žåè£å ã®é žæ§PHã¯ã埮ç²åã®æ®»ã«ã»
ãšãã©ãŸãã¯å šã圱é¿ãäžããªããããããªã
ãã埮ç²åã¯ãåå®®é ã«éã°ãããšãããã§äžæ§
ã®PHã«ãããããå€æ®»ã厩å£ããå³åº§ã«è¬å€ã®è§£
æŸãéå§ããããã¯ãæ¥æ¿ãªææã«ããã€ããé«
æ¿åºŠã®æ¯çŽ ã«ç¯ãããæ£è ã«æäœãããããã®é
éã¶ã®ã«é©ããŠãŠããããã®åŠæ¹ã¯ãåèªããã¹
ã«ç¬¬äžæ¬¡å ç«ãåããåŸã®äºåºŠç®ã®å¿çãæäžã
ãããšãå¿ èŠãšããããããªå Žåã«é©ããŠããã å°ã ãäžèª¿ãªæ£è ã®åŠçœ®ã«ãããŠã¯ãæåãŸã
ã¯æäœãéæ¬ çã«æäžããããšãã§ãããšããã
ããã¯ã第ïŒå³ã«ç€ºããããããªãåç¬ãŸãã¯ã
ããªãã¯ã¹ç©è³ªã«åæ£ãããè¬å€ïŒãšãè¬å€ãå«
ãŸãªããããªãã¯ã¹ç©è³ªïŒã®äº€äºã®å±€ãåäžå¿å±€
ã«ãããŠåœ¢æãããŠãããããªæ§é ãæã€åŸ®ç²å
ã䜿çšããããšã«ããéæã§ããããã®ãããªåŸ®
ç²åããè£ã«å ¥ããå Žåãè¬å€ã®è§£æŸã¯ã埮ç²å
ã®å€åŽã®å±€ã厩å£ãããŸã§èµ·ããªããäžå±€ãåºãŠ
ãããšè¬å€ã®è§£æŸãéå§ãããã®å±€ã厩å£ãããŸ
ã§ç¶ããè¬å€ã解æŸãããè¬å€ã®è§£æŸã¯ã次ã®äž
å±€ã§ããè¬å€ãå«ãŸãªãå±€ã«éãããšããåæ¢ã
ãããã®æè¡ã®é©å¿äŸã¯ãæãå€åŽã®è¬å€å±€ãæ
åããäžå®ã®ç¶æé±æã®éãæåã解æŸãã次ã
ã§äŸãã°ïŒãïŒé±éã®è¬å€ã解æŸããªãé±æãç¶
ããããªæŽ»æ§å ç«ã«ãããŠèŠãåºããããè¬å€ã
å«ãŸãªãå±€ã厩å£ããåŸãæå解æŸã®ç¬¬ïŒã®é±æ
ãå§ãŸãããã®ããã«ã埮ç²åãäžåºŠæäžããã
ãšã«ããã第äžåã®æè¬ãããã«ç¶ã次åã®æè¬
ãå¯èœã«ãªãã åå®®é ãéããŠåå®®ãžã®æåãŸãã¯æäœã®éæ¬
ã®ã¿ãªãããèªç¶ã®èŒžéæ©æ§ã掻çºã«ãã調æŽã
ãããã«é±æ調æŽãã«ã¢ã³ãæäžããå¿ èŠããã
å Žåã第ïŒå³ã«ç€ºããããªæåãŸãã¯æäœãšãé±
æ調æŽãã«ã¢ã³ã®äž¡æ¹ããããªãã¯ã¹ç©è³ªã«åæ£
ãããåäžæ§é ã®åŸ®ç²åãæäžããããšãã§ã
ãããã®ããã«ã埮ç²åãè£å ã«å ¥ãããšããã«
ã¢ã³ãšæåãŸãã¯æäœã®è§£æŸãå§ãŸããçµå±ã埮
ç²åã¯åå®®é ãéããŠåå®®å ã«éã°ãããé±æ調
æŽãã«ã¢ã³ãå«æããæå€æ®»ãããªãã¯ã¹ç©è³ªå±€
ãšãæåãŸãã¯æäœãå«æãããããªãã¯ã¹ç©è³ª
ã®å åŽè¯ãšãæã€åŸ®ç²åã䜿çšããã°ãæäžã®ã
ãéžæçæçãã§ããããã®ãããªåŸ®ç²åãæäž
ããå Žåãé±æ調æŽãã«ã¢ã³ã®ç¶æããã解æŸã
çãåå®®é ã茞éãåããããæã«ã埮ç²åã¯ã
åå®®é ããåå®®ã«èŒžéããããæåãŸãã¯æäœã®
解æŸã¯ã埮ç²åã®äžå±€ã«ããã埮ç²åã®æåãŸã
ã¯æäœã®è¯ãåºãŠããæã«ãåå®®é ãŸãã¯åå®®å
ã«ãããŠèµ·ãã第ïŒå³ã¯äžèšãããããªæ§é ã®åŸ®
ç²åå³ã¡ãå€åŽã®é±æ調æŽãã«ã¢ã³ãå«æããå±€
ïŒãå åŽã®æåãŸãã¯æäœãå«æããè¯ïŒïŒãå
ã¿èŸŒãã§ãããæåãŸãã¯æäœã¯ãåç¬ã§åŸ®ç²å
ã®è¯ãæ§æããããšãã§ãããæ®»ïŒïŒãã€ããã
ãã«ãããªãã¯ã¹ç©è³ªäžã«åæ£ãããŠãããããŸ
ããå€åŽã®å±€ãŸãã¯æ®»ïŒã¯ããããªãã¯ã¹ç©è³ªäž
ã«æçµé±æ調æŽãã«ã¢ã³ãåæ£ãããããšã«ãã
ã€ããã åè¿°ããããã«ãæäœãŸãã¯æåã¯ãåç¬ã§ã
ãŸãã¯é±æ調æŽãã«ã¢ã³ãšã®çµåãã«ãããŠãè¬
å€ãŸãã¯è€æ°ã®è¬å€ãã©ã®ããã«è§£æŸããããã«
äŸåããŠãçš®ã ã®ããã¡ã§åŸ®ç²åäžã«æ··åããã
ãšãã§ãããããã«ç¬¬ïŒã第ïŒå³åã³ç¬¬ïŒå³ã«ç€º
ããã¿ã€ãã®è€å±€åŸ®ç²åã¯ãéåžžåäžã®ãããªã
ã¯ã¹ç©è³ªããã€ããããããæ æ³ã«ãã€ãŠã¯æãŸ
ãããªãå Žåããããã埮ç²åã®é£ãåãã®å±€ã
ç°ãªããããªãã¯ã¹ç©è³ªã䜿çšããŠã€ããããšã
ã§ãããããã«ãå Žåã«ãã€ãŠã¯ãïŒçš®ä»¥äžã®ç
ç¶ãåŠçœ®ããããã«ãå éšçæ®åšç®¡ã«ïŒçš®ä»¥äžã®
æäœãŸãã¯æåãéã³ããããšãã§ããã ãã®ããã«ãäŸãã°ïŒçš®ã®ç°ãªãç æ°ãååç
ã«åŠçœ®ããããã«ãïŒçš®ã®ç°ãªãæäœãå«ãåäž
埮ç²åãã€ããããããæäžããã°ãããå®éã«
ããæ æ³äžã«ãããŠã¯ãåã埮ç²åäžã«ããæå
ãŸãã¯æäœã§ç¬¬ïŒã®äžèª¿ã«å¯ŸããŠã¯æ£è ã掻åç
ã«å ç«ããåæã«ç¬¬ïŒã®äžèª¿ã«å¯ŸããŠã¯æ£è ãå
åçã«å ç«ããã®ãæãŸããå Žåãããããã¡ã
ããïŒçš®ä»¥äžã®æäœãŸãã¯æåãïŒã€ã®åŸ®ç²åäž
ã«æ··åããå Žåã§ïŒãã®å Žåãããããæ¥è§Šãã
å¯èœæ§ããããïŒããã«åŸ®ç²åã®ç°ãªãå±€ã«ãªã
å Žåã«ã¯ããããã¯ãçžäºã«åå¿ããªããã®ã§ãª
ããŠã¯ãªããªãã ããã«ç¬¬ïŒå³ã«ã¯ãå Œçšã§ããå³ã¡çžäºã«åå¿
æ§ã®ãªãé¿åŠå€ïŒïŒãšé±æ調æŽãã«ã¢ã³ïŒïŒãã
ãããªãã¯ã¹ç©è³ªäžã«åæ£ããããããè¯ïŒïŒã
圢æããŠããä»çš®ã®åŸ®ç²åã®ããã¡ã瀺ãããŠã
ãããã®åŸ®ç²åã¯ããããªãã¯ã¹ç©è³ªïŒïŒã®æ®»ïŒ
ïŒäžã«ãè¬å€å«æãããªãã¯ã¹ç©è³ªã®ç²åãã«ã
ã»ã«åããããšã«ããã€ããããããããªãã¯ã¹
å åŽè¯ïŒïŒãšæ®»ïŒïŒã®ãããªãã¯ã¹ç©è³ªïŒïŒãã
ã³ïŒïŒã¯åçš®ã®ç©è³ªã§ãã€ãŠããç°çš®ã®ç©è³ªã§ã
ã€ãŠããããç°çš®ã®ãããªãã¯ã¹ç©è³ªã䜿çšãã
å Žåããããªãã¯ã¹ç©è³ªã®åŽ©å£é床ãç°ãªãã
ãšããŸãã¯ããããªãã¯ã¹ç©è³ªããã®è¬å€ã®æ¡æ£
é床ãç°ãªãããšã«ããå©ç¹ãå©çšã§ããããšã
å¿ èŠãªå Žåã«ç¹ã«æçšã§ãããé¿åŠå€ããã³é±æ
調æŽãã«ã¢ã³ã®è§£æŸã¯ãããªãã¯ã¹ç©è³ªã®æ®»ïŒïŒ
ã厩å£ãããŸã§çããªãã 第ïŒå³ã¯ããããªãã¯ã¹ç©è³ªïŒïŒäžã«ããé¿åŠ
å€ïŒïŒã®è¯ïŒïŒãã€ãããã次ãã§é ã«ãè¯ïŒïŒ
ã¯é±æ調æŽãã«ã¢ã³ïŒïŒãå«æãããããªãã¯ã¹
ç©è³ªïŒïŒã®æ®»ïŒïŒã«ããå å²ããã埮ç²åæ§é ã®
ãã®ã瀺ãããã®ç²åã®ããã¡ãæã€åŸ®ç²åã¯ã
æçµé±æã調æŽããåå®®é ããã®åŸ®ç²åã®èŒžéã
åºæ¿ããé±æ調æŽãã«ã¢ã³ïŒïŒã ãã®æåã®åºã
ã®è§£æŸãéæããããã«ãè£å ã«åŸ®ç²åãæ¿å ¥ã
ãããšãæãŸããå Žåã«ãããŠç¹ã«æå¹ã§ããã
ãã®ããã«ããŠãæçµé±æã®èª¿æŽããã³å°ãªããš
ã埮ç²åã®åæã®äœå 茞éã¯ãå åŽã®è¯ïŒïŒãã
ã«ãã»ã«åãããé¿åŠå€ïŒïŒã®è§£æŸãã§ãããã
å åã«é²åºãããæãŸã§ã«èµ·ãåŸãããã¡ããã
é¿åŠå€ã¯åç¬ã§ããŸãã¯ãæ®»ã®ãããªãã¯ã¹ç©è³ª
ïŒïŒãšåçš®ã§ãç°ãªããã®ã§ãã€ãŠãããŸããªã
ãè¯ã®ãããªãã¯ã¹ç©è³ªå šäœã«åæ£ããããã®ã
ã«ãã»ã«åããã å€å±€åŸ®ç²åã®ããã¡ã¯ã第ïŒïŒå³ã«ç€ºãããã
ãã®åŸ®ç²åã¯ãé¿åŠå€ïŒïŒãåç¬ã®ãŸãã¯ããã
ããããªãã¯ã¹ç©è³ªäžã«åæ£ãããå åŽè¯ïŒïŒã
ããªãããã®è¯ïŒïŒã¯ããããªãã¯ã¹ç©è³ªïŒïŒã®
æ®»ïŒïŒã«ããã«ãã»ã«åããããã®æ®»ïŒïŒã¯ãé
ã«é±æ調æŽãã«ã¢ã³ïŒïŒãå«æãããããªãã¯ã¹
ç©è³ªïŒïŒãããªãå€æ®»ïŒïŒäžã«ã«ãã»ã«åãã
ãããã®ç¹æ®ãªããã¡ã®åŸ®ç²åã¯ããã®åŸ®ç²åã
è£å ã«æäžããåŸãé±æ調æŽãã«ã¢ã³ãæäžãã
ããšãå¿ èŠãªãããªå Žåã«æçšã§ãããé±æ調æŽ
ãã«ã¢ã³ã®ãã¹ãŠã解æŸãããåŸã®é¿åŠå€ã®è§£æŸ
ã¯ãå åŽã®æ®»ïŒïŒããé¿åŠå€ã®è¯ïŒïŒããã®è§£æŸ
ãã§ããããã«ãªãã«å åãªçšåºŠãŸã§åŽ©å£ãããŸ
ã§é ãããäžæ¹ã埮ç²åã®èŒžéã¯ã埮ç²åã®å€§å
ãåå®®ã®äžã«éã³ããŸããŠãããé¿åŠå€ã®é ãã
解æŸãéæãããããã«è¡ãããã æ¬çºæã®åŸ®ç²åç¶è¬å€ã®ç©çç圢ç¶ã«ã€ããŠã¯
çç¶ãåµåœ¢ã®ãããªæŽã€ãããã¡ã®ãã®ãããäž
èŠåãªããã¡ãŸã§å¯èœãªããã¡ã®å€åãèš±ãã
ããããããªãã埮ç²åã®ããã¡ã¯ã埮ç²åã®äœ
å 茞éã«é¢ããŠã®èŠä»¶ãšãªããªããéåžžãå»è¬å€
ã¯åŸ®ç²åããããããªãã¯ã¹ç©è³ªã®æ®µã ã®åŽ©å£ã«
ãããããã³ïŒãŸãã¯ãããªãã¯ã¹ç©è³ªããã®å»
è¬å€ã®æµžéã«ããã溶åºããã æ¬çºæã®åŸ®ç²åã®å€§ããã¯ãéèŠã§ãããäœæ
ãªã該埮ç²åã¯ãçæ®åšç®¡ã®èªç¶ã®èŒžéæ©æ§ã«ã
ããåå®®é ããäžåãã«åå®®å ããã³ã€ãã«ã¯ã©
ãã管ã®äžã«ãŸã§éã¶ããšãã§ããããã«ç²Ÿæ¶²ä»£
çšæŽ»æ§ãæã€å¿ èŠãããããã§ããã埮ç²åãã
倧ãããããšã埮ç²åãè¿œãåºãããã«ãåå®®é
ã®èçž®ãçããŠããŸãããŸã埮ç²åãããŸãå°ã
ããããšãçæ®èåšã®äžã«äžåãã«éã¶ããšã§ã
ãªããªããéåžžã埮ç²åã¯ã20ã70ÎŒã奜ãŸãã
ã¯20ã60ÎŒã®å€§ããã®ãã®ãããã 埮ç²åã圢æãããŸãé¿åŠå€ããã³é±æ調æŽã
ã«ã¢ã³ããã®äžã«åæ£ããããããªãã¯ã¹ç©è³ªã¯
粟液代çšæŽ»æ§ã®ç¹ã®ã¿ã§ãªããçç©åŠçã«é©åã
ãããšããç¹ã§éèŠã§ããããããªãã¯ã¹ç©è³ªãš
ããŠäœ¿çšã§ããç©è³ªã§ããããã«ã¯ãããããç
æ®èåšã«ãããŠäžå©ãªå¹æããããããªããã®ã§
ãªããŠã¯ãªããªãããŸããçç©åŠçã«é©åãåŸã
ãã®ã§ããã¹ãã§ãåå®®é ãŸãã¯åå®®ã®çµç¹ãåº
æ¿ãããé ã¬ã³æ§ã§ãã€ããããŠã¯ãªããããŸ
ããäœå çµç¹äžã§ççãèµ·ãããªããã®ã§ããã¹
ãã§ããããŸãäœå çµç¹ãšé©åæ§ããããããã«
åå®®é ã®ç²æ¶²ãšæ··åã§ãããã®ã§ãªããŠã¯ãªããª
ããä»ã®éèŠãªèŠçŽ ãšããŠã¯ã該ãããªãã¯ã¹ç©
質ã¯äœå ã«ãããŠçç©åŠçã«å£åãåŸããã®ã§ã
ããååŠå·¥çšã«ãããäœå ã«ãããéç©ããªãã
ãã«ãçŽã¡ã«å解ããããšãã§ããªããã°ãªããª
ãããŸãã埮ç²åã®ããã¡ã«ããå Žåãå°ããšã
女æ§ã®æ¯æã®æçµé±æã«å¯Ÿå¿ããæéã«ããã€ãŠ
ãã€ãããšåŽ©å£ããèœåãæã€å¿ èŠãããã該ã
ããªãã¯ã¹ç©è³ªãšããŠäœ¿çšããããªãç©è³ªã®å¥œãŸ
ããäŸã«ã¯ãããªã°ãªã³ãŒã«é žãïœïŒïœâããªä¹³
é žããããã®å ±éåäœçãå«ãŸãããä»ã®æçšãª
ãããªãã¯ã¹ç©è³ªã«ã¯ã°ãªã»ããŒã«ã¢ããŒããã³
ãžã¹ãã¢ã¬ãŒãããããä»ã®ãããªãã¯ã¹ç©è³ªã«
ã¯ãåå®®é ã®äžæ§ç°å¢äžã«å解ãããããªãã®ã
å«ãŸããã æäœãŸãã¯æåãå«æãã埮ç²åã®æ§é ã«ã€ã
ãŠãå®è³ªçã«ããããªãå ¬ç¥ã®æäœãŸãã¯æåã
ã埮ç²åäžã«æ··å ¥ããããšãã§ããããç¹ã«çæ®
èåšã®ç¶æ ããã³ç æ°ã®åŠçã«ãããŠç¹ã«äœ¿çšã
ãããããªãã®ã奜ãŸããã æ¬çºæã®åŸ®ç²åäžã«æ··å ¥ããããšã®ã§ãã奜ãŸ
ããæåãšããŠã¯ã人éãŸãã¯åç©ã®ãã¯ããªã¢
èããã³ããŒã«ã¹èããããçæ®å·¥çšã«å«ãŸãã
é µçŽ ããã³ä»ã®çç©åŠçå åããŸã䜿çšããããš
ãã§ããã奜ãŸããç åèæåã«ã¯ããã€ã»ãªã¢
ãªã³ç èããã€ã¯ããã¯ããªãŠãŒã çµæ žèããã«
ãã¹ããŒã«ã¹ïŒããŠãŒã¢ãã¹ ïŒåããã³ïŒåïŒ
ãã€ã³ãã ã¢ã«ãã«ã³ãº ãã€ã³ãã ããã
ã«ã«ãº ããªã³ã¢ãã¹ ããŒãžããªã¹ãããšã¢ã
ã€ã©ã¹ ããŒãžããªã¹ã第矀é£éç¶çèãšã³
ãªããã€ã¯ããã©ãºã ãããã¹ããã¢ãã€ã©ã¹
ããŠã¯ã¬ã€ã€ãã°ã©ããŠããŒã ã€ã³ã°ã€ããŒ
ã¬ããªã³ããã㢠ããã¬ãŠã ããã¬ããã ã
ãªããŠãŒã ããã«ã»ã© ã¢ããŒãã¹ããã«ã»ã©
ã¡ãªãã³ã·ã¹ããã«ã»ã© ã¹ã€ã¹ããã«ãã© ã
ã€ãã¹ãã«ã³ãããã¯ãã« ããšãŒã¿ã¹ãã«ã³ã
ããã¯ãã« ããšãŒã¿ã¹ ã€ã³ãã¹ãã€ããªã¹ã
ã¬ããã¹ãã© ãã¢ãŒãããªã¹ããªã¢ ã¢ãã·ã
ã²ãã¹ããã«ã»ã© ãªãŒãã¹ãã€ã¯ã€ãŒã ãã«
ãã¹ ããŒã«ã¹ ïŒãã€ã¯ã€ãŒã ã¢ã«ããªã¿ã¹
ããŒã«ã¹ãIBRâIBPããŒã«ã¹ãBVDâMBã
ãŒã«ã¹ãã¯ã©ãã㢠ãã·ã¿ã·ãŒãããªã³ã¢ãã¹
ããŒã¿ã¹ããããœãã©ãºã ãŽã³ãã€ã€ããšã¹
ããšãªã㢠ã³ãªãã¢ã¯ãããã·ãªã¹ ãšã¯ãŠ
ã€ããµã«ã¢ãã© ã¢ããŒã¿ã¹ããªãŒãã¹ ãµã«ã¢
ãã© ã¢ããŒã¿ã¹ ãšã¯ãŠã€ããã»ãŠãã¢ãã¹
ã¢ãšã«ã®ããŒãµãã³ãªããã¯ããªãŠã ãšã¯ãŠ
ã€ãã³ãªããã¯ããªãŠã ããªã²ãã¹ãã¢ã¯ãã
ãã¯ããªãŠã¹ ã»ããã¹ããã€ã³ãã©ãºã ãã
ã²ãã¿ãªãŠã ãã¢ã¹ãã«ã®ã«ã¹ ããŠãŒãã¬ã
ã¹ãã¢ãã·ã㢠ã©ã¢ãŒãµãããªãããœãŒãããš
ã¯ã€ããŒãã ãããã·ã¢ ã«ããªã€ãã¯ãã¹ããª
ããŠã ãã¿ãŒããªã©ãããã çæ®å·¥çšå«ãŸããé µçŽ ã®å¥œãŸããäŸãšããŠã¯ã
ãªããã¯ã¬ã¢ãŒãŒãããŠãŒã©ããžããŒãŒãããªã
ã·ã³ãã°ãªã³ãŒã²ã³ ãã¹ãã€ã©ãŒãŒãã¹ããŒã
ã©ã¯ãã€ã㯠ããããã²ããŒãŒãã¹ããŒã ã
ã¢ã«ããããŒãŒãã¢ããã·ã³ããªãã¹ãã¢ã¿ãŒãŒ
ã¢ã«ã«ãªã³ ãã¹ãã¿ãŒãŒãã¢ã«ã«ãªã³ ãã¹
ãã¿ãŒãŒ ãšã¹ãã©ãŒãŒãã¢ãããããããŒãŒã
ããªãã·ã³ ãã¢ããªãã·ã³ãã¢ãã©ãŒãŒãã ã©
ãããŒãŒãã¢ã¯ããœããŒã« ãããã€ããŒãŒããž
ãšã¹ãã©ãŒãŒãã°ã«ã¿ãã³é žããããã²ããŒãŒã
ã³ãã¯é žããããã²ããŒãŒãããŒã¿ãŒâã°ãªã³ã
ã¹ãã¿ãŒãŒããªããŒãŒãATPâã¢ãŒãŒ ã¢ã«ã
ã¢ãŒããããŒã ã¬ã³ããŒã°ã«ã¿ãããã©ã³ã¹
ãããããŒãŒãã¹ãããŒã«âïŒâããŒã¿ãŒãªãŒã«
âããããã²ããŒãŒãDPNâãžâã¢ããã©ãŒãŒ
ãããã æåãšããŠåããã«ã¢ã³ã§ã¯ãããŠãŒãã³ã³ãª
ãªãã㯠ãŽãããããã€ã³ ãã«ã¢ã³ãããŠãŒ
ãã³ ãã©ã»ã³ã¿ã« ã©ã¯ããŒã²ã³ãããã²ã¹ã
ãã³ããšã¹ãã©ãžãªãŒã«çã奜ãŸãããä»ã®æå
ã«ã¯ãæ é€èœå±€ã®çŽ°è質衚é¢ã«çããèã«é¢ãã
现è質æåãããã äžè¿°ããç åèã«è¿œå ããŠã女æ§çæ®åšç®¡ã«æ
æãããããšã®ã§ããç åèã®æ··åç©ãããŸã埮
ç²åäžã«æ··å ¥ããããšãã§ããã 埮ç²åäžã«æ··å ¥ããããšã®ã§ããå身å ç«ã®ã
ãã®æäœã®äŸã«ã¯ã掻åå ç«ã®ããã«æå¹ã§ãã
äžèšã®æåã®ãã¹ãŠã«å¯Ÿå¿ãããã®ãå«ãŸããã
粟液ãåµãåŠåš ã«ããçæç©çã«å¯ŸããŠæå¹ãªæ
äœãããŸã䜿çšããããšãã§ããã æåãŸãã¯æäœãå«æããæ¬çºæã®åŸ®ç²åã察
象ã«æäžããå ŽåãæåãŸãã¯æäœã®å¿ èŠãšãã
ãæè¬éããå¿ èŠãšããæéã«ããã€ãŠå¿ èŠãšã
ãåããåŒãåºãã®ã«å åãªéã§æäžããããæ
åã«ã€ããŠã¯ãïŒã14æ¥ã®éã«ããã€ãŠãïŒæ¥åœ
ãçŽ0.5ãïŒmgãšãªãããã«ããã次åã®å ç«ã®
ããã«å¿ èŠãšãããæè¬ç¯å²ã¯ã24æéã«ããã€
ãŠïŒæ¥åœã0.5ãïŒmgãŸã§å€åãããæäœã®æäž
ã«ããå身å ç«ã«ã€ããŠã¯ãæäžãããæäœã®é
éã¯ãå¿ ããããèªããããæ²»çå¹æãšé¢é£ãã
ãã®ã§ã¯ãªããå身å ç«ã®ããã®æè¬ã«ã€ããŠã®
éèŠãªå åã¯ãæäœã®æ»Žå®éãŸãã¯çç©åŠçå¹èœ
ã§ãããæäœã®æ»Žå®éã¯ãè©Šéšç¶æ³äžã«ãããå¹
æãåŒãåºãæäœã®æ倧åžé床ã«çžåœãããæäœ
ã®ïŒçš®ã®ç°ãªã調æŽè£œåã¯ãããããç°ãªãçç©
åŠäžã®å¹èœãæã€ã®ã§ééåºæºã«ãããŠåæ§ã«å¹
é©ãããã®ã§ã¯ãªããæ¬çºæã®å®æœã«ãããŠæäž
ãããæäœã«ã€ããŠã¯ããããïŒïŒ500ã®å ç«åŠ
äžã®æ»Žå®éãæ倧ã®çç©åŠäžã®å¹èœã§ããããã
ã«å ç«ã°ãããªã³ãŸãã¯æäœãåå®®é ãåå®®ãã
ã³ã©ãã管ã«éã°ãããã®å²åã¯ãïŒæ¥åœãã®æ
äœã0.1mgãè¶ããŠã¯ãªããªããæ²»çäžã®å¹æã
äžããããã«æå¹ãªãã®æ°Žæºä»¥äžã®ãããã®æè¬
å²åããåãå ¥ããããšãã§ããã æåãæäœãŸãã¯é¿åŠå€ãå«æããæ¬çºæã®åŸ®
ç²åã¯ãè¬å€ç©è³ªãå«æãã埮ç²åã®è£œé ã®ãã
ã«ãä»æ¥ãŸã§ã«å©çšãããŠããåšç¥ã®è£œæ³ã®ãã
ãã«ãã€ãŠãã補é ããããšãã§ãããæåãŸã
ã¯æäœãããã«ååšãããããšãå¿ èŠãªå Žåã®é±
æ調æŽãã«ã¢ã³ã®éã¯ãèšççã§ã¯ãªãããéåžž
埮ç²åã¯ãçŽ10ééïŒ ãã60ééïŒ ã奜ãŸããã¯
10ééïŒ ãã50ééïŒ æã奜ãŸããã¯10ééïŒ ã
ã25ééïŒ ã®æäœãŸãã¯æåãå«æãããã®ã§ã
ãã èšåºè¬äžã«æäœãæäžããããšã«ããæ£è ã«å
身å ç«ãã€ããã ãããã®ç¬¬äžã®å¶éã¯ãåç©äž
ã§ç£åºãããæäœã¯ã人éã®åçŽè ã«æ³šå ¥ããå Ž
åãããªããã°ãã°è¡æž ç ãŸãã¯éé žçãèµ·ãã
ãšã§ãããããããªãããæ¬çºæã®å±éšçã«æäž
ããæè¡ã«ããã°ãå¿ èŠãšãããæäœãããå°é
ã®æè¬éã§ãã¿ãŸãæäœãå šèº«ã«æäžããããšã
ãªãã®ã§äžã«è¿°ã¹ããããªåé¡ãèµ·ããªãã掻å
å ç«ã¯ãææç ã«å¯Ÿããæ°žä¹ çãªä¿è·ã®ããã®ã
ããªå Žåã«ã¯ãå身å ç«ãããããå©ç¹ãããã
ãã®ããã«ãæåãæ¬çºæã®æ¹æ³ã«ããåå®®ãŸã
ã¯ã©ãã管ã«éãã å Žåãç®çãšããå ç«åŠäžã®
å¹æãçºæ®ããã°ããã§ãªããå šèº«ã®å ç«ã«å¯Ÿå¿
ããŠã€ããããæäœã®ã¿ã€ãããæ§é äžããã³åº
æ¬çã«ç¬ç¹ã§ããæäœãåæ³ãããå šèº«çãªæäœ
ã¯çæ®åšç®¡ããã¯åæ³ãããªãããã®ããå šèº«ç
å ç«ã¯ãåå®®é ãåå®®ããã³ã©ãã管ã®æ¶²äžã«æ
äœãã€ããã®ã«æå¹ãªæ¹æ³ã§ã¯ãªãã 掻åå ç«ã®ä»ã®ç¹ã¯ãå粟èœåã«é¢ä¿ããŠã
ãããã®å Žåã粟液æåã¯ãæåå«æã®åŸ®ç²åã
åå®®é ãåå®®ããã³ã©ãã管ã®äžãžã®èŒžéããã
ãšã«ããéã³èŸŒãŸãããç¶æãããæéã«ããã€
ãŠãã€ãããšè§£æŸãããæåã¯ãæ¬è³ªçã«åå®®
é ãåå®®ããã³ã©ãã管ãããªãå éšåšç®¡ãèŠã€
ãŠãã液ç¶å±€äžã«ä¿è·ã®ããã®æäœãåæ³ããã
ãã«ãåšç®¡ã®åæ³çµç¹ãåºæ¿ããã亀æ¥ããã³è£
å ãžã®ç²Ÿæ¶²ã®æŸäžã®åŸãåå®®é ã®ç²æ¶²äžã®æäœã
åå®®é äžã®ç²Ÿæ¶²ã®è çãèµ·ãããããŠåå®®å ã«ç²Ÿ
液ãããã«é²å ¥ããŠããã®ãé²æ¢ããã粟液ã«å¯Ÿ
ããæäœã¯ãŸãè çã ãã§ãªãææ³ã§ãã粟液ã
äžæŽ»æ§åããã æ¬çºæã®é¿åŠå€å«æ埮ç²åã«ã€ããŠã¯ãç®çãš
ããé¿åŠå¹æãæã€ãã®ã§ãç¹ã«åºä¹³åç©ã«ãã
ãŠå¹æã®ãããã®ã§ãããããªãé¿åŠå€ã®çš®é¡ã
æ¬çºæã®åŸ®ç²åäžã«å ¥ããããšãã§ãããé¿åŠå€
ã®å¥œãŸããäŸãšããŠã¯ãããã«ããšããã·ããªãª
ãã·ãšãã¬ã³ ãšãããŒã«ããã³ãŒãããŠã ã¯
ãã©ã€ã ïŒãã³ãžã«ãžã¡ãã«ãïŒïŒâïŒïŒïŒïŒïŒ
ïŒïŒïŒâããã©ã¡ãã«ããã«âããšããã·ïŒãšã
ãã·ïŒãšãã«ãã¢ã³ã¢ããŠã ã¯ãã©ã€ãïŒãã¯ã
ãªã³ãããŒã«ïŒïŒâã¯ããâïŒâã€ã³ãããŒã«ïŒ
çã®ãããªç²Ÿæ¶²æ®ºçååç©ãããã³ããã²ã¹ãã
ã³ïŒâ³ïŒâãã¬ã°ããâïŒïŒ20âãžãªã³ïŒããšã¹
ãã©ãžãªãŒã«ïŒãšã¹ãã©ãžãªãŒã«ïŒïŒ17βâãžã·
ããªããŒãïŒãã¬ãã³ããã³ïŒ17âããããã·â
19âãã«â17αâãã¬ã°ã³âïŒâãšã³â20âã€ã³
âïŒâãªã³ïŒããã¬ã°ã¹ãã¬ã«ïŒïœïŒïŒâ13βâ
ãšãã«â17αâãšããã«â17βâããããã·âïŒ
âãšã³âïŒâãªã³ïŒããšãããžãªãŒã«ãžã¢ã»ããŒ
ãïŒ3βïŒ17βâãžã¢ã»ããã·â17αâãšããã«â
ïŒâãšã¹ãã¬ã³ïŒããªãã¹ãã¬ããŒã«ïŒ17αâãš
ããã«ãšã¹ãã«âïŒâãšã³â17βâãªãŒã«ïŒãã¡
ãããã·âããã²ã¹ããã³ã¢ã»ããŒãïŒ17βâã
ãããã·â6αâã¡ãã«ãã¬ã°ã³âïŒâãšã³âïŒïŒ
20âãžãªã³ïŒãžã¡ãã¹ããã³ïŒ17βâããããã·
â6αâã¡ãã«â17âïŒâããããã«âã¢ã³ãã
ã¹ãâïŒâãšã³âïŒâãªã³ïŒãã¡ã²ã¹ãããŒã«ã¢
ã»ããŒãïŒ17αâããããã·âïŒâã¡ãã«ãã¬ã°
ã³âïŒïŒïŒâãžãšã³âïŒïŒ20âãžãªã³ ã¢ã»ããŒ
ãïŒãã¯ãã«ããžãã³ ã¢ã»ããŒãïŒïŒâã¯ãã
â17âããããã·âãã¬ã°ãâïŒïŒïŒâãžãšã³â
ïŒïŒ20âãžãªã³ ã¢ã»ããŒãïŒããšããã«ãšã¹ã
ã©ãžãªãŒã«ïŒ17αâãšããã«âïŒïŒïŒïŒïŒïŒ10ïŒ
âãšã¹ãã©ããªãšã³3βâãžãªãŒã«ïŒãã¡ã¹ãã©ã
ãŒã«ïŒïŒâã¡ããã·â19âãã«ãŒ17αâãã¬ã°ã
ãŒïŒïŒïŒïŒïŒïŒ10ïŒâããªãšã³â20âã€ã³â17â
ãªãŒã«ïŒçã®ãããªå€©ç¶ãŸãã¯åæãã«ã¢ã³ãå«
ãŸãããæ¬çºæã®ç¯å²å ã«ããä»çš®ã®ååç©ã®äŸ
ã«ã¯ãåºä¹³é¡ã«ãããŠåæã«å èãèªçºãããã
ãªãã®ããããå èè¬æŽ»æ§ããã€ååç©ã®å¥œãŸã
ãäŸã«ã¯ãæãã¹ã¿ãã³é¡ã现èæ¯æ§è¬ããšã«ãŽ
ããã¢ã«ã«ãã€ãé¡ããã«ã¢ã³ãããã¹ã¿ã°ã©ã³
ãžã³é¡E2ããã³F2αïŒ11αïŒ15ïŒïœïŒâãžãããã
ã·âïŒâã±ãããã¹ã¿âïŒâã·ã¹â13âãã©ã³ã¹
âãžãšãã€ãã¯é žããã³ã9αïŒ11αâ15ïŒïœïŒâ
ããªããããã·âããã¹ã¿âïŒâã·ã¹â13âãã©
ã³ã¹âãžãšãã€ãã¯é žã®åã ïŒã®ãããªããã¹ã¿
ã°ã©ã³ãžã³é¡ã亀æç¥çµç Žå£æ§ååç©çãå«ãŸã
ãããã¡ãããåã ã®ååç©ãçç©åŠçã«é©åã
åŸããã®ã§ããå Žåã¯ãçš®ã ã®é¿åŠå€ã®æ··åç©
ãããŸã䜿çšã§ããã è£å ã«å ¥ããæ¬çºæã®åŸ®ç²åã®éã¯ãç®çãšã
ãé¿åŠå¹æãéæããããã«åå®®ããã³ã©ãã管
ã«éã°ããªããã°ãªããªãé¿åŠå€ã®éã«äŸåã
ããé¿åŠå¹æããããããã«ã¢ã³ã®å Žåã«ãããŠ
ã¯æäžãã¹ããã«ã¢ã³ã®æè¬ã¯ãïŒæ¥åœã20ÎŒg
ã1000ÎŒgã®ç¯å²ã«ããã粟液殺çé¿åŠå€ã®å Žå
ã§ã¯ãæçµé±æã®ã»ãšãã©ã®æ¥ã«ããã€ãŠæ¯æ¥ã®
æè¬éãæè¬ããå¿ èŠã¯ãªããåŠåš ãå¯èœãªäžé
é±æã®ãããã®æ°æ¥éã«ç²Ÿæ¶²æ®ºçå€ãåŠåš ãé²æ¢
ããã®ã«å åãªçšåºŠã®æè¬éã§æè¬ããã®ã¿ã§ã
ããéåžžãïŒæ¥éãïŒæ¥åœã25ÎŒgã1000ÎŒgã®æ
è¬éã«ããã°ãç®çãšããå¹æãéãããããã
ããã®å èè¬ã¯ãæçµã®åæ¢æã®ããåŸã®ïŒãïŒ
æ¥éãïŒæ¥åœããïŒã500mgã®æè¬éã§æäžãã
ã°ãããæåãŸãã¯æäœãå«æãããããŠæçµé±
æ調æŽãã«ã¢ã³ã®ããã®åŸ®ç²åã®è£œé ã«éããŠ
ã¯ã埮ç²åã®è£œé æ³ãšããŠã®åŸæ¥æ³ã®ãããã§ã
å©çšããããšãã§ãããç¹å®ã®æ¹æ³ã®éžæã¯äž»ã«
ãããªãã¯ã¹ç©è³ªã«ããæè¡äžã®å¿ èŠæ§ããã³ã
埮ç²åã®äœ¿çšç®çã«äŸåãããäžè¬ã«ããã€ã¯ã
ã«ãã»ã«åæ¹æ³ã¯ãïŒã€ã®ã¿ã€ãã«åé¡ãããã
å³ã¡(1)æ°Žçžãšææ©çžã®åé¢å·¥çšã溶èåæ£ããã³
ã¹ãã¬ãŒä¹Ÿç¥ãå«ãçžåé¢æ¹æ³ã(2)çé¢éåãå³
æéåããã³ååŠçèžçºæåºãå«ãçé¢åå¿ã(3)
æµååºã¹ãã¬ãŒã³ãŒãã€ã³ã°ããã³è€æ°ãŸãã¯å
äžå£ã«ããé å¿åã«ããã³ãŒãã€ã³ã°ãéé»ã³ãŒ
ãã€ã³ã°ããã³ç©ççèžæ°æåºãå«ãç©ççæ¹
æ³ãã§ããã å»çå€ããã³æ²»çå€ãå«æãã埮ç²åã¯ãçš®ã
ã®æ¹æ³ã§è£å ã«å ¥ããããšãã§ããã奜ãŸããæ¹
æ³ã¯ãç¹å®æ°ã®åŸ®ç²åããè£å ã«ç°¡åã«æã§æ¿å ¥
ããããšãã§ããããã«ãã¶ã€ã³ãããã³ã³ãã
ãŒäžã«åäœãããããšã«ãããã®ã§ãããæ¿å ¥ã³
ã³ãããŒã¯ãè£å ã«å ¥ããåŸãæ°å以å ã«æº¶è§£
ãã埮ç²åã解æŸããããšã®ã§ããçç©åŠçã«å
解å¯èœãªç©è³ªããã€ããããå¿ èŠããããè¬çšã¿
ã€ãã®ãŒã©ãã³ã«ãã»ã«ãã埮ç²åã®ããã®èŒžé
æ©æ§ãšããŠäŸ¿å©ã«äœ¿çšããããšãã§ãããæè¬é
ã«ã€ããŠã¯ãæ¿å ¥è£ å ·äžã®åŸ®ç²åã®æ°ãå¢ããã
ããæžããããããããšã«ããå€ããããšãã§ã
ãããã¡ãããçš®ã ã®ä»ã®æ¹æ³ã®ãããããããŸ
ããã®å¥œãŸããæ¹æ³ãšåæ§ã«å©çšããããšã§ã
ããäŸãã°ã埮ç²åã¯ããŒã©ãã³ã®ãããªé©åœãª
åæ£åªäœã䜿çšããããšã«ãã埮ç²åãåŠçãã
æãåçŽã§æãçŽæ¥çãªæ¹æ³ã§ããåºäœè£çšåº§è¬
ã«æ圢ããããšãã§ãããã¯ãªãŒã ããŒãªãŒãçº
泡äœãŸãã¯æ¶²ç¶ã®ãã®ãã埮ç²åã®åæ£åªäœãšã
ãŠäœ¿çšã§ããããã®ã¿ã€ãã®è£œå€ã¯è£ å¡«å¯èœãªæ³š
å°åšãŸãã¯ãšã¢ããŸã«è£ å ·ãŸãã¯ããŒãããŠãŒã
ãŸãã¯ãã«ãã®ãããªå å§è£æ¿å ¥å ·ã䜿çšããŠè£
å ã«å ¥ããããšãã§ãããè£ãŸãã¯çŽè žã«å»è¬å€
ãæäžããããã®ä»ã®çš®é¡ã®è£ å ·ã䟿å©ã«äœ¿çšã
ãããšãã§ããããŒã©ãã³ã«ãã»ã«ãããŸã埮ç²
åã®éæ¬ã®ããã«éœåã®ããéæ¬å ·ã§ããã 以äžãæ¬çºæã«ã€ããŠã®ãããå®å šãªç解ã®ã
ãç¹å®ã®å®æœäŸãæãããããããã®å®æœäŸã¯ã
åã«æ¬çºæã説æããããã®ãã®ã«ããããç¹ã«
ç¹å®ããªãããããæ¬çºæãäœãå¶éãããã®ã§
ã¯ãªãã å®æœäŸ ïŒ ããã²ã¹ããã³å«æããªä¹³é žãã€ã¯ãã«ãã»ã«
ã®è£œé 2.5gã®ããã²ã¹ããã³ãš10.0gã®dlâããªä¹³é ž
ãã38gã®å¡©åã¡ãã¬ã³ã«æº¶è§£ãããåŸãããç²
çæ§æº¶æ¶²ã¯ã120mlã®ïŒééïŒ ã®ããªããã«ã¢ã«
ã³ãŒã«æº¶æ¶²ãå«ã250mlçšããŸã«æ³šã蟌ãã ãåŸ
ãããåæ£æ¶²ãå®å®ãªãšãã«ãžãšã³ãçŽåŸ50ã
100ÎŒã®ç¯å²ã§ããå°æ»Žãã€ããããã«ãªããŸã§
çŽ2000rpmã§æ¹æããããšãã«ãžãšã³ãçºæ³¡ãã¯
ããããŸã§ç空ã«åŒãã次ãã§æ¹æã600rpmãŸ
ã§æžããããïŒæéåŸãã»ãšãã©ã®å¡©åã¡ãã¬ã³
ã¯èžçºãããé£ç¶çæ¹æã¯ãåæã®ãã€ã¯ãã«ã
ã»ã«ãåéããªãããã«å¿ èŠã§ãªãã 次ãã§ãã®ãšãã«ãžãšã³ãé å¿åé¢ã«ãããæ°Ž
æ§ããªããã«ã¢ã«ã³ãŒã«æº¶æ¶²ãéãã«æ³šãããã
ãŠãã€ã¯ãã«ãã»ã«ããè±ã€ãªã³åæ°Žã®150mläž
ã«åæ£ãããããã®åŸãçŽ18æéã«ããã€ãŠæ¹æ
ãããæ°Žåæ£æ¶²ãç空ã«ããã 次ãã§åæ£æ¶²ãé å¿åé¢ã«ãããåŸããããã€
ã¯ãã«ãã»ã«ããæ°Žã§æŽããããã«ç空濟éã«ã
ãéãããã€ã¯ãã«ãã»ã«ãã宀枩äžã§é«åºŠã®ç
空äžã«äžå€ä¹Ÿç¥ããããããããµããã«ããã43
ã61ÎŒã®ç¯å²ã®éšåãåŸãããã®è£œé å·¥çšã«ã
ãã22±1.5ééïŒ ã®ããã²ã¹ããã³ãå«æãã
ãã€ã¯ãã«ãã»ã«ãåŸãã å®æœäŸ ïŒ ããã²ã¹ããã³å«æã°ãªã»ããŒã«ã¢ãã¹ãã¢ã¬
ãŒããã€ã¯ãã«ãã»ã«ã®è£œé 4gã®æº¶èã°ãªã»ããŒã«ã¢ãã¹ãã¢ã¬ãŒãã«1.0g
ã®ããã²ã¹ããã³ãæ·»å ãã溶èæ··åç©ã®äžéš
ãã溶解ã¹ãã¬ã€ãŒã®è²¯èµåšã«æ³šã蟌ãã§ã167
âãŸã§å ç±ãããå·åŽãè¡ãããã«è£ 眮å ã«çªçŽ
ã®æµããæ¯å60lå ¥ããã溶解混åç©ãåŽé§åã
ãããã®ã¹ãã¬ã€ãŒäžãžã®çªçŽ ã®æµãã¯ãæ¯å
5.75lã®æ倧é床ã«èª¿æŽããããšã¢ããŸã«ã¯ãçŽ
ã¡ã«ã¹ãã¬ãŒããããã€ã¯ãã«ãã»ã«ã¯éãã
ãããµããã«ããããã43ã61ÎŒã®éã®ç¯å²ã®å€§
ããåºåãéããããããã®æ¹æ³ã«ãã補é ãã
ããã€ã¯ãã«ãã»ã«ã¯ãçç¶ã§ããã20ééïŒ ã®
ããã²ã¹ããã³ã®çè«éãå«ãã§ããã å®æœäŸ ïŒ ïŒé ã®ã²ã²ã«ã7.87mgã®ããã²ã¹ããã³ãå«æ
ããdlâããªä¹³é žãã€ã¯ãã«ãã»ã«ãã泚å°ãäž
æ¹ïŒé ã®ã²ã²ã«ã¯7.87mgã®ããã²ã¹ããã³ãå«æ
ããdlâããªä¹³é žãã€ã¯ãã«ãã»ã«ãè£ãéããŠ
æäžããããã¹ãŠã®ã²ã²ã¯ç¬¬ïŒæ¥ã«åŠçœ®ãããã
ã«åå®®ã®çæ€ã第12æ¥ã«åã€ããæ¯æ¥ã®ãšã¹ãã©
ãžãªãŒã«ããã³ããã²ã¹ããã³ã®è¡æ¶²ã¬ãã«ãã
ãŸãåŸããããæ¯æ¥ã®åå®ã®çµæã¯ç¬¬ïŒïŒå³ã«ç€º
ããã第ïŒïŒïŒ¡å³ã¯ããã€ã¯ãã«ãã»ã«ã®çèå
泚å°ã«ã€ããŠã®ããã²ã¹ããã³ããã³ãšã¹ãã©ãž
ãªãŒã«ã®ã¬ãã«ããäžæ¹ç¬¬ïŒïŒïŒ¢å³ã«ã¯ããã€ã¯
ãã«ãã»ã«ãè£ã«æäžããå Žåã«ã€ããŠã®ããã²
ã¹ããã³ããã³ãšã¹ãã©ãžãªãŒã«ã®ã¬ãã«ã瀺ã
ãã®ã§ãããå³äž35.75mgã¯æäžãããã€ã¯ãã«
ãã»ã«ã®ééã§ãããããã²ã¹ããã³å«æéã¯å
è¿°ããããã«7.87mgïŒ7.87mg÷35.75mgÃ100ïŒçŽ
22ééïŒ ïŒã§ãããçèå 泚å°ããããã²ã²ã®æ¹
ãè£å ã«åŠçœ®ããã²ã²ãããé«ãããã²ã¹ããã³
ã®æ¿åºŠãæããã«èŠãåºããããããã«ã€ããŠã¯
äºã€ã®å¯èœæ§ãäºæž¬ããããå³ã¡ (1) è£å ã«å ¥ãããããã€ã¯ãã«ãã»ã«ã®äžéšã
ããåŠçœ®åŸã®ïŒæ¥ç®ãŸã§ã®ãã€ãŠããªãããšã (2) è£å ã«å ¥ããããšã«ããããã€ã¯ãã«ãã»ã«
ãã解æŸãããããã²ã¹ããã³ã®äžéšããè¡æ¶²
ã®æµãã«ãšã©ããªãããããã®å¯èœæ§ã®äž¡æ¹ã
å€åãäºã€ã®åŠçœ®æ¹æ³ã®éã®ããã²ã¹ããã³ã®
å šèº«çã¬ãã«ã«ãããå·®ç°ã«é¢äžããŠãããã
ãã²ã¹ããã³ã®å šèº«ãžã®éæ¬ãåç¬ã§ãããè£
å ã«åŠçœ®ããåç©ã«ãããŠãåå®®ãžã®çŽæ¥ã®å±
éšç茞éã®å¯èœæ§ãæé€ããããšãããšãçè«
çã«ã¯æ³šå°ã«ããåŠçœ®ãããã²ã²ã«ãããŠã¯ã
è£å ã«åŠçœ®ãããã²ã²ã«ãããŠãããã匷ãé¿
åŠå¹æãæåŸ ã§ããããããŠæçšéã«å¯Ÿå¿ãã
å®éšããã®çµæã¯ããã®æåŸ ãæ¯æããŠããã
ããããªãããã²ã²ã®åå®®å èçæ€ã®æ¯èŒã®ã
ãã®çµç¹åŠäžã®å®éšã¯ãã®ä»®å®ãæ¯æããŠããª
ããè£æè¬ã«ããæ²»çããã²ã²ã«ãããããã²
ã¹ããã³äžèªå ã«ããåæ³æŽ»æ§ã®ã¬ãã«ã«ã€ã
ãŠãçèå 泚å°ã«ããæ²»çãããã²ã²ãšæ¯èŒã
ãå Žåãçµç¹åŠäžã®å®éšã§ã¯ãé¡èãªæžå°ã¯çŸ
ãããªããããã¯ãããã²ã¹ããã³ã®å šèº«çã¬
ãã«ã«ãããå·®ç°ã«åºããã°ãããã»ã©äºæã
ããªãã€ãããšã§ããããã®è¡šé¢äžã®ççŸãã
çºèŠã¯ãå®éã«ãè£å åŠçããã²ã²ã«ã€ããŠ
ã®ãããã²ã¹ããã³ã®å±éšç茞éã®å¯èœæ§ãæ¯
æããŠããã第ïŒïŒïœå³ããã³ç¬¬ïŒïŒïœå³ã¯ã
7.87mgã®ããã²ã¹ããã³ãå«æããŠãããã€ã¯
ãã«ãã»ã«ã®è£å æäžã«ããåŠçœ®ãããã²ã²ã®
åå®®å èã®çµç¹ã®å€èŠ³ã瀺ããã®ã§ããã
ïŒåã ã20åããã³100åã§æ¡å€§ããïŒïŒ¥æ±æ
çµç¹ã§ãããïŒç¬¬ïŒïŒïœããã³ïŒïŒïœå³ã¯ã
åã 20åããã³100åã§æ¡å€§ããåãçµç¹
ïŒPASæ±æïŒã§ããã è£ã«åŠçœ®ããåç©ã«ãããããã²ã¹ããã³ã®å±
éšçéæ¬ãæ¯æããçµç¹åŠäžã®èšŒæ ã®ç¬¬ïŒã¯ãå
å®®å èçµç¹ã«ãããããã²ã¹ããã³ã«èªåŒããã
å€åãã埮ç²åã泚å°ã«ããåŠçœ®ãããã²ã²ã®å
å®®å èã§ã¯åäžã«å šäœã«èµ·ãããäžæ¹åŸ®ç²åãè£
å ã«æ¿å ¥ãããã«ããåŠçãããã²ã²ã§ã¯ããã®
å¹æãå±éšåãããŠãããè¡šé¢äžç®ã®äžã«ããè¡š
é¢è ºã«ãããŠç¥èŠã§ãã匷床ã®åºæ¿ã§ãè ºããè º
ãŸã§å€åããïŒç¬¬ïŒïŒå³åç §ïŒãšãã芳å¯ã«åºã
ããŠããããããã泚å°ã«ããåŠçœ®ãåããã²ã²
ã«ãããŠã¯ãè¡šé¢è ºã«ãµãããŠã¯ãªã€ãŒ
ïŒSubnuclearïŒç©ºèããªããè£ã«åŠçããã²ã²ã«
ãããŠã¯è¡šé¢è ºã«ããããã®ãµãããŠãŒã¯ãªã€ãŒ
空èãååšãããšããããšã¯ãè£ã«åŠçœ®ããã²ã²
ã«ãããŠãå±éšçãªåå®®å éšãžã®éæ¬ãè¡ããã
ããšã蚌æ ç«ãŠãŠããã é»åé¡åŸ®é¡ãèµ°æ»ããããšã«ããè¡šé¢äžç®çµç¹
ã®æ¯èŒå®éšã¯ããã€ã¯ãã«ãã»ã«ã«ããè£å åŠçœ®
ã«ããå±éšåãããé¿åŠå¹æã«ã€ããŠã®ããã«é²
ãã 蚌æ ãæäŸããŠãããå³ã¡ç¬¬ïŒïŒå³ã¯ãåå®®
ã®äžç®è¡šé¢ã®çµç¹ãæ¯èŒããŠãããã®ã§ããã第
ïŒïŒïœå³ã¯åžžæ ã®æªåŠçœ®ã®ç¬¬12æ¥ç®ã®ã²ã²ã®åå®®
å èã第ïŒïŒïœå³ã¯åžžæ ã®æªåŠçœ®ã®ç¬¬20æ¥ç®ã®å
å®®å èã第ïŒïŒïœå³ã¯ãåŠçœ®ãæœãã12æ¥ç®ã®å
å®®å èïŒ7.87mgã®ããã²ã¹ããã³ãå«æãããã€
ã¯ãã«ãã»ã«ã®çèå 泚å°ã«ããïŒã第ïŒïŒïœå³
ã¯ãåŠçœ®ãã»ã©ããã12æ¥ç®ã®åå®®å èïŒ7.87mg
ã®ããã²ã¹ããã³ãå«æãããã€ã¯ãã«ãã»ã«ã®
åå®®å æäžã«ããïŒã§ããã ããã²ã¹ããã³ã¯ãè ºã®äžç®çŽ°èã®å è¡šé¢
ïŒluminal surfaceïŒã«é¡èãªåŸ®å°çµšæ¯æ¬æ¥ã®çªèµ·
ã®çæãå°ã³ãã埮å°çµšæ¯ã¯ãæåµã®åã«ã¯ãæ®
éã¯ååšããªããïŒç¬¬12æ¥ç®ã®èª¿æŽãåç §ïŒãã
ãæåµã®åŸã«ã¯ãéåžžã«ç®ç«ã€ãŠãããïŒç¬¬20æ¥
ç®ã®èª¿æŽãåç §ïŒç¬¬ïŒæ¥ã第12æ¥ã®éã«é£ç¶çã«
ããã²ã¹ããã³åŠçãè¡ããšå€æ°ã®åŸ®å°çµšæ¯ã®çª
èµ·ã®çæãèµ·ããã 埮å°çµšæ¯ã¯ã泚å°ã§åŠçœ®ããã²ã²ã®åå®®å èè¡š
é¢äžã«ãåäžãªååžã§çãããããããªããè£å
ã«åŠçœ®ããã²ã²ã«ãããŠã¯ã埮å°çµšæ¯ã¯ç¬ç¹ã®æ
ç¹ã§çããã埮å°çµšæ¯ã®ãããç¶ã®äžåäžãªååž
ã¯ã埮å°çµšæ¯ã®ãããªãäžç®çŽ°èã«ããã垯åãš
埮å°çµšæ¯ã倧ãããå€ãã垯åãšã®éã«çããã
è¡šé¢äžç®ã®åœ¢æ ã«ãããããã²ã¹ããã³ã«ããç
ããå€åã®äžåäžãªååžã¯ãããã²ã¹ããã³ã®åº
æ¿ã®å±éšåããã垯åã瀺ããã®ã§ãããå šèº«ç
ã«æäžããå Žåãåå®®å èã®ãã¹ãŠã®åž¯åãåäž
ãªè¬å€ã®æäžãåããããå±éšçæäžã®å Žåã¯ã
埮ç²åãåå®®å ã«ååšãããšããã«ãããããé«
ããŸãã¯ããäœãæäžãåããã 第ïŒïŒïŒ¡å³ããã³ç¬¬ïŒïŒïŒ¢å³ã¯ãçèå 泚å°ã«
ããå ŽåïŒç¬¬ïŒïŒïŒ¡å³ïŒãšè£å æäžã«ããå Žå
ïŒç¬¬ïŒïŒïŒ¢å³ïŒã®ã²ã²ã«ã€ããŠã®äžèšã®æ¡ä»¶äžã«
ãããŠã®1.57mgã®ããã²ã¹ããã³å«æãã€ã¯ãã«
ãã»ã«ã®æäžã«ããããã²ã¹ããã³ãšãšã¹ãã©ãž
ãªãŒã«ã¬ãã«ãæ¯èŒãããã®ã§ãããå³äž7.15mg
ã¯æäžãããã€ã¯ãã«ãã»ã«ã®ééã§ããããã€
ã¯ãã«ãã»ã«ããã®ãããªå°éã§æäžããå Žåã
ããã泚å°ã«ããæäžããå Žåãšã¹ãã©ãžãªãŒã«
ã«ã€ããŠã¯ããããªé»æ¢å¹æã瀺ãããè£å æäž
ã®å Žåã«ã¯ãå¹æããªãã泚å°ã§åŠçœ®ããã²ã²ã®
å Žåãå€ççããã²ã¹ããã³ã¯ã第ïŒæ¥ç®ãš12æ¥
ç®ã®éã«è¡æ¶²äžã«äœã¬ãã«ã§ååšãããããããª
ããè£çµç±ã®å Žåãå€ççããã²ã¹ããã³ã¯ã第
ïŒæ¥ç®ãã第12æ¥ç®ã®éã«ãããŠãåææè¡ã®æ
ç¥ç¯å²ã§ã¯è¡æ¶²äžã«æ€åºãããªãã€ãã 第ïŒïŒå³ã«ç€ºãããæ¯èŒãã«ã¢ã³ããŒã¿ããã³
å±éšçéæ¬ã®å¯èœæ§ãé€å€ããå Žåãè£ã«åŠçœ®ã
ãã²ã²ã®åå®®å èã®çµç¹ã¯ãåžžæ ã®æªåŠçœ®ã®èª¿æŽ
ã«ãããŠèŠ³å¯ããããã¿ãŒã³ãšäŒŒãŠãããäºæž¬ã
ãã®ãçè«çã§ããããã«ã¿ããã埮ç²åã®äœæ
è¬éã§ãè£çµç±ã§åŠçœ®ããã²ã²ã«ãããããã²ã¹
ããã³ããã³ãšã¹ãã©ãžãªãŒã«ã®äž¡æ¹ã®è¡æ¶²ã¬ã
ã«ãåžžæ ã«ãããŠçãããããšåäžã§ããããš
ãããã®äºæž¬ã«å¯Ÿããçè«çæ ¹æ ã§ãããããã
ãªããã泚å°ã«ããåŠçœ®ããåç©ã«ã€ããŠã¯ãã
ã®åŠçã«ãããæ€åºã§ããã ãã®ããã²ã¹ããã³
ã¬ãã«ãã第ïŒã12æ¥ç®ã®éã«è¡æ¶²äžã«çºèŠãã
ãã®ã§åäžã®çè«çæ ¹æ ã¯ä¿ãŠãªããããã«ãšã¹
ãã©ãžãªãŒã«ã¬ãã«ã¯ãåžžæ ã®èª¿æŽãšæ¯èŒããå Ž
åãããåäœäžããããã«ã¿ãããããããŸãã
çµç¹åŠäžã®èª¿æ»çµæã¯ããã®äºæž¬ãããçµæã«å
ãããã®ã§ãããè£å çµç±ã«ããåŠçœ®ãããã²ã²
ã«ããã枬å®å¯èœãªå šèº«çãªããã²ã¹ããã³ããª
ãã®ã«ãããããããåå®®å èã¯æãããªåŠåš å
ã®å¹æã瀺ãã é»åé¡åŸ®é¡ãèµ°æ»ãããããšã«ããè¡šé¢äžç®çµ
ç¹ã®æ€æ»ã§ã¯ã第ïŒïŒå³ã«ç€ºãããã«ããã²ã¹ã
ãã³ã®åºæ¿ã®æãããªèšŒæ ã瀺ã埮å°çµšæ¯ã®é »ç¹
ãªçºçãçŸããããç¹ã«ã第ïŒïŒïœå³ããã³ç¬¬ïŒ
ïŒïœå³ã¯ãæçµé±æã®ç¬¬12æ¥ç®ã«åŠçœ®ããã²ã²ã®
è¡šé¢äžç®ã®äœãæ¡å€§ïŒ9600ïŒããã³é«ãæ¡å€§
ïŒ18240ïŒã«ããé¡åŸ®é¡åŸåçã§ããã第ïŒïŒïœå³
ã¯ãäžç®è¡šé¢ã«ããããã€ã¯ãã«ãã»ã«å«æãã
ã²ã¹ããã³ã瀺ãäžç®ã®é¡åŸ®é¡åçã§ãããäžæ¹
第ïŒïŒïœå³ã¯ããã€ã¯ãã«ãã»ã«ãã®ãã®ã®é¡åŸ®
é¡åçã§ãããäžç®çµç¹ã«ãããããã²ã¹ããã³
ã«ããèªåŒãããå€åã¯ãæ¡çšããæ€åºè©Šéšæ³ã«
ãã€ãŠæž¬å®ããã«ã¯äœãããå šèº«çãªããã²ã¹ã
ãã³ã«å¯Ÿå¿ããŠçããããããããããã説æ
ã¯ãããã²ã¹ããã³ã®çŽæ¥ã®å±éšçåå®®å éæ¬ã«
ããçµæã§ãããšããããšã«ãªãã æã匷調ãããã¹ãç¹ã¯ããã€ã¯ãã«ãã»ã«ã®
å°ãªãæè¬éïŒå³ã¡ããã²ã¹ããã³ã®7.87mgïŒ
ã§ãåæ³å€åããåå®®å èã«ãããŠçãããšãã
ããšã§ãããããã«ãå€åã䌎ãæè¬éã®å¯Ÿå¿
ã¯ãæè¬éã®å¢å ã«ãšããªããçæ®æ©èœãé»æ¢ã
ãã®ã«å åãªå¹æã¬ãã«ãéæããããšãå¯èœã§
ããããšã®ç€ºåã衚瀺ããŠããã 第ïŒïŒïŒ¡å³ããã³ç¬¬ïŒïŒïŒ¢å³ã¯ãæçµé±æã®å
æ¥ã«ããäºé ã®ã²ã²ã®éã®åå®®é çèã®å瞮掻å
ãæ¯èŒãããã®ã§ãããW.D.Blairããã³L.R.
Beckã«ããScriptor PublicationïŒã³ãã³ããŒã²
ã³ïŒçºè¡ã®Ovun Transport and Fertility
Regulation 1976幎ã®41ã74é ã®èšèŒã«ããã€ã
ãããç¹æ®å€æåšããåã ã®ã²ã²ã®åå®®é ã«å ¥ã
ããã®ãçšããŠããã®å³ã«ç€ºãããåå®®é ã®åçž®
ã®ãã¿ãŒã³ã枬å®ããããã®å€æåšããã¹ããªã
ããã€ãŒãèšé²åšã«ã€ãªãã ã第ïŒïŒïŒ¡å³ã¯ããš
ã¹ãã©ãžãªãŒã«ãå«æãã埮ç²åãè£å ã«å ¥ãåŠ
眮ããã²ã²ããåŸãããçµæã瀺ããã®ã§ããã
äžæ¹ç¬¬ïŒïŒïŒ¢å³ã¯ã埮ç²åã§åŠçããªã調æŽã²ã²
ããåŸãããçµæã瀺ããçµæã¯åŠçœ®ããããšã«
ãããåå®®é ã®åçž®ã®é »åºŠããã³æ¯å¹ ã®äž¡æ¹ãåº
æ¿ããããããã®åçž®ã¯ããã®åšç®¡ãéããŠåŸ®ç²
åãåããã æ¬é¡çºæã®å¥œãŸããæ æ§ã®è¥å¹²ã以äžã«èŠçŽã
ãŠåæããã (1) æåãŸãã¯æäœãå«æããŠãã埮ç²åãã女
æ§çæ®èåšã«å ¥ãããã®åŸ®ç²åãçæ®åšç®¡ã®èª
ç¶ã®éæ¬æ©æ§ã«ãããåå®®é éšãéããŠåå®®ã
ãã³ã©ãã管ã®äžã«éã°ããããã§æåã埮ç²
åã«ãã€ãŠã解æŸãããããšãããªã女æ§çæ®
èåšã®å ç«åå¿ã掻åçãŸãã¯ååçã«èªåŒã
ãæ¹æ³ã (2) 埮ç²åã20ã70ÎŒã®å€§ããç¯å²ã§ããããã
ãªãã¯ã¹ç©è³ªãããªä¹³é žãããªã°ãªã³ãŒã«é žãŸ
ãã¯ãããã®æ··åç©ã§ããåèšç¬¬ïŒé èšèŒã®æ¹
æ³ã (3) æåãããã¯ããªã¢èãŸãã¯ããŒã«ã¹èã§ã
ãåèšç¬¬ïŒé èšèŒã®æ¹æ³ã (4) æäœãŸãã¯æåãšãæçµé±æ調ç¯ãã«ã¢ã³ã
å«æãã埮ç²åãè£ã«å ¥ãã埮ç²åããã®ãã«
ã¢ã³ã®åžåã«ããå éšçæ®åšç®¡ã®èªç¶ã®éæ¬æ©
æ§ãåºæ¿ãã埮ç²åã粟液代çšæŽ»æ§ã«ãããå
å®®é ããåå®®ããã³ã©ãã管ã®äžã«ãã®éæ¬æ©
æ§ã§éã°ããããã§ã埮ç²åããæäœã解æŸã
ããããšãããªã女æ§çæ®èåšãååçãŸãã¯
掻åçã«å ç«ããæ¹æ³ã (5) æçµé±æ調æŽãã«ã¢ã³ãããã²ã¹ãã³ãŸãã¯
ãšã¹ããã²ã³ã§ããåèšç¬¬ïŒé èšèŒã®æ¹æ³ã (6) æåããããŒã«ã¹èãŸãã¯ãã¯ããªã¢èã§ã
ãåèšç¬¬ïŒé èšèŒã®æ¹æ³ã (7) è£å ã§ããšã¹ããã²ã³ããæçµé±æã®ãšã¹ã
ãã²ã³æ®µéã®ïŒã14æ¥ãéãåããããã«ãå®
å®ããŠè§£æŸããããã«è£å ã«ãšã¹ããã²ã³ãå«
æãã埮ç²åãå ¥ããåå®®é ã®åŸ®ç²åã®éæ¬ã
ä¿é²ããè£å ã§ããã²ã¹ãã³ããæçµé±æã®ïŒ
ã28æ¥åŸã«è§£æŸããæçµé±æã®ããã²ã¹ãã³æ®µ
éãéãåããããã«ãè£å ã«ããã²ã¹ãã³ã
å«æãã埮ç²åãå ¥ããããã«æçµé±æã®12ã
16æ¥ã®éã«ãæäœãŸãã¯æåãå«ã埮ç²åãã
åå®®é ãéããŠåå®®ããã³ã©ãã管ãŸã§æ倧é
æ¬ããããšãã§ãããããããææã«ãæåãŸ
ãã¯æäœãå«ã埮ç²åãè£å ã«å ¥ããåå®®ãã
ã³ã©ãã管ã§æäœãŸãã¯æåã解æŸããããã
ã«ããããšãããªã女æ§çæ®èåšã«å¯ŸããŠæäœ
ãŸãã¯æåãæè¬ããŠã女æ§ã®æçµé±æãéã
åããæ¹æ³ã (8) é¿åŠå€ãšçç©åŠçã«å£åãåŸãçç©åŠçã«å Œ
çšã§ãããããªãã¯ã¹ç©è³ªãããªã粟液代çšæŽ»
æ§ãæããé¿åŠã®ããã«æå¹ãªéã®åŸ®ç²åãè£
ã®äžã«å ¥ãããããŠããã®åŸ®ç²åããçæ®èåš
ã®èªç¶ãªèŒžéæ©æ§ã«ãããåå®®é ãéããŠåå®®
ã«éæ¬ããããããã§åŸ®ç²åããé¿åŠå€ã解æŸ
ããããšã«ãããé¿åŠå€ãåå®®ããã³ã©ãã管
ã«çŽæ¥éæ¬ãããããšã«ãããªããé¿åŠå€ã®å
å®®ããã³ã©ãã管ãžã®èŒžéæ¹æ³ã (9) 埮ç²åããæçµé±æã®äžéé±æãã以åã«è£
ã«å ¥ããããšããããŠé¿åŠå€ãããã²ã¹ããã³
ãŸãã¯ãšã¹ãã©ãžãªãŒã«ã§ãããåèšç¬¬ïŒé èš
èŒã®æ¹æ³ã (10) é¿åŠå€ããçæ®èåšã«ïŒæ¥åœã0.10ã1.0mg
ãã€è§£æŸãããåæ第ïŒé èšèŒã®æ¹æ³ã (11) é¿åŠå€ãåå®®ããã³ã©ãã管ã«éæ¬ãããã
ã®æ¹æ³ã§ãã€ãŠã埮ç²åããé¿åŠå€ãšããŠãã«
ã¢ã³ã䜿çšããå Žåãé±æ調æŽãã«ã¢ã³ãšããŠ
é¿åŠå€ãšç°ãªããã®ã䜿çšãããšããæ¡ä»¶äž
ã«ãçç©åŠçã«å£åããããšãã§ãããããç
ç©åŠçã«å Œçšããããšã®ã§ãããããªãã¯ã¹ç©
äžã«ååšããé¿åŠå€ãšé±æ調æŽãã«ã¢ã³ãšãã
ãªããã®ã§ããããã®ç²Ÿæ¶²ä»£çšæŽ»æ§ãæãã埮
ç²åãè£å ã«é¿åŠã®ããã®å¹æéã§å ¥ããåå®®
é ãéããŠåå®®ããã³ã©ãã管ã®äžãžãšåãã
çæ®èåšã®èªç¶èŒžéæ©æ§ãåºæ¿ããã®ã«å åãª
éã«ãããŠã埮ç²åããé±æ調æŽãã«ã¢ã³ãé£
ç¶çã«è§£æŸããã埮ç²åãåå®®é ããåå®®ãã
ã³ã©ãã管ã®äžã«ééãããšããããã§é¿åŠå€
ã®è§£æŸãçããããã«ããããšãããªãæ¹æ³ã (12) 埮ç²åããæçµé±æã®äžéé±æ以åã«è£ã«å ¥
ããåèšç¬¬11é èšèŒã®æ¹æ³ã (13) æçµé±æ調æŽãã«ã¢ã³ããããã²ã¹ãã³ãŸ
ãã¯ãšã¹ããã²ã³ã§ããåèšç¬¬11é èšèŒã®æ¹
æ³ã (14) ãšã¹ããã²ã³å«æ埮ç²åãè£ã«å ¥ãããã
ã§ãšã¹ããã²ã³ãå®å®ããŠè§£æŸãããæçµé±æ
ã®ãšã¹ããã²ã³åå¿ææã®ïŒã14æ¥ãéãå
ãããããŠãåå®®é ã§ã®åŸ®ç²åã®èŒžéãä¿é²
ããããã²ã¹ãã³å«æ埮ç²åãè£å ã«å ¥ããè£
ã«ãããŠãããã²ã¹ãã³ãæçµé±æã®ïŒã28æ¥
ã®åŸã«è§£æŸãããããã«ãããæçµé±æã®ãã
ã²ã¹ãã³æ®µéãéãåããããã«é¿åŠå€ãå«æ
ãã埮ç²åããæçµé±æã®12ã16æ¥ã®éã«ãã
ãåå®®é ãéããŠåå®®ããã³ã©ãã管ãžã®æ倧
茞éã®ããã«å åãªããææã«è£ã«å ¥ããåå®®
ããã³ã©ãã管ã§é¿åŠå€ã解æŸãããããã«ã
ãããšãããªãã女æ§çæ®èåšãžã®é¿åŠå€ãæ
è¬ããŠã女æ§ã«ãããæçµé±æãéè€ããæ¹
æ³ã (15) ãšã¹ããã²ã³ãã埮ç²åããïŒæ¥åœã0.1ã
ïŒmgã®é床ã§è§£æŸãããããã«ããã²ã¹ãã³ã
ïŒæ¥åœã0.5ãïŒmgã§è§£æŸãããåèšç¬¬14é èš
èŒã®æ¹æ³ã (16) 埮ç²åå šäœããããã²ã¹ããã³ãåæ£ãã
ãããšã®ã§ããããªä¹³é žãããªã埮ç²åãè£ã«
å ¥ãã埮ç²åããã®ããã²ã¹ããã³ã®è§£æŸã«ã
ãã埮ç²åã®åå®®é ããåå®®ãžã®èŒžéãè¡ãã
ãã®èªç¶ã®èŒžéæ©æ§ãåºæ¿ãããããã«ç®çãš
ããé¿åŠå¹æãéæããã®ã«å åãªéã«ãããŠ
åå®®é ã«ããã埮ç²åããã®ããã²ã¹ããã³ã®
åå®®ããã³ã©ãã管ãžã®ããã«é²ãã 解æŸãè¡
ãããšãããªããå éšçæ®åšç®¡ãžã®é¿åŠå€ã®æ
è¬ã«ããå éšçæ®åšç®¡ã®èªç¶ã®èŒžéæ©æ§ãåºæ¿
ããæ¹æ³ã
第ïŒå³ã¯ãè¬å€ãå«æããåäžæ§é ã®æ¬çºæã®
埮ç²åç¶è¬å€ãã第ïŒå³ã¯ããããªãã¯ã¹ç©è³ªã®
æ®»ã«ããèŠããããããªãã¯ã¹ç©è³ªäžã®è¬å€ã®è¯
ããã€ãããã埮ç²åç¶è¬å€ãã第ïŒå³ã¯ããã
ãªãã¯ã¹ç©è³ªã®æ®»ã«ããèŠãããè¬å€ã®è¯ãããª
ã埮ç²åç¶è¬å€ãã第ïŒå³ã¯ããããªãã¯ã¹ç©è³ª
ãšè¬å€ã®äº€äºã®å±€ãããªãããŸããæ§é ã®åŸ®ç²å
ç¶è¬å€ãã第ïŒå³ã¯ã第ïŒã®çš®é¡ã®è¬å€ãå«æã
ããããªãã¯ã¹ç©è³ªã®æ®»ã«ããèŠãããäžçš®ã®ç¹
å®ç²åç¶è¬å€ã®è¯ãããªã埮ç²åç¶è¬å€ãã第ïŒ
å³ã¯ããããªãã¯ã¹ç©è³ªäžã®é¿åŠå€ããã³é±æ調
æŽãã«ã¢ã³ãããªãåäžæ§é ã®åŸ®ç²åç¶è¬å€ãã
第ïŒå³ã¯ããããªãã¯ã¹ç©è³ªã®æ®»ã«ããèŠããã
é¿åŠå€ããã³é±æ調æŽãã«ã¢ã³ã®è¯ãããªã埮ç²
åç¶è¬å€ãã第ïŒå³ã¯ããããªãã¯ã¹ç©è³ªã®æ®»ã«
ããèŠããããããªãã¯ã¹ç©è³ªäžã®é¿åŠå€ããã³
é±æ調æŽãã«ã¢ã³ã®è¯ãããªã埮ç²åç¶è¬å€ãã
第ïŒå³ã¯ããããªãã¯ã¹ç©è³ªäžã®é±æ調æŽãã«ã¢
ã³ã®æ®»ã«ããèŠããããããªãã¯ã¹ç©è³ªäžã®é¿åŠ
å€ã®è¯ãããªã埮ç²åç¶è¬å€ãã第ïŒïŒå³ã¯ãé¿
åŠè¬ãšé±æ調æŽãã«ã¢ã³ãå šãç°ãªãå±€ã«åæ£ã
ããŠããè€å±€åŸ®ç²åç¶è¬å€ãã第ïŒïŒïŒ¡å³ããã³
第ïŒïŒïŒ¢å³ã¯çèå ããã³è£å ã«ãããã7.87mg
ã®ããã²ã¹ããã³ã䜿çšããŠåŠçœ®ããã²ã²äžã®ã
ãã²ã¹ããã³ããã³ãšã¹ãã©ãžãªãŒã«ã®è¡æ¶²ã¬ã
ã«ãã第ïŒïŒå³ã¯ãã²ã²ã®åå®®å èã®çµç¹æ§é ã®
å€èŠ³ã®é¡åŸ®é¡åçãã第ïŒïŒå³ã¯ãã²ã²ã®åå®®äž
ç®çµç¹ã®è¡šé¢ã®åœ¢æ ã瀺ãäžé£ã®é¡åŸ®é¡åçãã
第ïŒïŒïŒ¡å³ããã³ç¬¬ïŒïŒïŒ¢å³ã¯ãçèå ããã³è£
å ããããã1.57mgã®ããã²ã¹ããã³ã§åŠçãã
ã²ã²ã®ããã²ã¹ããã³ããã³ãšã¹ããã²ã³ã®è¡æ¶²
ã¬ãã«ãã第ïŒïŒå³ã¯ãã²ã²ã®åå®®é å èã®è¡šé¢
äžç®çµç¹ã®åœ¢æ ã瀺ãäžé£ã®é¡åŸ®é¡åçãããã
ã³ç¬¬ïŒïŒïŒ¡å³ããã³ç¬¬ïŒïŒïŒ¢å³ã¯ããšã¹ãã©ãžãª
ãŒã«å«æã®åŸ®ç²åã§åŠçãããã®ããã³ãã«ã¢ã³
å«æ埮ç²åã§åŠçããªããã®ãšã®ïŒçš®ã®éã®ã²ã²
ã®å瞮掻æ§ã®èšé²ãããããã瀺ãã
埮ç²åç¶è¬å€ãã第ïŒå³ã¯ããããªãã¯ã¹ç©è³ªã®
æ®»ã«ããèŠããããããªãã¯ã¹ç©è³ªäžã®è¬å€ã®è¯
ããã€ãããã埮ç²åç¶è¬å€ãã第ïŒå³ã¯ããã
ãªãã¯ã¹ç©è³ªã®æ®»ã«ããèŠãããè¬å€ã®è¯ãããª
ã埮ç²åç¶è¬å€ãã第ïŒå³ã¯ããããªãã¯ã¹ç©è³ª
ãšè¬å€ã®äº€äºã®å±€ãããªãããŸããæ§é ã®åŸ®ç²å
ç¶è¬å€ãã第ïŒå³ã¯ã第ïŒã®çš®é¡ã®è¬å€ãå«æã
ããããªãã¯ã¹ç©è³ªã®æ®»ã«ããèŠãããäžçš®ã®ç¹
å®ç²åç¶è¬å€ã®è¯ãããªã埮ç²åç¶è¬å€ãã第ïŒ
å³ã¯ããããªãã¯ã¹ç©è³ªäžã®é¿åŠå€ããã³é±æ調
æŽãã«ã¢ã³ãããªãåäžæ§é ã®åŸ®ç²åç¶è¬å€ãã
第ïŒå³ã¯ããããªãã¯ã¹ç©è³ªã®æ®»ã«ããèŠããã
é¿åŠå€ããã³é±æ調æŽãã«ã¢ã³ã®è¯ãããªã埮ç²
åç¶è¬å€ãã第ïŒå³ã¯ããããªãã¯ã¹ç©è³ªã®æ®»ã«
ããèŠããããããªãã¯ã¹ç©è³ªäžã®é¿åŠå€ããã³
é±æ調æŽãã«ã¢ã³ã®è¯ãããªã埮ç²åç¶è¬å€ãã
第ïŒå³ã¯ããããªãã¯ã¹ç©è³ªäžã®é±æ調æŽãã«ã¢
ã³ã®æ®»ã«ããèŠããããããªãã¯ã¹ç©è³ªäžã®é¿åŠ
å€ã®è¯ãããªã埮ç²åç¶è¬å€ãã第ïŒïŒå³ã¯ãé¿
åŠè¬ãšé±æ調æŽãã«ã¢ã³ãå šãç°ãªãå±€ã«åæ£ã
ããŠããè€å±€åŸ®ç²åç¶è¬å€ãã第ïŒïŒïŒ¡å³ããã³
第ïŒïŒïŒ¢å³ã¯çèå ããã³è£å ã«ãããã7.87mg
ã®ããã²ã¹ããã³ã䜿çšããŠåŠçœ®ããã²ã²äžã®ã
ãã²ã¹ããã³ããã³ãšã¹ãã©ãžãªãŒã«ã®è¡æ¶²ã¬ã
ã«ãã第ïŒïŒå³ã¯ãã²ã²ã®åå®®å èã®çµç¹æ§é ã®
å€èŠ³ã®é¡åŸ®é¡åçãã第ïŒïŒå³ã¯ãã²ã²ã®åå®®äž
ç®çµç¹ã®è¡šé¢ã®åœ¢æ ã瀺ãäžé£ã®é¡åŸ®é¡åçãã
第ïŒïŒïŒ¡å³ããã³ç¬¬ïŒïŒïŒ¢å³ã¯ãçèå ããã³è£
å ããããã1.57mgã®ããã²ã¹ããã³ã§åŠçãã
ã²ã²ã®ããã²ã¹ããã³ããã³ãšã¹ããã²ã³ã®è¡æ¶²
ã¬ãã«ãã第ïŒïŒå³ã¯ãã²ã²ã®åå®®é å èã®è¡šé¢
äžç®çµç¹ã®åœ¢æ ã瀺ãäžé£ã®é¡åŸ®é¡åçãããã
ã³ç¬¬ïŒïŒïŒ¡å³ããã³ç¬¬ïŒïŒïŒ¢å³ã¯ããšã¹ãã©ãžãª
ãŒã«å«æã®åŸ®ç²åã§åŠçãããã®ããã³ãã«ã¢ã³
å«æ埮ç²åã§åŠçããªããã®ãšã®ïŒçš®ã®éã®ã²ã²
ã®å瞮掻æ§ã®èšé²ãããããã瀺ãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ è£å ã«æäžããã埮ç²åç¶è¬å€ã§ãã€ãŠãã
ãªä¹³é žãããªã°ãªã³ãŒã«é žãã°ãªã³ãŒã«ãšä¹³é žãš
ã®å ±éåäœãã°ãªã»ããŒã«ã»ã¢ãåã¯ãžã»ã¹ãã¢
ã¬ãŒãããéžã°ãããããªãã¯ã¹äžã«å°ãªããšã
äžçš®ã®è¬å€æåãå«æããŠãªãçŽåŸ20ã70ÎŒmã®
倧ããã®åŸ®ç²åç¶è¬å€ã ïŒ åèšè¬å€æåãšããŠãæååã¯æäœãå«æã
ããããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èš
èŒã®åŸ®ç²åç¶è¬å€ã ïŒ åèšè¬å€æåãšããŠãåå®®ããéšãåºæ¿ãã
ãšãšãã«æçµåšæã調æŽããæçµåšæ調æŽãã«ã¢
ã³ãšé¿åŠå€ãšãå«æãããããšãç¹åŸŽãšããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®åŸ®ç²åç¶è¬å€ã ïŒ åèšè¬å€æåãšããŠãããã²ã¹ãã€ã³åã³ãš
ã¹ããã²ã³ã®äœããäžæ¹ãããã¯äž¡æ¹ãå«æãã
ãããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒ
ã®åŸ®ç²åç¶è¬å€ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95210978A | 1978-10-17 | 1978-10-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5555114A JPS5555114A (en) | 1980-04-22 |
| JPH024576B2 true JPH024576B2 (ja) | 1990-01-29 |
Family
ID=25492596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13251079A Granted JPS5555114A (en) | 1978-10-17 | 1979-10-16 | Fine drug |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPS5555114A (ja) |
| BE (1) | BE879442A (ja) |
| ZA (1) | ZA795549B (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2664906B2 (ja) * | 1987-08-13 | 1997-10-22 | ã¹ããŒã«ã»ãªãµãŒãã»ã¢ã³ãã»ãã€ããããã¡ã³ãã»ã³ãŒãã¬ãŒã·ã§ã³ | æ¹è¯ãããåºä¹³é¡ã®å ç«æ³ |
| FR2619503A1 (fr) * | 1987-08-20 | 1989-02-24 | Hutchinson | Application de microcapsules a la fabrication d'un dispositif prophylactique en materiau elastomere, comme un preservatif ou analogue, et son procede de fabrication |
| US5993856A (en) * | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
-
1979
- 1979-10-16 BE BE0/197671A patent/BE879442A/fr not_active IP Right Cessation
- 1979-10-16 JP JP13251079A patent/JPS5555114A/ja active Granted
- 1979-10-17 ZA ZA00795549A patent/ZA795549B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE879442A (fr) | 1980-04-16 |
| ZA795549B (en) | 1980-11-26 |
| JPS5555114A (en) | 1980-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4756907A (en) | Active/passive immunization of the internal female reproductive organs | |
| US4585651A (en) | Active/passive immunization of the internal female reproductive organs | |
| US4732763A (en) | Active/passive immunization of the internal female reproductive organs | |
| EP0799025B1 (en) | Intravaginal drug delivery devices for the administration of 17beta-oestradiol precursors | |
| Brannon-Peppas | Novel vaginal drug release applications | |
| Benagiano et al. | Contraception today | |
| CA1143289A (en) | Microparticle drug delivery system | |
| ES2337129T3 (es) | Sistema de administracion de medicamento comprendiendo un estrogeno tetrahidroxilado para el uso en la anticoncepcion hormonal. | |
| JPH09131404A (ja) | è å è¬å€æŸåºåšå · | |
| Johansson et al. | New delivery systems in contraception: vaginal rings | |
| PL206010B1 (pl) | Årodek farmaceutyczny do antykoncepcji doraźnej zawierajÄ cy lewonorgestrel i zastosowanie lewonorgestrelu | |
| US20190201418A1 (en) | Treatment of uterine fibroids by intravaginal administration of a low dose of selective progesterone receptor modulator (sprm), anti-progestin, or anti-progestational agent | |
| Lee et al. | Drug delivery: Vaginal route | |
| Beck et al. | Long-acting injectable microsphere formulation for the parenteral administration of levonorgestrel | |
| Beck et al. | Controlled-release delivery systems for hormones: a review of their properties and current therapeutic use | |
| JP2009539759A (ja) | çµå£ïŒçžæ§äœçšéé¿åŠè¬ã«å¯Ÿããæ°ããæäžèšç» | |
| JPH024576B2 (ja) | ||
| EP3784180A1 (en) | Targeted delivery of progestins and estrogens via vaginal ring devices for fertility control and hrt products | |
| CA2517778A1 (en) | Extended transdermal contraceptive regimens | |
| WO2012121778A1 (en) | Treatment of endometriosis by intravaginal administration of selective progesterone receptor modulator (sprm), anti-progestin, or anti-progestational agent | |
| JP2001505589A (ja) | éã®é¿åŠè¬ãšããŠã®ã¢ã³ããã²ã³åã³éé¿åŠã¢ã³ããã²ã³è£å äœ | |
| Ye et al. | Research progress of progesterone preparations: a mini review | |
| Lipp | Novel drug delivery systems for steroidal hormones | |
| Nayak et al. | Novel approaches in vaginal drug delivery systems for local and systemic treatments | |
| US20230404911A1 (en) | Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof |